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Autism spectrum disorder (ASD) is a lifelong, behaviorally defined neurodevelopmental 
condition that is characterized by deficits in social communication, interaction, and 
repetitive behaviors. These behavioral symptoms are associated with atypical brain 
structure, function, and connectivity. The studies that comprise this thesis employed 
structural magnetic resonance imaging (MRI) to address aims in three areas of ASD 
research. First, we examined a novel neuroimaging feature based on signal intensity 
contrast between grey and white matter to quantify atypical microstructure at the grey-
white matter boundary in ASD. We found reduced tissue contrast at the grey-white matter 
boundary among adults with ASD when compared typically developing (TD) controls. 
This result indicates that measures of tissue contrast may serve as an in vivo proxy 
measure of atypical cortical microstructure that has previously been reported in 
histological studies. Second, we trained multivariate pattern recognition models to 
identify individuals with ASD based on measures of cortical morphometry, and examined 
the predictive value of these models in a representative clinical sample. We demonstrated 
that these models have modest ability to distinguish cases from controls in the research 
setting. Only one model that was based on measures of grey-white matter tissue contrast 
identified individuals with and without ASD diagnoses at high overall accuracy (81%) in 
the clinical setting. However, this model did not provide significant accuracies above 
chance in the research setting, and therefore these results should be considered as 
preliminary and suggestive only. Third, we established normative models of phenotypic 
diversity in brain structure associated with biological sex in a sample of TD males and 
females which was subsequently applied to males and females with ASD. Across 
different morphometric features, females with ASD displayed a significant shift towards a 
more male-typical presentation of the brain. Sample probabilities for ASD also increased 
with predicted probabilities for male-typical brain phenotypes across both sexes. These 
studies highlight advances in the field of structural neuroimaging research in areas of 
feature development, clinical translation, and efforts to understand the modulating role of 
biological sex on the prevalence of ASD. Taken together, the work presented within this 
thesis thus constitutes an important step toward establishing translational imaging tools 
for ASD that may one day be applied in the clinical setting.  
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Figure 4.7, Gaussian Process Classification Predictions within the Testing Set using 
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Chapter 1: Introduction  
Autism spectrum disorder (ASD) is a complex neurodevelopmental condition. While 
progress continues to be made in understanding the neurological origins of ASD the 
underlying neurodevelopmental mechanisms and biological markers of the condition 
remain unclear. The broad aim of this thesis is to advance our knowledge of ASD in a 
way that offers real world translational benefits to patients through applications of 
structural brain imaging. More specifically the studies that compose this work focus 
on i) novel ways to measure atypical brain structure in ASD, ii) testing the efficacy of 
measures of brain structure to identify ASD within the clinic, and iii) examining how 
biological sex/gender may modulate risk for the condition. 
 
I begin this introductory chapter by introducing the behavioral ASD phenotype and 
associated diagnostic criteria. The role of biological sex/gender in ASD will then be 
discussed followed by current etiological theories for the condition. I will then discuss 
evidence for atypical brain structure in ASD with a focus on cortical magnetic 
resonance imaging (MRI) findings and review studies that apply particular types of 
‘machine learning’ methods to classify ASD using MRI scans. Lastly, I will outline 
the aims of the three studies, which compose the body of this thesis. 
1.1 Autism Spectrum Disorder  
Autism spectrum disorder (ASD) is a lifelong behaviorally defined 
neurodevelopmental condition characterized by deficits in social interaction and 
communication in addition to the presentation of repetitive and/or restricted behaviors 
(World Health Organization, 2004). The earliest reports of the ASD phenotype are 
attributed to Kanner (1943) and Asperger (1944). In these foundational works Kanner 
and Asperger both detail case studies of children in which typical autistic behaviors 
are observed. By definition ASD is phenotypically heterogeneous, encapsulating a 
spectrum of individuals whose behavioral deficits range from severe impairment (e.g. 
learning disability, non-verbal) to high functioning (e.g. average or above average IQ, 
relatively minor impairments to social communication) (Wing, 1997). In addition to 
the core features, individuals with ASD experience high rates of comorbidity with 
other psychiatric and medical conditions including; social anxiety disorder, attention-
deficit disorder (ADD), attention-deficit hyperactivity disorder (ADHD), oppositional 
defiant disorder (ODD), obsessive-compulsive disorder (OCD), specific phobia, 
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gastrointestinal problems, and epilepsy (Simonoff et al., 2008, Leyfer et al., 2006, 
Amiet et al., 2008) (Figure 1.1).  
 
 
Figure	 1.1,	 The	 Autism	 Spectrum	 (autismspeaks):	 Autism	 Spectrum	 Disorder	 (ASD)	 is	 defined	 by	
core	 symptoms	 (red	 circles).	 However,	 the	 condition	 is	 often	 accompanied	 by	 several	 associated	
neurological	 (dark	 grey	 circles)	 and	 systemic	 (gold	 circles)	 issues.	 Individuals	 with	 ASD	 also	
experience	 increased	 rates	 of	 related	 comorbid	 disorders	 (light	 grey	 circles)	 and	 intellectual	
disability	(dotted	line).	
 
Large population studies carried out around the globe report ASD prevalence to range 
from 0.5% to 2% in the general population. Over the past few decades it has been 
widely speculated that ASD prevalence is increasing. However, empirical evidence 
suggests that these increases can largely be attributed to growing awareness of the 
condition and greater accessibility of diagnostic services (Mazumdar et al., 2013, 
Hansen et al., 2015).  
 
As a behaviorally defined disorder the diagnosis of ASD is reliant on parental 
interviews and/or assessments and observations of patient’s behaviors. A clinical 
ASD diagnosis can be granted by meeting the diagnostic criteria outlined in the 
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Diagnostic and Statistical Manual of Mental Disorders (DSM V) (American 
Psychiatric Association, 2013) or the International Statistical Classification of 
Diseases, 10th Revision (ICD-10) (World Health Organization, 2004), which is the 
standard criteria used within the United Kingdom. To reach a diagnosis for 
“childhood autism” under the ICD-10 atypical or impaired development in at least 
one of the following categories must be evident before the age of three years; i) 
“receptive or expressive language as used in social communication”, ii) “the 
development of selective social attachments or of reciprocal social interactions”, and 
iii) “functional or symbolic play”. Furthermore, individuals must display at least six 
symptoms associated with ASD, with at least one of these falling under each of the 
categories of i) reciprocal social interaction, ii) qualitative abnormalities in 
communication, iii) and restricted, repetitive, and stereotyped patterns of behavior, 
interests, or activities. Lastly, the clinical phenotype must not be attributable to 
another pervasive developmental disorder or condition. Full ICD-10 criteria for 
childhood ASD are provided in Appendix I.  
 
The clinical diagnostic criterion outlined by the ICD-10 encompasses significant 
phenotypic heterogeneity. While there is extensive evidence to suggest that ASD is 
associated with several genetic and neurobiological markers (Ruggeri et al., 2013, 
Ecker and Murphy, 2014) currently there are no reliable diagnostic biomarkers 
validated for clinical use in the condition. Therefore, two ‘gold-standard’ assessment 
tools may be used as additional confirmation of a diagnosis of ASD, namely the 
Autism Diagnostic Interview-Revised (ADI-R) (Lord et al., 1994) and Autism 
Diagnostic Observation Schedule (ADOS) (Lord et al., 2000). Both these measures 
require administration by an experienced clinical interviewer.  
 
The ADI-R is a clinical structured caregiver interview appropriate for children and 
adults with a mental age of 18 or more months. The ADI-R provides a diagnostic 
algorithm for ASD as described by the ICD-10 and focuses on probing behaviors in 
the three main symptom areas of social interaction, communication, and 
repetitive/restricted behaviors. The 93-item interview covers the patient’s full 
developmental history, and usual lasts 1-2 hours. Questions focus on current behavior 
as well as a period between the ages of 4 and 5 years when several behaviors 
associated with ASD are likely to be most evident. Exceptions to this are questions 
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regarding group play (4-10 years), reciprocal friendships (5+ years), and 
circumscribed interests (3+ years) that are appropriate only for particular ages. As 
ASD is a lifelong neurodevelopmental condition, meeting ADI-R criteria for a 
diagnosis is key for establishing a childhood origin of ASD, particularly in diagnoses 
of adults on the spectrum.  
 
In contrast to the ADI-R, the ADOS involves a series of semi-structured assessments 
of communication, social interaction, play and/or imaginative thinking scenarios 
conducted with the patient. Four modules of the ADOS are available to allow for 
administration across the spectrum of impairment observed in ASD. The choice of 
module depends on the individual’s competency in using phrase speech (i.e. non-
echoed, meaningful word combinations that are spontaneous, contain at least three 
words, and sometimes a verb), verbal fluency, and age. As the ADOS is used to assess 
current symptom presentation it is considered a gold standard metric not only for 
diagnosis but also for quantification of current ASD symptoms.  
 
1.2 Sex Differences in Autism Spectrum Disorder 
Of significant note is the preponderance of males with ASD. Based on large-scale 
population studies conducted around the globe currently it is estimated that ASD is 2-
5 times more prevalent in males than females (Lai et al., 2017). This male bias in 
ASD diagnoses may partly be related to differences in the ASD phenotype in females 
who have been shown to display less severe impairments in the repetitive behaviors 
domain and improved skills in coping with social deficits (Szatmari et al., 2012, 
Mandy et al., 2012). Such phenotypic differences between males and females with 
ASD have likely contributed to the historical view of ASD as a ‘male condition’ and 
subsequent under diagnosis of females on the spectrum. 
 
However, as awareness of females with ASD increases population studies continue to 
show a male bias in prevalence, albeit in a lower range of 1.7-2.5 males for every 1 
female with the condition (Kim et al., 2011, Mattila et al., 2011, Idring et al., 2012). 
This indicates that in addition to male biased diagnostic criteria and tools, sex 
differentiated developmental processes may have a modulating effect on the risk for 
ASD. For example, multifactorial liability models propose that liability for ASD is 
	 17	
distributed throughout the population with males and females experiencing different 
liability thresholds for the development of ASD (Werling and Geschwind, 2013) 
(Figure 1.2).  
 
 
Figure	 1.2	 Multifactorial	 Liability	 Model	 of	 Autism	 Spectrum	 Disorder	 (Werling	 and	 Geschwind,	
2013,	 Reich	 et	 al.,	 1975):	 Within	 this	 model	 liability	 for	 ASD	 is	 distributed	 throughout	 the	
population.	However	 female	specific	 ‘protective	 factors’	shift	 liability	away	 from	and	male-specific	
‘risk	factors’	towards	the	minimum	total	liability	needed	for	an	individual	to	develop	ASD.		
 
Multifactorial liability models of ASD propose so-called ‘male risk’ and/or ‘female 
protective’ factors inherent to the sexes that shift liability toward or away the 
minimum liability threshold required for an ASD phenotype to manifest. Genetic 
studies have provided some evidence for a ‘female protective effect’ reporting 
increased genetic load for ASD risk genes among siblings of females with the 
condition than siblings of males with ASD (reviewed in (Werling, 2016)). Beyond 
well-established findings of increased brain size in males (Voigt & Pakkenburg, 
1983), there is growing evidence that sex differences in brain structure exist 
(Jahanshad & Thompson, 2017). Several of these differences have been identified in 
brain regions indicated in ASD (for review see (Ruigrok et al., 2014)) suggesting 
diversity in brain structure associated with sex may modulate ASD risk. However, to 
date the role of sex differences in ASD liability has been largely understudied. Thus, 
	 18	
while there is some evidence that suggests differences between the sexes in both ASD 
clinical and biological phenotypes (Lai et al., 2017, Werling 2016), much work 
remains in understanding the role of sex related risk factors in ASD. 
 
1.3 The Etiology of Autism Spectrum Disorder 
Postmortem evidence indicates that ASD pathology is likely to first manifest during 
the early prenatal stages of development (Bauman and Kemper, 2005). For example, 
reduced numbers of cerebellar Purkinje cells have been observed in both childhood 
and adult ASD cases (Bailey et al., 1998, Duong et al., 1986, Arin et al., 1991). 
During fetal development axons climbing from the inferior olive region of the 
brainstem synapse with Purkinje cell dendrites within a transitory zone beneath the 
Purkinje cells known as the lamina dessicans (Rakic, 1971). Within human fetuses the 
lamina dessicans is no longer present after 28-30 weeks gestation (Rakic and Sidman, 
1970). After this time, due to the strong connective relationship between Purkinje 
cells and olivary neurons, loss or damage to Purkinje cells causes retrograde losses of 
olivary neurons (Norman, 1940, Holmes and Stewart, 1908, Greenfield and Aring, 
1954). Thus, findings of reduced Purkinje cells with persevered olivary neurons 
within ASD cases indicate that the development of ASD pathology occurs at some 
time prior to the resolution of the lamina dessicans at 28-30 weeks gestation.  
 
Consensus thinking recognizes the role of complex interactions between several 
possible genetic, epigenetic, and environmental risk factors in the development and 
manifestation of an ASD phenotype (Sandin et al., 2014). It would be beyond the 
scope of this thesis to discuss all of these factors in detail. Here I will briefly highlight 
a selection of some of the factors known to be associated with increased risk for the 
development of ASD followed by a discussion of current etiological theory. 
 
1.3.1 Environmental Factors 
Various environmental factors have been implicated in ASD. Of these the most 
widely discussed is the idea that vaccinations (particularly the measles, mumps, and 
rubella [MMR] vaccination) cause ASD. Despite the large amount of attention paid to 
this potential relationship there is no empirical evidence that strongly supports this 
claim. In fact a large body of evidence shows no relationship between MMR 
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vaccination and increased risk for ASD (DeStefano et al., 2004, DeStefano et al., 
2013, Smith and Woods, 2010, Klein et al., 2011, Klein et al., 2012, Klein and Diehl, 
2004, Peltola et al., 1998, Taylor et al., 1999, Taylor et al., 2002, Kaye et al., 2001, 
Black et al., 2002, Farrington et al., 2001, Dales et al., 2001, Davis et al., 2001, 
Fombonne and Chakrabarti, 2001, Nejad et al., 2012, Lingam et al., 2003, Smeeth et 
al., 2004, Chen et al., 2004, Honda et al., 2005, Richler et al., 2006, Fombonne et al., 
2006, D’Souza et al., 2006, Uchiyama et al., 2007, Baird et al., 2008, Hornig et al., 
2008). Similar evidence refutes a relationship between thimerosal (a preservative 
historically used in vaccines) and ASD (Hviid et al., 2003, Jacquemont et al., 2006, 
Madsen et al., 2003, Stehr-Green et al., 2003, Andrews et al., 2004, Fombonne et al., 
2006, Thompson et al., 2007, Pichichero et al., 2008, Schechter and Grether, 2008, 
Price et al., 2010, Mrozek-Budzyn et al., 2010). Taken together this evidence 
overwhelmingly suggests that childhood vaccinations do not lead to ASD. 
 
Some environmental factors that have been associated with increased risk for ASD 
include; parental age (Gardener et al., 2009), low birth weight (Schendel and Bhasin, 
2008), multiple births (Croen et al., 2002), maternal infections and illness during 
pregnancy (Sandin et al., 2014, Lichtenstein et al., 2010, Hallmayer et al., 2011a, 
Atladóttir et al., 2010, Lee et al., 2015) and exposure to toxins (Adams et al., 2009). 
However, each of these factors taken in isolation accounts for only a small minority of 
total ASD cases.  
1.3.2 Genetic Factors 
The role of genetics in ASD susceptibility has been highlighted by studies showing an 
increased recurrence risk of up to 20% in families with a child with ASD (Ozonoff et 
al., 2011). Early twin studies showed ASD to be a highly heritable condition with 
concordance rates of 82-92% amongst monozygotic twins compared to 1-10% in 
dizygotic twins (Bailey et al., 1995, Folstein and Rutter, 1977), although a more 
recent study revealed higher concordance rates (>20%) among dizygotic twins 
(Hallmayer et al., 2011b).  
 
While there is a consensus that genetic factors contribute to ASD, extensive 
heterogeneity exists in the specific genetic pathways leading to the development of 
the condition. For example, in ~10% of ASD cases specific genetic conditions (e.g. 
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fragile X syndrome, Rett syndrome, 22q-11 deletion disorder etc.) can be identified 
(Tammimies et al., 2015, Carter and Scherer, 2013). These cases where ASD is a 
secondary diagnosis to a known genetic condition are referred to as ‘syndromic’ 
autism (as opposed to ‘idiopathic’ autism). Within ~10-20% of the ASD population 
chromosomal rearrangements as well as rare and de novo copy-number variants can 
be observed compared to 1-2% in the general population (Jacquemont et al., 2006, 
Sebat et al., 2007). Additionally significant increases in rare and de novo coding 
sequence mutations affecting neuronal genes have been observed in ASD and could 
account for approximately 5-10% of cases (Huguet et al., 2013). Several risk genes 
for ASD have only recently been identified (C Yuen et al., 2017) and add to the over 
850 genes currently implicated in ASD (sfari.org/resources/sfari-gene). These genes 
largely focus around processes that effect neurogenesis and neuronal and synaptic 
homeostasis such as chromatin remodeling, metabolism, mRNA translation, and 
synaptic functioning (Huguet et al., 2013, Packer, 2016). However, much like known 
environment risk factors, each of these specific risk genes in isolation is more than 
likely to confer a small amount of risk for ASD and therefore account for a small 
proportion of cases within the total population.  
1.3.3 Competing Aetiological Theories 
1.3.3.1	The	“Autisms”	
The complex heterogeneity of ASD phenotypes and genotypes has led to competing 
aetiological theories for the condition. On one hand, it has been proposed that ASD is 
actually comprised of several disorders that are individually rare each having its own 
aetiology. This concept of ASD as the “Autisms” helps explain the heterogeneity of 
the condition in terms of both behavioral manifestation and apparent underlying 
casual mechanisms (Geschwind and Levitt, 2007).  
 
1.3.3.2	Unitary	Theory	
Another contrasting view is that ASD is a unitary disorder resulting from a common 
cause. Support for this theory is hindered due to a failure to identify a common causal 
mechanism for ASD, the observed heterogeneity of the condition, and the ever-
increasing list of environmental and genetic risk factors (Boucher, 2011). However, 
recently it has been proposed that ASD may arise from the single pathophysiological 
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mechanism, namely heterochronic division of germinal cells during early 
development leading to subsequent neural migration abnormalities (Casanova, 2014, 
Packer, 2016). Under this unitary theory differences in individual ASD phenotypes 
can be explained by the severity and nature of the initial triggering exogenous factor, 
differences in the neurodevelopmental period which the insult was experienced, and 
the genetic susceptibility of the patient (Casanova, 2007).  
 
1.3.3.3	Atypical	Brain	Connectivity	
A widely accepted hypothesis that accommodates both the “Autisms” and unitary 
aetiological theories attributes ASD behaviors to aberrant brain connectivity 
(Belmonte et al., 2004). Under this view atypical neural connectivity is described in 
two key facets, namely local over connectivity (i.e. within brain regions) and long-
range under connectivity (i.e. between brain regions). Behaviorally, aspects of the 
ASD phenotype such as hyper-arousal, reduced selectivity, and increased 
computational noise have been linked to possible local over connectivity (Belmonte 
and Yurgelun-Todd, 2003). Respectively, under connectivity between distant cortical 
regions may explain deficits in information integration observed in the condition (i.e. 
weak “central coherence”) (Geschwind and Levitt, 2007, Frith, 2004, Just et al., 
2012).  
 
Evidence for atypical connectivity in ASD has been provided by both postmortem and 
in vivo studies. For example, reports of increased neuronal dendritic spine counts in 
ASD (Tang et al., 2014, Hutsler and Zhang, 2010) are suggestive of excessive local 
connectivity in the condition. Structural imaging results also show reduced intrinsic 
wiring costs within cortical grey matter in ASD (Ecker et al., 2013b) that may 
represent a bias towards local over global information processing (Happé and Frith, 
2006).  
 
Poor connectivity between brain regions in ASD is supported by functional magnetic 
resonance imaging (fMRI) findings of lower degrees of synchronization across 
cortical networks responsible for language processing and executive functioning (Just 
et al., 2007, Just et al., 2004). Other studies of under connectivity have focused on 
white matter deficits, particularly in the corpus callosum due to its role in providing 
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long range connections between the brain’s two hemispheres and potential mediation 
of inter-regional cortical synchronization (Uhlhaas et al., 2009). Within ASD, 
diffusion-imaging measures of lower fractional anisotropy and increased radial 
diffusivity in the corpus callosum have been reported (Alexander et al., 2007, Barnea-
Goraly et al., 2004, Shukla et al., 2010). Studies using magnetic transfer imaging have 
also reported atypical myelin development in the structure (Gozzi et al., 2012). These 
results likely reflect underlying changes in myelination, density, and size of axons 
within the tract (Hong et al., 2011) which are likely to adversely affect long range 
connectivity in the ASD brain. Additional ways that atypical cortical structure 
observed in ASD might affect brain connectivity are discussed in section 1.4.2. 
 
1.4 The Structure of the Brain in Autism Spectrum Disorder 
Indications of abnormalities in the neuroanatomical structure of the autistic brain 
arose from some of the first documented observations of the condition, where Kanner 
(1943) noted ASD patients to have significantly larger head size than typically 
developing (TD) individuals. Since these early observations several different research 
techniques have been applied in order to better understand atypical neuroanatomical 
structure in ASD (Ecker and Murphy, 2014). These studies have led to the 




indicated	 in	 social	 (blue),	 communication	 (yellow),	 and	 repetitive	 and	 restricted	 behaviors	 (red)	
domains	are	highlighted.		
This thesis focuses on applications of structural magnetic resonance imaging (MRI) 
methods, namely surface based morphometry (SBM) in order to i) identify novel 
ways to measure atypical brain structure in ASD, ii) test the efficacy of measures of 
brain structure to identify ASD within clinical samples, and iii) examining how 
normative variance in SBM measures associated with biological sex are associated 
with risk for the condition. Accordingly, the focus of this section will be a review of 
in vivo structural neuroimaging studies of the brain in ASD with a focus on SBM 
studies cortical structure. 
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1.4.1 Volumetric Differences in the Autistic Brain 
Consistent with early observations (Kanner, 1943), findings of increased global brain 
size in ASD, particularly among younger patients, remains one of the most widely 
reported and cited neuroanatomical findings in the condition. Some of the first MRI 
studies in ASD showed patients to have significantly larger mid-sagittal brain areas 
apposed to healthy controls (Piven et al., 1992, Piven et al., 1996). Furthermore, it 
was revealed that these increases were not gross in nature, but rather differed between 
the frontal, temporal, parietal, and occipital lobes (Piven et al., 1996, Piven et al., 
1995). In line with these MRI studies, findings using measures of head circumference 
have shown ASD patients to have higher rates of macrocephaly than the general 
population (Davidovitch et al., 1996, Woodhouse et al., 1996, Fidler et al., 2000, 
Miles et al., 2000, Dementieva et al., 2005).  
 
Current evidence shows the ASD brain to have a nonlinear growth trajectory that 
when compared to TD controls experiences periods of precocious growth during the 
first few years of life, which are then followed by a deceleration leading to harder to 
distinguish differences in adolescence and later adulthood (Courchesne et al., 2011a). 
These early increases in brain volumes among young children with ASD appear to 
have an anterior to posterior growth gradient (Courchesne et al., 2004) showing the 
greatest GM differences in the frontal and temporal lobes (Carper et al., 2002). There 
is also some preliminary evidence to suggest that the observed enlargements in brain 
volumes in young children with ASD are driven by disproportional increases in WM 
compared to GM (Courchesne et al., 2001, Hazlett et al., 2005, Ben Bashat et al., 
2007), yet it remains unclear if these WM increases persist into later life (Palmen et 
al., 2005, Hazlett et al., 2006, Barnea-Goraly et al., 2004). Furthermore, in line with 
the heterogeneous nature of the condition, recent evidence suggests that brain 
overgrowth in ASD may be specific to a subset of the ASD population (Libero et al., 
2016). 
 
Several MRI studies have used voxel based morphometry (VBM) methods 
(Ashburner and Friston, 2000) to explore regional differences in brain volumes 
(NicklJockschat et al., 2012). While these studies are largely consistent in reporting 
distributed patterns of volumetric differences in ASD (Ecker et al., 2012, Hyde et al., 
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2010, McAlonan et al., 2005) they often differ on specific brain regions identified as 
well as the directionality of their findings. Some limitations common to all imaging 
studies of ASD contribute to the lack of replicability of VBM findings. These include 
i) heterogeneity of ASD phenotypes and genotypes ii) non linear changes in brain 
structure across developmental stages (Ecker et al., 2014, Courchesne et al., 2011a), 
and iii) small samples often drawn from homogenous subgroups of the autism 
spectrum (e.g. high functioning adult males, ect.). Despite inconsistencies, VBM 
studies have been valuable in linking regional atypical brain volumes to ASD 
symptomatology (Ecker et al., 2012) and highlighting anatomical heterogeneity across 
the spectrum (McAlonan et al., 2009, McAlonan et al., 2008). 
 
1.4.2 Cortical Morphometry of the Autistic Brain 
The pathological processes underlying volumetric abnormalities in ASD remain 
unclear. More recent studies of cortical structure have moved beyond measures of 
volume to investigations of the dimensions and shape (i.e. morphometry) of the 
cortex. Surface based morphometry (SBM) comprises a series of structural MRI 
methods that use tessellated reconstructions of the cortical surface to quantify a 
variety of morphological features relating to brain structure. These studies are 
particularly valuable in ASD for their potential to indicate developmental pathways in 
the condition that are associated with specific features of neural architecture, 
particularly in cortical grey matter (i.e. the cerebral cortex).  
 
The cerebral cortex is organized according to different cellular layers and follows a 
columnar architecture. At their core, cortical minicolumns are comprised of radially 
oriented arrays of pyramidal projection neurons. Inputs and outputs from these 
pyramidal neurons are modulated by GABAergic interneurons that lie within the core 
and periphery of mini-columns allowing for area and task specific information 
processing (Kawaguchi and Kubota, 1997, Sanders et al., 2012, DeFelipe, 1997). 
Several types of progenitor cells and related molecular and genetic signaling 





the	 main	 types	 of	 progenitor	 cells	 involved	 in	 the	 development	 of	 the	 cerebral	 cortex.	 Arrows	
indicate	 lineage	 relationships	 between	 cell	 types.	 During	 cortical	 expansion	most	 neuroepithelial	
cells	 divide	 symmetrically	 to	 amplify	 their	 numbers	 and	 generate	 apical	 radial	 glial	 cells	 (aRGC).	
During	neurogenesis	 these	aRGCs	divide	 into	neuron	 cells	directly	or	 via	 intermediate	progenitor	
cells	 (IPC).	 IPCs	 divide	 solely	 into	 neurons,	 allowing	 for	 rapid	 proliferation	 of	 cortical	 neurons.	
Neurons	 migrate	 along	 scaffolding	 provided	 by	 aRGC	 fibers	 to	 form	 cortical	 units	 known	 as	





According to the radial unit hypothesis (Rakic, 1995) the quantity of neuron cells 
within each individual minicolumn is a main determinant of cortical thickness (CT) 
while cortical surface area (SA) is closely related to the number of minicolumns (i.e. 
radial units). It is now widely believed that intermediate progenitor cells (IPC) are a 
principle modulator of CT (Pontious et al., 2007). These cells divide solely into 
neurons (Miyata et al., 2004, Noctor et al., 2004) and are responsible for the vast 
proliferation of neuronal cells within the cortical sheet. These neuronal cells migrate 
from the ventricular zone along scaffolding fibers provided by apical radial glial cells 
(aRGC) leading to the formation of cortical minicolumns. Increases in SA have thus 
been linked to the length of symmetrical division cycles for neuroepithelial progenitor 
cells responsible for the expansion of aRGC (Pontious et al., 2007).  
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There is a large body of postmortem evidence that suggests disruptions to the above 
developmental processes in ASD. For example, individuals with ASD have been 
shown to have increased minicolumn density in frontal and temporal regions 
(Casanova et al., 2006, Casanova et al., 2002). Shorter distances between these 
cellular units could introduce hyper connectivity within local brain regions resulting 
in signal delays and metabolic inefficiencies in connecting disparate brain regions, 
potentially leading to ASD behaviors (Belmonte et al., 2004, Horwitz et al., 1988, Just 
et al., 2004, Casanova et al., 2003). As could be predicted by this increased column 
density, greater numbers of prefrontal neuron cells in young children with ASD have 
also been reported (Courchesne et al., 2011b). The presence of supernumerary 
neurons within white matter bellow the cortical sheet and poor definition of the grey-
white matter boundary in ASD (Avino and Hutsler, 2010, Bailey et al., 1998) also 
point towards disruptions to neuronal migratory processes in the condition. Together 
these findings provide evidence for atypical cell division of neuronal progenitors and 
the subsequent migration of neuron cells to their target locations within the 
developing cortex in ASD (Casanova, 2014). Furthermore, it can be predicted that 
disruptions to these foundational developmental processes have lasting impact on the 
structural morphology of the cortex.  
 
Several researchers have applied SBM methods to quantify differences in cortical 
features associated with diagnoses of ASD. To date CT is the most reported in the 
condition, although results have been mixed. Some studies have reported decreased 
CT in ASD (Hadjikhani et al., 2006, Scheel et al., 2011, Ekman et al., 1975), others 
no differences (Hazlett et al., 2011, Hutsler et al., 2007), and others still CT increases 
in the condition (Hardan et al., 2006). These inconsistent findings can likely be 
largely attributed to nonlinear changes in CT across developmental stages (Ecker et 
al., 2014). For example, within a large multi-centre study including individuals from 
6-35 years of age, Khundrakpam et al. (2017) reported CT increases in young children 
with ASD were greatest around the age of ten. Due to accelerated cortical thinning 
these differences decreased into adolescence and adulthood such that little to no 
difference was observed at 35 years (Khundrakpam, 2017). These findings are 
supported by both histological (Hutsler et al., 2007) and longitudinal MRI findings 
(Hardan et al., 2009) reporting accelerated reductions in CT with age in ASD 
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compared to TD controls, which is consistent with the observed developmental 
trajectory of volume measures within the condition (Courchesne et al., 2011a). 
 
However, imaging studies of both CT and SA have found closer links between SA 
expansion and observed early life volumetric increases in ASD (Hazlett et al., 2011, 
Hazlett et al., 2017). One recent study reported that accelerated SA expansion 
between 6 and 12 months predicted increased brain volumes at 24 months (Hazlett et 
al., 2017). Furthermore, Ecker et al. (2013a) found that 56% of a distributed pattern of 
volumetric differences in adults with ASD was driven by underlying changes in SA 
measures compared to 8% for CT, with only 5% shared between the two. The small 
degree of overlap between CT and SA findings highlights the need for studies that 
differentiate volumetric measures into these component measures. Furthermore, 
findings by Ecker et al. (2013a) and Hazlett et al. (2017) of a greater contribution of 
SA expansion to volumetric differences advance theories that processes governing SA 
expansion are a possible aetiological agent in ASD. However, it should be noted that 
Ecker at al. (2013a) was only able to highlight these underlying relationships through 
liberal statistical thresholding (uncorrected p<0.05). When corrected for multiple 
comparisons no significant differences in SA measures were observed, which is 
consistent with a few other reports (Wallace et al., 2013, Raznahan et al., 2009). 
Furthermore, another study has reported reduced cortical SA within the left fusiform 
and bilateral middle temporal cortices in ASD (Libero et al., 2014), which were also 
reported by Ecker et al. (2013a). 
 
In addition to SA and CT, individuals with ASD have been shown to have atypical 
morphology associated with cortical folding. For example, an early MRI study 
conducted by Piven et al. (1990) found significantly more instances of cortical 
malformations relating to folding among ASD cases including; i) polymicrogyria 
(excessive small folding), ii) schizencephaly (clefts lined within the cortical grey 
matter) and iii) macrogyria (increased gyri size) (Piven et al., 1990). Other early MRI 
studies have reported atypical placement of major sulci within the frontal and 
temporal lobes (Levitt et al., 2003) and increased gyrification in frontal brain regions 
(Hardan et al., 2004) in children and adolescences with ASD.  
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More recent studies using MRI based gyrification index (GI) measures (Zilles et al., 
1988, Su et al., 2013) to quantify cortical folding have reported decreased GI in ASD 
(Bos et al., 2015). Recently SBM studies using a vertex wise implementation of the 
GI, namely the local gyrification index (lGI) (Schaer et al., 2008), have reported 
decreased gyrification in inferior fronto-parietal and posterior medial cortical regions 
(Schaer et al., 2013) as well as the supramarginal gyrus (Libero et al., 2014). Others 
have reported regional patterns of increased lGI in ASD (Wallace et al., 2013, Ecker 
et al., 2016). Some studies have linked differences in gyrification in ASD to 
underlying changes in WM diffusion measures (Ecker et al., 2016, Bos et al., 2015, 
Schaer et al., 2013) which provides preliminary evidence for what are likely to be 
complex interrelations between white matter and grey matter development which may 
contribute to atypical intra- and inter-cortical connectivity in the condition. 
 
In addition to gyrification other studies have sought to quantify various aspects of 
sulcal morphometry and the relationship between these features and ASD 
symptomology. For example, increased sulcal depths within ASD participants have 
been reported and found to correlate with ADOS social interaction scores (Auzias et 
al., 2014, Nordahl et al., 2007). Furthermore, abnormalities in sulcal length and SA 
have been noted in ASD (Shokouhi et al., 2012, Nordahl et al., 2007). Some of these 
abnormal findings appear to be larger within younger children on the spectrum 
suggesting a “normalization” of these measures into adolescence and adulthood 
similar to the trajectory observed in volumetric measures (Nordahl et al., 2007).  
 
The mechanisms underlying and relating to cortical folding are numerous and 
complex (Fernández et al., 2016). Folding has been related to differential growth rates 
between outer and inner cortical layers (Richman et al., 1975, Kriegstein et al., 2006), 
proliferation of bRGCs (NonakaKinoshita et al., 2013, Reillo et al., 2011), axonal 
tension (Van Essen, 1997), and the neural complexity of a particular brain region (i.e. 
numbers of neurons, synaptic density, and/or dendritic arborization) (Welker, 1990). 
Studies of cortical folding are further complicated by large variances in the degree of 
gyrification across individuals in the normative population (Bartley et al., 1997). This 
is supported by findings of discordant folding patterns between monozygotic twins 
pairs where only one twin had a diagnosis of ASD (Kates et al., 2009). This is in 
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contrast to volumetric measures of the brain, which have been found to be highly 
concordant between twins (White et al., 2002). These twin studies and the lack of 
correlation between cortical folding and measures that are largely genetically 
determined such as total brain volume and body weight and length (Zilles et al., 1988, 
Rogers et al., 2010) indicate that measures of gyrification may be more sensitive to 
environmental factors than measures that are largely genetically determined (Zilles et 
al., 2013). 
 
The identification of group differences in SBM measures such as CT, SA, sulcal 
depth and lGI are valuable for their ability to highlight different developmental 
pathways that may contribute to ASD pathology. In doing so these studies can narrow 
focus on or introduce novel etiological targets for the condition. For example, IPCs 
and the proliferation of neuron cells (Pontious et al., 2007), dendritic arborization 
(Huttenlocher, 1990), and myelination (Sowell et al., 2004) have all been attributed to 
changes in CT while the length of symmetrical division cycles for aRGC progenitor 
cells appear to correspond with proliferation of cortical minicolumns and SA 
(Pontious et al., 2007). Parsing out the deterministic mechanisms responsible for 
cortical folding abnormalities in ASD may be more difficult due to the potentially 
large contribution of environmental factors in the development of folding patterns 
(Zilles et al., 2013). However, current evidence suggests that cortical folding relates 
to bRGCs and differential expansion rates of the outer and inner cortical surface 
(Richman et al., 1975, Kriegstein et al., 2006, NonakaKinoshita et al., 2013, Reillo 
et al., 2011) thus, cortical folding may be related to processes governing the 
expansion of cortical SA. 
 
To date, results reported by SBM studies in ASD have been somewhat inconsistent. In 
many cases this can be attributed to the complex developmental trajectories that 
morphometric cortical features undergo (Ecker et al., 2014). This is further 
complicated by relatively small samples sizes and the large degree of phenotypic 
heterogeneity among the ASD population. Several of these studies are likely 
underpowered due to such small samples as one power study estimated that 50 
subjects per group are needed to detect a 0.25mm differences in CT between two 
groups (Pardoe et al., 2013). To date, most SBM studies fall below this number of 
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participants. Thus, work remains to be done in confirming differences in 
morphological phenotypes across the spectrum as well as untangling the numerous 
genetic and molecular pathways that regulate their development. Additionally, some 
atypical structural features that have been identified in postmortem studies of ASD 
brains, such as integrity of the grey-white matter boundary, have yet to be 
investigated in vivo.  
 
1.5 Beyond Group Differences: Pattern Recognition in Autism Spectrum 
Disorder 
Until recently, the majority of neuroimaging research in psychiatric conditions has 
employed mass-univariate statistical methods based the general linear model (GLM) 
(Friston et al., 1994). The GLM is a valuable tool for identifying mean differences 
between groups. However, these models are not suited to make predictions for 
individual cases based on multivariate patterns within the data (i.e. predictions 
regarding group membership or clinical outcome), and thus offer limited translational 
value to clinical applications. Alternatively, a class of ‘machine learning’ methods 
known as multivariate pattern classification (MVPC) can be applied to generate 
image-based predictive models that have the potential to be utilized as diagnostic 
tools and intervention outcome measures.  
 
Within ‘machine learning’ an algorithm is said to learn from experience E with 
respect to some class of tasks T and performance measure P. Learning is said to occur 
when performance in task T improves with experience E as measured by performance 
P (Mitchell, 1997). Within this context classification poses a supervised learning 
problem in which examples from a training set of empirical data are mapped to a 
known output such as a class label. In brief MVPC algorithms differentiate cases 
between two or more classes in the following way. During a ‘training phase’ the 
model is initially trained using well-defined samples or data subsets (e.g. ASD and 
controls) to establish a mathematical criterion or decision function that best 
distinguishes between the groups. During the ‘testing phase’ the decision function is 
applied to predict the label of an unseen data point. Often MVPC model performance 
is validated within the same sample using cross-validation methods. However, gold 
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standard assessment of a predictive model’s accuracy in distinguishing between 
classes is reliant on validation using completely independent testing data.  
 
A variety of MVPC algorithms including the Support Vector Machine (SVM) 
(Vapnik, 1995) and Gaussian Process Classification (GPC) (Rasmussen and Williams, 
2006) as well as numerous others (e.g. linear discriminant classifiers, logistic 
regression, decision trees, random forest, etc.) have been successfully trained using 
various structural and functional imaging data modalities to distinguish individuals 
diagnosed with various neuropsychiatric disorders from healthy controls and/or to 
predict treatment outcome or subjective states (Wolfers et al., 2015, Arbabshirani et 
al., 2016). These findings provide proof of concept for the development of safe, in 
vivo diagnostic and prognostic tools and biomarkers for a variety of psychiatric 
conditions. However, until these models undergo stringent validation on independent 
data sets that accurately reflect the clinical environment their potential translational 
value remains to be realized.  
 
1.5.1 Multivariate Pattern Classification in Autism Spectrum Disorder 
In a behaviorally defined disorder such as ASD the development of biologically based 
diagnostic and prognostic markers would represent an invaluable tool to clinicians. 
Furthermore, identification of a biomarker for ASD could provide pathways towards 
better understanding the casual mechanisms for the condition. While several genetic 
and neurobiological markers have been proposed, there are currently no reliable 
biomarkers that have been validated for clinical use in ASD (Ruggeri et al., 2013, 
Ecker and Murphy, 2014). Classification of ASD using MRI features is one pathway 
towards the development of a biomarker for the condition. To date several MVPC 
methods have been applied to a variety of neuroimaging data and psychiatric 
conditions (Wolfers et al., 2015, Arbabshirani et al., 2016). The results of MVPC 




Table 1: Multivariate Pattern Classification Studies of Autism Spectrum Disorder  
Modality Features Classifier Number of Subjects 
Biological 
Gender ASD age 
Overall 
Accuracy Reference 
sMRI Cortical Thickness  and Volumetric ROIs  SVM TDC=325, ASD=325 
Male and 
Female 17.8±7.4 59% Sabuncu et al. (2014) 
sMRI Cortical Thickness and Volumetric ROIs Multi-kernel SVM TDC=59, ASD=58 
Male and 
Female 10.8±4.0 96.3% Wee et al. (2014) 
sMRI VBM GM and WM volume maps SVM TDC=24, ASD=24 
Male and 
Female 13.2±0.6 92% Uddin et al. (2011) 
sMRI Cortical Thickness  Logistic model trees TDC=16, ASD=22 
Male and 
Female 9.2±2.1 87% Jiao et al (2010) 
sMRI VBM and SBM based ROI SVM TDC=20, ASD=21 Male 4.1±0.8 74% Gori et al. (2015) 
sMRI GM volume map SVM TDC=40, ASD=52 
Male and 
Female 14.4±1.7 80-85% Segovia et al. (2014) 
sMRI VBM GM and WM volume maps SVM TDC=22, ASD=22 Male 27.0±7.0 77% Ecker et al.(2010) 
sMRI 
Cortical Thickness, Surface Area, Sulcal 
depth, Curvature, Metric Distortion SVM TDC=20, ASD=20 Male 33.0±11.0 85% Ecker et al.(2010) 
sMRI VBM GM volume maps SVM TDC=38, ASD=30 Female 4.4±1.5 80% Calderoni et al. (2012) 
sMRI Volumetric measures 
Discriminant function 
analysis TDC=15, ASD=52 Male 3.4±0.7 
92.3-
95.8% Akshoomoff et al. (2004) 
sMRI 
Age, Sex, Volume, Surface Area, and 
Cortical Thickness ROIs 
Three-Stage Deep 
Learning Network HRN = 145, ASD=34 
Male and 
Female 
6 and 12 
months 94% Hazlett et al. (2017) 
sMRI Extra-axial Cerebrospinal Fluid Decision Tree HRN = 174, ASD= 47 
Male and 
Female 6 months 66-72% Shen et al. (2017) 
dMRI FA and MD based ROI SVM TDC=30, ASD=45 
Male and 
Female 10.5±2.5 80% Ingalhalikar er al. (2011) 
fMRI  
Activation of selected voxels during 
social interaction task Gaussian naïve Bayes TDC=17, ASD=17 
Male and 
Female 25.6±6.7 97% Just et al. (2014) 
fMRI 
Language and theory of mind task based 
functional connectivity Logistic regression TDC=14, ASD=13 Male 21.4±3.9 96% Murdaugh et al. (2012) 
fMRI 
Activation of selected voxels during 
social interaction task SVM TDC=14, ASD=15 
Male and 
Female 28.6±1.8 92.3% Chanel et al. (2016) 
rsfMRI rsfMRI ICA components Logistic regression TDC=20, ASD=20 
Male and 





morphometry	dMRI	=	diffusion	MRI,	 FA	=	 fractional	 anisotropy,	MD	=	mean	diffusivity,	 fMRI	=	 functional	MRI,	 rsfMRI	=	 resting	 state	 functional	MRI,	MRS	=	
magnetic	resonance	spectroscopy,	SVM	=	support	vector	machine,	TDC	=	typically	developing	controls.		
Table 1: Multivariate Pattern Classification Studies of Autism Spectrum Disorder (continued) 
Modality Features Classifier Number of Subjects 
Biological 
Gender ASD age 
Overall 
Accuracy Reference 
rsfMRI ROI based functional connectivity Random forest TDC=126, ASD=126 
Male and 
Female 14.8±1.6 79% Chen et al. (2015) 
rsfMRI  ROI based functional connectivity 
Logistic regression 
and SVM TDC=59, ASD=59 Male 17.66±2.7 77% Plitt et al (2015) 
rsfMRI ROI based functional connectivity 
Probabilistic neural 
network TDC=328, ASD=312 
Male and 
Female 13.2±3.1 90% Iidaka (2015) 
rsfMRI ROI based functional connectivity Thresholding TDC=40,  ASD=40 Male 22.7±7.4 79% Anderson et al. (2011) 
fMRI and 
dMRI Functional connectivity and FA values SVM TDC=15, ASD=15 not reported 21.1±0.9 95.9% Deshpande et al. (2013) 
sMRI, dMRI 
and MRS 
Cortical Thickness, FA and 
neurochemical concentration Decision tree TDC=18, ASD=19 
Male and 
Female 27.1±1.3 91.9% Libero et al. (2015) 
sMRI and 
rsfMRI 
rsfMRI, Cortical Thickness and Volume 
based graph theory metrics Random forest TDC=153, ASD=127 
Male and 
Female 13.5±6.0 70% Zhou et al. (2014) 
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The use of MVPC models based on brain imaging data in ASD was first reported by 
Akshoomoff et al. (2004). Using a discriminate function and pre-selected volumetric 
regions of interest (ROIs) from young children and TD controls a high classification 
accuracy (95%) was achieved. However, this rate was not based on a thorough cross 
validation but on reclassification of the entire sample and is therefore inherently 
circular. More recent studies employing SVM algorithms to classify ASD cases using 
volumetric GM and WM ROIs have reported overall classification accuracies ranging 
from 65-90% for different brain regions (Uddin et al., 2011, Segovia et al., 2014). In 
addition to these volumetric ROI studies whole brain VBM data has been shown to 
classify adult male ASD cases with a cross-validated accuracy of 81% (Ecker et al., 
2010b). 
 
When comparing structural MRI measures used to predict ASD diagnoses, models 
using SBM features such as CT have been generally shown to outperform those using 
volumetric features (Jiao et al., 2010). A study by Ecker et al. (2010a) investigating 
the predictive value of five SBM measures (CT, SA, sulcal depth, mean radial 
curvature, and metric distortion) used a SVM to classify adult males with ASD and 
matched controls. These studies revealed that CT measures in the left hemisphere 
produced the highest cross-validated prediction accuracy (90%). Other SVM studies 
using a variety of regional cortical volume and thickness features have also 
successfully classified ASD cases from controls albeit at lower discriminative 
accuracies (59-74%) (Gori et al., 2015, Sabuncu and Konukoglu, 2014). In addition to 
being able to classify cases from controls, measures of interregional CT covariance 
have also been shown to be predictive of current symptom measures among ASD 
patients (Sato et al., 2013).  
 
In addition to volumetric and morphometric features both diffusion and functional 
MRI (fMRI) features have been used to classify ASD. To date, two studies 
investigating the predictive power of mean diffusivity and fractional anisotropy 
diffusion measures in ASD using a SVM have reported classification accuracies in 
line with the best performing SBM based models (~80%-89%) (Ingalhalikar et al., 
2010, Ingalhalikar et al., 2011). Activation patterns during theory-of-mind and 
language fMRI tasks as well as resting state brain activity (rsMRI) have been used to 
classify individuals with ASD from controls with varying reported accuracies 
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(Deshpande et al., 2013, Murdaugh et al., 2012, Uddin et al., 2013, Anderson et al., 
2011, Wee et al., 2016, Iidaka, 2015, Plitt et al., 2015). 
 
Recent studies have begun to implement methodologies that combine multiple 
neuroimaging modalities into single predictive models. Decision tree algorithms have 
been used to combine selections of diffusion, morphometric, and MR spectroscopy 
features as inputs for ASD classification. Under this framework one model was able 
to achieve a 91.9% classification accuracy between ASD cases and controls. These 
findings also highlighted the potential utility for MVPC methods to aid in 
understanding ASD risk factors and etiology. For example, if certain favorable values 
among features within the decision tree were present an individual could be protected 
from an ASD classification, even in the presence of other unfavorable metrics (Libero 
et al., 2015). Other studies have combined diffusion MRI with auditory task based 
magnetoencephalography (MEG) data, resulting in the successful classification of 
ASD cases from TD controls at a CV accuracy of 83.3% (Ingalhalikar et al., 2014). 
Another recent study employed multi-kernel learning SVM methods to investigate the 
predictive capacity of combined vertex based surface measures (i.e. CT, grey and 
white matter surface volumes), subcortical volumetric ROI data, and interregional 
correlation measures. Using this methodology the researchers reported a CV accuracy 
over 96% (Wee et al., 2014).  
 
Two recent studies have shown promise in predicting ASD diagnoses at 24 months 
based on MRI measures at 6 month, an age before diagnosis is possible using current 
gold standard criterion. The first of these studies used a three stage deep learning 
algorithm employing age and sex data along with volumetric, CT, and SA based 
ROIs. This study was able to classify high-risk infants who received an ASD 
diagnosis at 24 months from those who did not at accuracies of 95%. The second 
study utilized measures of extra-axial spinal fluid at 6 months to classify high-risk 
infants with ASD at 24 months (Shen et al., 2017). This study achieved a cross-
validated classification accuracy of 69% within the training sample, as well as an 
accuracy of 72% when applied to an independent data set.  
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1.5.2 Towards Translational Tools 
While the above studies provide proof of concept for imaging based diagnostic 
models in ASD, translating these tools from the research to ‘real-world’ clinical 
settings raises additional hurdles. To date no studies have tested classification models 
for ASD trained in the research environment on independent samples that are 
representative of the broader clinical population. This is important because several 
differences exist between research and clinical ASD cohorts. For example, individuals 
with ASD recruited within the research environment will generally be excluded if 
they have comorbid conditions, are taking certain medications, or fail to reach cut-
offs on behavioral metrics such as the autism diagnostic interview (ADI) and/or 
autism diagnostic observation schedule (ADOS). As such, many individuals who 
would qualify for a clinical ASD diagnosis would not meet inclusion criteria for 
research. Thus, inherent differences in the clinical phenotype between individuals in 
research and clinical ASD samples are likely. Accordingly, if imaging-based 
prediction models are to be adopted in the clinical setting, a critical first step will be 
the testing of models trained in the research setting on separate (i.e. independent) 
samples that are representative of the clinical population.  
1.6 The Current Thesis: Aims and Hypotheses  
This chapter has outlined several advances that have been made in structural MRI 
studies of ASD. Broadly, this thesis aims to advance this literature in a way that offers 
the potential for real world benefits to patients and stakeholders. With regards to this 
aim this thesis includes fours studies that focus on i) the development of novel 
informative imaging features for ASD, ii) evaluating the efficacy of structural 
neuroimaging measures to predict ASD diagnosis within clinical samples, and iii) 
investigating the role of normative sex differentiation in brain structure on the 
probability for ASD. 
 
1.6.1 Study 1: In Vivo Evidence of Reduced Integrity of the Grey-White 
Matter Boundary in Autism Spectrum Disorder 
Reduced integrity of the grey-white matter boundary has previously been reported by 
postmortem studies in individuals with ASD (Avino and Hutsler, 2010). However, 
prior to this work no in vivo studies have examined this atypical structure in the 
condition. Here, we used structural MRI to examine differences in tissue contrast 
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between grey and white matter at the boundary between these tissue types as well as 
across different cortical layers. As individuals with ASD are thought to have a less 
well defined transition between grey and white matter we hypothesized that 
individuals with ASD would show significant reductions in measures of tissue 
contrast taken at and around the grey-white matter boundary.  
 
1.6.2 Study 2: Clinical Validation of Pattern Classification Models for 
Autism Spectrum Disorder 
Several proof of concept studies have shown promise in developing diagnostic 
imaging tools for ASD using multivariate pattern classification (MVPC) and SBM 
measures (see section 1.4.1 for review). However, to date these models have not been 
tested on samples that are representative of the clinical setting. Thus, this study first 
aimed to train SVM and GPC models to separate adult ASD patients from TD 
controls acquired in the research setting using a variety of morphological cortical 
features, including features that have not previously been reported (i.e. lGI and tissue 
contrast). The second and primary aim of this study was to then test the ability of 
classifiers trained within the research setting to make diagnostic predictions within an 
independent clinical sample consisting of individuals who had been referred for a 
specialist ASD diagnostic assessment. 
 
1.6.3 Study 3 and 4: Association Between the Probability of Autism 
Spectrum Disorder and Normative Sex-Related Phenotypic 
Diversity in Brain Structure 
Male preponderance is an understudied hallmark of ASD and other 
neurodevelopmental and psychiatric conditions. While some degree of male 
preponderance is likely attributable to sex differences in the ASD phenotype and male 
biased diagnostic tools, it has been purposed that variance in biology attributable to 
normative sex differences may modulate ASD risk (Werling, 2016). Thus, these 
studies sought to understand how biological sex/gender is associated with probability 
for ASD. The aims of these studies were three-fold; i) provide a phenotypic 
characterization of normative sex related diversity in brain structure, ii) determine 
how diversity in sex based neurophenotypes is associated with probability for ASD, 
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and iii) estimate how much ASD prevalence in the general population might vary as a 











































































































Chapter 2: Magnetic Resonance Imaging and Analysis 
Methods 
 
I will begin this chapter by discussing the basic physical principles underlying 
Magnetic Resonance Imaging (MRI) (Lauterbur, 1973, Mansfield, 1977), as reviewed 
by Sprawls (1987). Details of basic MRI scanning sequences and those used to 
acquire structural images of the brain within this thesis will then be covered. Last, I 
will discuss methods for the analysis of MRI images including surfaced based (SBM) 
morphometry, the general linear model (GLM), and multivariate pattern classification 
(MVPC) (i.e. “machine learning”) techniques.  
 
2.1 Principles of Nuclear Magnetic Resonance 
Magnetic resonance imaging (MRI) is made possible by interactions of atomic nuclei 
and radio waves that occur when objects are placed within a magnetic field. Under 
these conditions atoms take on a resonant characteristic whereby electromagnetic 
radiation is absorbed and rereleased at a particular frequency. This phenomena is 
generally known as Nuclear Magnetic Resonance (NMR) (Bloch, 1946, Purcell et al., 
1946). The resonance frequency of materials (e.g. animal tissue) in a magnetic field 
typically occurs within the radio frequency (RF, ~3 kHz to 300GHz) of the 
electromagnetic spectrum. This allows for NMR RF signal to be captured using a 
radio-receiver coil and later displayed as images (i.e. MRI).  
 
The magnetic properties and potential NMR RF signal of individual nuclei are reliant 
on their neutron-proton composition. Nuclei with an odd number of protons and 
neutrons act in themselves as small magnets with a magnetic dipole. Nuclei with this 
magnetic property have increased NMR susceptibility. Of all nucleotides, hydrogen-1 
(1H) is unique in that it occurs in relatively high concentrations in most human tissues 
and is highly sensitive to NMR. These properties make 1H key to the efficacy of MRI 
in humans.  
 
In order to produce NMR a magnetic nucleus (e.g. 1H) must be placed within a static 
magnetic field denoted as !". MRI scanners use superconducting electrical coils to 
generate highly homogeneous magnetic fields in the range of 1.5 to 7 tesla (T), with 
3T magnets being the standard at time of writing for clinical research. During 
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scanning, a patient lies within this electrical coil (i.e. bore) so that the magnetic field 
runs parallel to the individual’s body.   
  
During MRI scanning protocols NMR RF signal is captured across segmented three-
dimensional volumetric units known as voxels. The RF signal intensity at each 
individual voxel is determined by characteristics of the tissue, namely 1) the 
concentration of chemical elements, 2) quantity of magnetic isotopes, and 3) the 
NMR sensitivity of the specific nuclides within the tissue. Signal from a voxel is 
emitted as the result of stimulation by short RF energy pulses applied during the 
imaging cycle. The NMR process involves a series of interactions involving the 
magnetic nuclei, the magnetic field, and these RF pulses and signals.  
 
When not undergoing strong magnetic forces magnetic nuclei (e.g. 1H) will be 
randomly oriented throughout the body. However, when placed within a magnetic 
field (!") these nuclei experience torque to bring their magnetic dipole in alignment 
with the direction of the field. Due to agitation caused by thermal energy only a small 
percentage of the total nuclei (on the order of a few out of a million) come into 
alignment during MRI scanning of the human body. The number of magnetic nuclei 
that align with the magnetic field is a function of the field strength of the MRI 
scanner.  
 
Once aligned with !"  nuclei are not static but precess (an oscillation similar to a 
spinning top wobbling) along the axis of the magnetic field (Figure 2.1 A). The 
precession of an atomic nucleus in a magnetic field occurs at a specific frequency 
making it susceptible to RF energy applied at the same frequency. This frequency is 
known as the resonant frequency, or Larmor frequency ($), 
(2.1) $ = &	( !" 
 
Where !" = the applied magnetic field strength, and & = the gyromagnetic ratio or 
resonance quality of the nuclei ).  When RF energy is applied at the Larmor frequency 
the absorption of this energy by the nuclei will cause it to flip its alignment away 
from the direction of !", resulting in a state of increased energy or excitation (Figure 
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2.1 B). In the excited state the nuclei experiences increasing force from !" to align 
with the main direction of the magnetic field. A nuclei in an excited state returns to 
alignment with !" by transferring energy to surrounding material in a process known 




Parallel	 vertical	 arrows	 indicate	 the	 direction	 of	 the	 main	 magnetic	 field	 (*+).	 A.)	 When	 placed	
inside	*+	a	 magnetic	 nuclei	 (red	 sphere)	 will	 align	*+	and	 precess	 (i.e.	 spin)	 around	 its	 magnetic	





Relaxation rates of individual nuclei are influenced by the structure surrounding them 
and differ across various tissues. These differing relaxation rates are a key component 
in producing the contrasts seen in MR images of the brain.  
 
2.2 Magnetic Characteristics of Tissue 
When tissue is placed within a magnetic field the nuclei of that tissue will align in 
parallel to the main direction of the field. Although only a small proportion of nuclei 
will come into alignment a net magnetization vector (M0) is formed within the tissue 
voxel. An equilibrium state known as longitudinal magnetization occurs when M0 is 
aligned with !". If nuclei are perturbed out of this state via application of RF energy 
they will seek to regain longitudinal magnetization through relaxation. This relaxation 
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occurs at an exponential rate. As a convention, the time needed for recovery of 63% 
of the maximum longitudinal magnetization energy is known as T1 (Figure 2.2). The 
angle at which a nuclei aligns itself in relation to !"	as a result of an RF pulse is know 
as the flip angle (FA) or α. Application of a 90 degree RF pulse (i.e. FA=90) results in 
longitudinal magnetization being reduced to zero. This unstable condition is known as 
saturation and will lead to longitudinal magnetization being recovered exponentially 
through relaxation.  
 
 
Figure	 2.2,	 Longitudinal	 Magnetization	 (Sprawls,	 1987):	 The	 rate	 at	 which	 longitudinal	




When RF energy is applied to nuclei they will enter an excited state in which M0 is 
not aligned with !", this is known as transverse magnetization. This excited state is 
unstable and quickly decays via a relaxation process known as free induction decay 
(FID). The time required for 63% of the initial transverse magnetization to dissipate 
after excitation is known as T2 (Figure 2.3). Due to its instability, transverse 
magnetization decay occurs much quicker that T1 relaxation. Therefore, T2 values are 









Differing T1 and T2 relaxation times across tissues are what lead to contrast within 
MRI images. In basic MRI sequences contrast is controlled via two factors Time of 
Repetition (TR) and Time to Echo (TE). TR is the length of one image acquisition 
cycle as well as the interval between the start of longitudinal relaxation and signal 
measurement. On the other hand, TE is the time interval between the beginning of 
transverse relaxation and signal measurement.  
 
In addition to T1 and T2 the concentration of protons within a particular voxel (i.e. 
proton density) is a third factor that can influence MRI image contrast. Proton density 
contrast is relatively weak compared to T1 contrast early in longitudinal relaxation. 
Therefore, proton density images are best captured with long TR times (e.g. three or 
more T1 intervals) when longitudinal magnetization approaches its maximum value.  
 
Images designed to maximize T1 contrast are known as T1 weighted, and are a 
commonly used form of structural MRI. T1 weighted images can be formed by 
application of an RF pulse at the Larmor frequency resulting in excitation. From this 
state different tissues will recover longitudinal magnetization at different rates. The 
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physical composition of the voxel, the molecular size of the nuclei within that voxel, 
and the strength of the magnetic field combine to determine these T1 values. For 
example, fluids (such as cerebral spinal fluid [CSF]) have relatively long T1 values 






producing	 contrast	 in	 the	pixel	 (i.e.	 voxel)	 intensities.	 Images	 that	maximize	T1	 contrast	 are	often	
used	in	structural	MRI	research.	
 
Setting a TR to capture RF signal at a point where T1 contrast is significantly different 
across tissues, prior to a voxel fully regaining longitudinal magnetization, results in a 
T1 weighted image (Figure 2.4). Within these images tissue with a short T1 (e.g. white 
matter [WM]) will appear brighter than those with longer T1 values (e.g. grey matter 
[GM]). The choice of flip angle (α) is an important factor in producing T1 weighted 
images. For each value of T1 the optimum flip angle for acquiring signal is known as 
the Ernst angle and is calculated as, 
(2.2) α-./01 = 2.3340	(	67898:	)	
 
Additional MRI contrasts can be produced by utilizing differences in transverse 
magnetization relaxation rates across tissues. These images are known as T2 weighted, 
	 62	
with contrast being dependent on the TE selected by the user. Furthermore, inherent 
inhomogeneity of !" within each individual voxel will cause dephasing of transverse 
magnetization at a rate much faster than would be indicated by the intrinsic T2 
characteristics of the tissue. The actual transverse relaxation time taking into account 
this dephasing effect is known as T2*, which is always less than T2. Contrast resulting 
from T2* is a key property in the imaging of changes in blood oxygenation, known as 
functional MRI (fMRI). 
2.3 Magnetic Resonance Images 
Magnetic resonance images are three-dimensional volumes comprised of individual 
units (i.e. voxels) that encode signal intensity resulting from emitted NMR RF energy. 
MRI protocols can be described in two main phases, namely signal acquisition and 
image reconstruction. During signal acquisition a particular sequence of RF pulses 
and magnetic field gradients (i.e. controlled inhomogenities in !" ) are applied. 
Differences between MRI methods are determined by these pulse sequences. Here I 
will describe some characteristics of basic MRI pulse sequences followed by spatial 
encoding of MR signal and MR image reconstruction.  
2.3.1 Basic Magnetic Resonance Imaging Pulse Sequences  
The process of MRI signal acquisition can be separated into longitudinal and 
transverse magnetization phases. Transition between these two phases is produced by 
the application of an RF pulse characterized by α, causing excitation. The transverse 
magnetization phase concludes with the echo event, which is produced by either the 
application of RF pulses (e.g. spin-echo, inversion recovery methods) or field gradient 
(i.e. gradient-echo methods) and results in the emission of RF signal.  
 
Basic spin-echo pulse sequences are characterized by the application of a 90-degree 
excitation pulse followed by a 180-degree pulse that produces the echo event and RF 
signal (Figure 2.5). Spin-echo imaging methods can be used to produce T1, T2, or 
proton density weighted images by manipulating TR and TE. For example, T1 
weighted images require a short TR and TE, proton density images a long TR and 




Figure	 2.5,	 Development	 of	 Image	 Contrast	 in	 a	 Spin-Echo	 Sequence	 (Sprawls,	 1987):	 Here	 the	
imaging	 cycle	 begins	 with	 the	 application	 of	 a	 90	 degree	 RF	 pulse.	 Tissue	 A	 and	 B	 then	 recover	




transverse	 relaxation	 tissue	 A	 and	 B	 have	 different	magnetization	 as	 a	 result	 of	 differing	T1	 and	
proton	 density	 characteristics.	 However,	 due	 to	 different	 T2	 properties	 between	 the	 tissues	 as	
transverse	relaxation	progresses	T2	contrast	develops.	At	a	time	selected	by	the	user	an	echo	event	
is	 triggered	 by	 the	 application	 of	 a	 180	 degree	 RF	 pulse	 resulting	 in	 the	 emission	 of	 RF	 signal.	
Adjusting	TR	and	TE	times	will	result	in	different	weighted	images	(i.e.	T1,	T2,	proton	density).	
 
In addition to the 90-degree excitation pulse and 180-degree RF pulse used in basic 
spin-echo techniques, inversion recovery (IR) MRI protocols employ an additional 
180-degree pulse at the beginning of the scanning sequence (Figure 2.6). The time 
between the initial 180-degree and 90-degree pulses is known as the inversion time 
(TI). There are two main benefits in the application of IR sequences that result from 
the longer longitudinal magnetization relaxation rates they provide. 1) IR sequences 
with a short TI can be used to nullify signal from tissues that have a relatively short T1 
(e.g. fat). 2) IR sequences with long TI give more time for T1 contrast to develop. This 
makes IR MRI particularly well suited to produce T1 weighted images commonly 
used in structural MRI analyses. The images used throughout this thesis are a form of 




Figure	 2.6,	 Development	 of	 T1	 Contrast	 in	 an	 Inversion	 Recovery	 Sequence	 (Sprawls,	 1987):	






Differing from spin-echo techniques, gradient-echo sequences are characterized by 
their application of a RF excitation pulse with a relatively small α (i.e. >90-degrees). 
Flip angles of less than 90-degrees cause less longitudinal magnetization to be 
converted into transverse magnetization. Therefore, over a short TR more longitudinal 
magnetization and less transverse magnetization signal intensity can be captured, with 
net signal intensity being the combination of the two. The relatively short TR needed 
to acquire these images gives the benefit of reduced total acquisition time.  
Gradient-echo sequences employ a single RF energy pulse per imaging cycle in order 
to not affect the longitudinal magnetization. However, when TR is set to be only 
slightly longer than TE time it is possible for an echo event to be produced by each 
excitation pulse. Thus, transverse magnetization in a gradient-echo sequence has two 
components; free induction decay (T2*) and the spin-echo event resulting from the 
previous RF pulse (T2). By not applying a second RF pulse during each imaging cycle 




In order to produce T1 weighted images with a gradient-echo sequence the spin-echo 
component resulting from carryover transverse magnetization across imaging cycles 
is spoiled (i.e. eliminated) by altering the phase relationship of the RF excitation 
pulses or through the application of dephasing gradient pulses. Popular gradient-echo 
sequences used for structural MRI include gradient recalled acquisition in steady state 
(GRASS) and spoiled gradient recalled-echo (SGPR). 
 
2.3.2 Spatial Encoding and Image Reconstruction of Magnetic 
Resonance Signal  
During the acquisition phase NMR RF signal from a particular voxel is encoded with 
distinct frequency and phase properties in order to identify the spatial origin of the 
signal during image reconstruction. Frequency and phase encoding are achieved 
through the application of magnetic field gradients (i.e. controlled changes in field 
strength) at specific times along three orthogonal directions (i.e. x, y, and z) within a 
MRI scanner.  
 
A gradient applied along the direction of !"  can be used to selectively image a 
particular slice of tissue. Tissue across the gradient will experience minor differences 
in field strength and therefore have slightly different resonant frequencies. Thus, over 
the course of a single TR an excitation pulse can be applied at different frequencies to 
selectively excite and capture signal from each slice of tissue. A phase encoding 
gradient can then be applied in order to alter the precession rate in voxels across this 
gradient. The phase encoding gradient is only applied for a short amount of time 
leaving each voxel in a different phase (i.e. position) of precession (i.e. phase 
encoded). In order to produce a distinct phase relationship for each voxel in an image 
phase encoding must be repeated n times, where n = the number of voxels. Last, the 
application of a frequency encoding gradient at the time of the echo event when signal 
is captured is used to isolate signal from a particular column of voxels within a slice. 
The frequency encoding gradient causes magnetic nuclei to precess at different rates 
and therefore produce different signal frequencies across the gradient.  
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Combined effects of slice, phase, and frequency encoding gradients cause individual 
voxels to have unique differences in phase in one direction and frequency in another. 
Thus, while signal from all voxels within an MRI image are captured as a single 
composite signal and stored in what is known as K space a Fourier transformation can 
be used to isolate the spatial location of a particular voxel’s signal from the composite 
signal. The spatial sorting of the composite RF signal captured by the MRI scanner in 
K space into an image via Fourier transformation comprises the most commonly 
applied form of MR image reconstruction.  
 
Up to this point of the chapter I have described elements common to several standard 
structural MRI methods. I will now describe the quantitative relaxometry MRI 
technique used to produce synthetic T1 weighted IR images described in this thesis, 
namely Driven Equilibrium Single Pulse Observation of T1 and T2 (DESPOT1 and 
DESPOT2) (Deoni et al., 2005, Deoni et al., 2003). 
2.4 Driven Equilibrium Single Pulse Observation of T1 and T2 Mapping 
Traditional structural MRI methods result in images that display qualitative 
differences in T1 or T2 contrast between tissue types. Alternatively intrinsic T1 and T2 
relaxation times can be determined and mapped in a voxel-wise manner (Breger et al., 
1986, Johnson et al., 1987, Kjær et al., 1987). MR sequences that quantify relaxation 
times are commonly referred to as relaxometry or quantitative mapping methods. 
These techniques offer several benefits over traditional structural MRI. For example, 
contrast within a synthetic T1 weighted image produced using quantitative mapping is 
determined solely by differences in T1 properties of the tissue being imaged with 
extraneous effects such as T2 and proton density removed. Furthermore, relaxometry 
methods are less sensitive to hardware-related effects (i.e. RF coil sensitivity, 
electronic amplifier gains etc.) that may vary across scanners or even scanning 
sessions. This makes these methods ideal for comparison of images acquired across 
different scanning sites or for longitudinal acquisitions (Deoni et al., 2008).  
 
The structural MRI data described within this thesis was acquired through a 
DESPOT1 sequence (Deoni et al., 2005, Deoni et al., 2003). In order to determine T1 
at each voxel, DESPOT1 acquires a series of SPGR images with a range of flip angles 
and constant TR. Signal from an SPGR can be calculated given, 
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(2.3) ;<=>?90)/α = ;<=>?912/α 	@	-7: +	BC(1 − -7:)	 
 
Where ;<=>?9  is the SPGR signal intensity given flip angle α , BC  is a factor 
proportional to the equilibrum longitudinal magnetization, and -7: = 6FG − 898H . By 
plotting =IJKLMN(OP  versus =IJKLMQROP  T1 can be calculated from the slope of the resulting line,  
(2.4) S: = 	− STln 0W4G6  
 
The results of DESPOT1 mapping were then used to produce synthetic IR T1 
weighted images using the following steps. 1.) Signal from non-brain tissue was 
removed using the brain extraction tool (BET) (Smith, 2002), 2.) intra-session images 
were non-linearly co-registered using an automated three-dimensional multi-scale 
approach based on normalized cross-correlation (Collins et al., 1994). 3.) T1 maps 
were then calculated in the ImageJ (http://rsb.info.nih.gov/ij/) analysis package using 
plug-ins freely available at www.fmrib.ox.ac.uk/~sdeoni/ (Deoni et al., 2008). This 
process resulted in the formation of high-resolution structural T1 weighted “synthetic” 
IR images, with 1x1x1mm resolution, a 256x256x176 matrix, TR=1800ms, TI=50ms, 
FA=20’’, and FOV=5cm. 
2.5 Cortical Surface Reconstruction using Freesurfer Software 
In neuroimaging, morphometry methods comprise techniques that investigate the size 
and shape of the brain and its structures. Surface Based Morphometry (SBM) relies 
on reconstructions of the cortical surface from MRI images to quantify different 
structural aspects of brain anatomy. Here, I describe the pre-processing steps used to 
generate SBM models of the brain and morphometric features calculated using these 
models. 
 
Volumetric segmentation and reconstruction of tessellated models of the cortical 
surface from the T1 weighted structural MRI images described above was performed 
using the Freesurfer image analysis suite, which is documented and freely available 
for download online (http://surfer.nmr.mgh.harvard.edu/). The technical details of the 
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Freesurfer segmentation and reconstruction procedures are described in prior 
publications (Dale et al., 1999, Dale and Sereno, 1993, Fischl and Dale, 2000, Fischl 
et al., 2001, Fischl et al., 2002, Fischl et al., 2004a, Fischl et al., 1999a, Fischl et al., 
1999b, Fischl et al., 2004b, Han et al., 2006, Jovicich et al., 2006, Ségonne et al., 
2004, Reuter et al., 2010, Reuter et al., 2012) and have been demonstrated to show 
good test-retest reliability across scanner manufacturers and field strengths (Reuter et 
al., 2012, Han et al., 2006).  
 
Briefly, the Freesurfer processing pipeline includes motion correction and averaging 
(Reuter et al., 2010) of one or more volumetric T1 weighted MR images, removal of 
non-brain tissue using a hybrid watershed/surface deformation procedure (Ségonne et 
al., 2004), automated Talairach transformation, segmentation of the subcortical white 
matter and deep grey matter volumetric structures (including hippocampus, amygdala, 
caudate, putamen, ventricles) (Fischl et al., 2004a, Fischl et al., 2002), intensity 
normalization (Sled et al., 1998), tessellation of the grey-white matter boundary, 
automated topology correction (Ségonne et al., 2007, Fischl et al., 2001), and surface 
deformation following intensity gradients to optimally place the grey-white and grey-
cerebrospinal fluid borders at the location where the greatest shift in intensity defines 
the transition to the other tissue class (Dale et al., 1999, Dale and Sereno, 1993, Fischl 
and Dale, 2000). Once the cortical models are complete, a number of deformable 
procedures can be performed for further data processing and analysis including 
surface inflation (Fischl et al., 1999a), registration to a spherical atlas which is based 
on individual cortical folding patterns to match cortical geometry across subjects 
(Fischl et al., 1999b), and parcellation of the cerebral cortex into units with respect to 
gyral and sulcal structure (Desikan et al., 2006, Fischl et al., 2004b). 
 
Within this thesis tessellated models of the cortical surface were used to calculate a 
variety of morphometric measures of brain anatomy for later analysis. 1) Cortical 
thickness (CT) is calculated as the closest distance from the grey-white boundary to 
the grey-CSF boundary at each vertex on the tessellated surface (Fischl and Dale, 
2000). CT maps are created using spatial intensity gradients across tissue classes and 
are therefore not simply reliant on absolute signal intensity. These maps are not 
restricted to the voxel resolution of the original data thus are capable of detecting 
submillimeter differences between groups. Freesurfer procedures for the measurement 
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of CT have been validated against histological analysis (Rosas et al., 2002) and 
manual measurements (Salat et al., 2004, Kuperberg et al., 2003). 2) Measures of 
cortical pial and white matter surface areas (SA) are derived using a pycnophylactic 
interpolation method described in detail by Winkler et al. (2012). 3) Measures of 
cortical volume are calculated as the product of pial SA and CT. This Freesurfer 
approach to calculating volume differs from traditional imaging measures of brain 
volumes such as VBM in which volume is calculated by counting voxels inclusive to 
segmentations of GM, WM, and CSF as determined by signal intensity. 
 
Additional measures of the cortical surface may be used to describe the topography of 
the convolutions in the cortical sheet. These include 4) average convexity or 
concavity (SULC), which indicates the depth/height at each vertex above the average 
cortical surface, measuring sulcal depth or gyral height respectively. SULC captures 
large-scale cortical geometric features and is insensitive to noise in the form of small 
wrinkles in a surface and can be used to quantify the primary folding pattern of the 
cortical surface. 5) Mean radial curvature (CURV) quantifies folding of the small 
secondary and tertiary folds in the cortical surface that would not be captured by 
measures of large-scale geometric features (i.e. SULC measures). 6) Metric distortion 
(i.e. Jacobian) is calculated as the degree of displacement and convolution of the 
cortical surface relative to the average template. Unlike SULC and CURV, which 
measure specific aspects of cortical geometric features (e.g. folding patterns of sulci 
and gyri), metric distortion estimates the overall degree of folding including 
geometric distortions otherwise not specified. 7) Further estimates of the degree of 
cortical gyrification can be achieved through calculation of the local gyrification 
index (lGI). Methods used to calculate lGI have been previously validated by Schaer 
et al. (2008). In brief, lGI measures quantify of the proportion of pial surface 
invaginated within sulcal folds via a ratio of the outer to pial surface area within 
spherical regions of interest placed across each vertex on the cortical surface. 
 
It is critical to note that all the above measures are susceptible artefacts caused by 
movement during image acquisition. The effects of these artefacts, such as motion 
induced blurring, are not trivial and are particularly relevant when studying conditions 
associated with atypical movement such as ASD. To date, outside of eliminating 
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motion during acquisition adequate solutions for dealing with these artefacts are 
limited (Reuter et al. 2015). 
2.6 Mass Univariate Magnetic Resonance Imaging Analyses  
Several different methodologies can be employed for analysis of MRI data. Often the 
goal of these methods is the identification and mapping of differences related to a 
variable(s) of interest across each individual voxel or vertex. These techniques are 
referred to as mass univariate methods as they involve repeating univariate statistical 
tests across each voxel or vertex. Applications of multiple regression, more 
specifically the general linear model (GLM) (Friston et al., 1994a) are among the 
most popular methods for this type of MRI investigation. Within this section I will 
introduce the GLM as well as discuss ways of dealing with statistical limitations that 
result from calculating significance in mass univariate analyses (i.e. the multiple 
comparison problem).  
2.6.1 The General Linear Model 
The GLM builds upon simple linear regression methods for identifying associations 
between predictor variables and responses. An example first order regression model 
with two predictor variables can be given as,  
(2.5) X( = 	Y" +	Y:@(: +	YZ@(Z +	[( 
 
Where Yi is the response given predictor variables Xi1 and Xi2 in the ith sample. The 
model parameters in this example are Y", Y:, and YZ, with an error term [( . The Y 
parameters may be referred to as partial regression coefficients as they reflect the 
partial effect of the corresponding predictor variable when all other predictor 
variables within the model are held constant. Assuming -{[(} = 0, the regression 
function (i.e. regression surface or response surface) for this model example is,  
(2.6) -{X} = 	Y" +	Y:@: +	YZ@Z 
 
Points on this regression surface correspond to the mean response Y given any 
combination of X1 and X2.  
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A GLM may be given using the same formula as the example above. However, the 
variables (e.g. X1, X2) need not only represent qualitative predictor variables. For 
quantitative (i.e. categorical) variables binary indicator variables are used to identify 
different classes (e.g. male=0, female=1; patient=0, control=1, etc.). Furthermore, if 
the effects of predictor variables are not additive (i.e. the effect of one variable is 
dependent on the level of another) an interaction term can be included.  
(2.7) X( = 	Y" +	Y:@(: +	YZ@(Z + Y^@(:	@(Z +	[( 
 
Here Y^ represents the interaction effect between variables X1 and X2 on Y. The GLM 
may also take into account non-linear effects through the use of polynomials. For 
example, quadratic or cubic relationships can be investigated using Xi2 or Xi3 
respectively,  
(2.8) X( = 	Y" +	Y:@(: +	YZ@(:Z + Y^@(Z 
 
The GLM encompasses most types of statistical inference including the t-test and 
analysis of variance (ANOVA). An ANOVA can be given in GLM terms when a 
predictor variable (i.e. independent variable) is categorical. Within an ANOVA this 
categorical variable is known as a factor and the categories as levels of the factor. 
Under GLM framework these levels are coded using dummy variables. For example, 
an ANOVA with a factor comprised of three levels can be given as, 
(2.9) X( = 	Y" +	Y:@(: + YZ@(Z 
 
Here, X1 codes for the first level such that X1=1 if the observation is within this level 
or X1=0 if not. The same applies for the second level, which is coded for by X2. The 
third level’s mean is predicted by Y" and therefore is not coded.  
 
Using the framework outlined above the GLM is able to take into account any number 
and combination of linear, non-linear, and/or interactions terms within a single model. 
Thus, the GLM offers flexibility to test for a variety of different effects. Some 
examples include; group comparisons, effects of age or gender, relationships between 
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age or gender and diagnosis, and correlations with specific behavioral measures or 
symptom metrics.  
 
In order to perform a particular statistical test using a GLM, data included in the 
model is first defined as a design matrix where each column corresponds to a 
qualitative variable or indicator variable. For example, for the following GLM, 
(2.10) X( = 	Y" +	Y:_`6(: +	YZa6/b6.(Z + Y^_`6(:	a6/b6.(Z +	[( 
 
a corresponding design matrix would be given as, 
 Y" Age Male Female Age * Male Age * Female 1	 23 0 1 0 23 1	 24 0 1 0 24 1	 29 1 0 29 0 1	 30 1 0 30 0 …	 … … … … … 
Significance of an effect at each voxel or vertex i can be tested using a t test (Student, 
1908) of linear contrasts between conditions. Using the above design matrix as an 
example, to test for a difference between genders we would use the contrast c = [0 1 -
1 0 0], for a main effect of age c = [1 0 0 0 0], or an interaction effect between age 
and gender c = [ 0 0 0 1 -1]. The significance of each of these effects at data point i is 
then tested with,  
(2.11) 1( = 3. d(/[( 
 
Where bi is the corresponding parameter estimates at data point i. This t statistic and 
the number of degrees of freedom can then be used to calculate the probability of 
significance (i.e. p value) for an effect at a particular vertex or voxel. Spatial mapping 
of ti is referred to as statistical parametric mapping (SPM) and reflects data points that 
are statistically related to the user defined contrast (Friston et al., 1994a, Worsley et 
al., 1996).  
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Within this thesis, GLM analyses of morphometric brain features were conducted 
using the SurfStat toolbox (http://www.math.mcgill.ca/keith/surfstat/) implemented in 
MATLAB (R2014a; MathWorks). 
2.6.2 Correcting for Multiple Comparisons 
Mass univariate analyses of brain imaging data apply a large number of independent 
statistical tests. Therefore, probability theory dictates that a large degree of false 
positives will be detected in these analyses (type I errors). For example, a p-value of 
0.05 denotes a 5% type I error rate. Setting a significance threshold of p=<0.05 one 
could expect up to 5 false positives for every 100 tests. In vertex wise analyses it is 
common to employ over 200,000 independent statistical tests, which leads to an 
unacceptably high rate of expected type I errors (approximately 10,000). Addressing 
this so called multiple comparison problem is critical for valid interpretation of voxel 
or vertex-wise neuroimaging analyses (Bennett, 2010).  
 
Due to the spatial relationships inherent between voxels or vertices within 
neuroimaging data (caused by biology, signal acquisition, image smoothing etc.) 
multiple comparison corrections are often performed on clusters of spatially 
contiguous significant statistical values. This allows for using a type I error rate that 
determines the likelihood that a cluster or ‘family’ of spatially contiguous significant 
statistics has arisen by chance, i.e. a Family-Wise Error (FWE) rate. A traditional 
method of testing against the null hypothesis using FWE is Bonferroni correction. 
This correction adjusts the tolerable type I error rate (α) for an individual test in order 
to account for the total number of independent tests (n). such that the corrected p 
value for an individual test is equal to α/n.  However, Bonferronni correction is overly 
conservative (i.e. prone to type II errors) for most neuroimaging analyses. This is due 
to fewer independent observations (i.e. functional or structurally related brain regions) 
existing compared to the actual number of voxels or vertices. Furthermore, estimation 
of the number of independent observations in a particular image is hindered by spatial 
smoothing (i.e. averaging or ‘blurring’ of the image) which is commonly 
implemented to increase the signal to noise ratio in image analyses. Therefore, 
methods have been developed to correct for the multiple comparison problem while 
taking into account the smooth spatial covariance that results from SPM, one example 
being random field theory (RFT) (Friston et al., 1994b). 
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In brief, given a significant cluster of statistical values (i.e. t scores) RFT calculates 
the height threshold for a smoothed statistical map that gives the desired FWE rate 
(e.g. p<0.05). The height threshold is considered to be the individual statistical value 
necessary within a cluster in order to reject the null hypothesis that all points in the 
cluster originated from the null distribution. The process of RFT can be explained by 
three key stages being; 1) the calculation of the number of resolution elements in an 
image, these elements being analogous to independent observations (Worsley et al., 
1992). 2) The calculation of the Euler characteristic (EC), the EC being equivalent to 
the number of significantly contiguous clusters of vertices or voxels post thresholding 
(Worsley, 1994). 3) The application of RFT and subsequent thresholding of 
significant clusters that do not meet the selected FWE rate. This method of correction 
has been applied to several types of neuroimaging data including non-isotropic 
images such as cortical surface based reconstructions (Worsley et al., 1999).  
2.7 Multivariate Pattern Classification 
Mass univariate analyses offer a powerful tool for investigating differences between 
groups. However, these methods are not suited to make predictions for individual 
cases regarding group membership or clinical outcome measures, and thus offer 
limited translational and clinical value. Alternatively, ‘machine learning’ based 
pattern recognition methods can be used to generate image-based predictive models 
that have the potential to be utilized as diagnostic tools and intervention outcome 
measures. 
 
Within ‘machine learning’ an algorithm is said to learn from experience E with 
respect to some class of tasks T and performance measure P. Learning is said to occur 
when performance in task T improves with experience E as measured by performance 
P (Mitchell, 1997). For example, a diagnostic model using pattern recognition could 
seek to learn to make diagnostic predictions (T), based on MRI scans of the brains of 
patients and controls (E), with performance (P) being measured by diagnostic 
accuracy. In supervised learning problems examples from a training set of empirical 
data are mapped to an output. These outputs may be either a continuous variable, in 
the case of a regression problem, or class label, in the case of a classification problem. 
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Within this section I will first describe two multivariate pattern classification (MVPC) 
algorithms implemented in this thesis, namely the Support Vector Machine (SVM) 
(Vapnik, 1995, Boser et al., 1992) and Gaussian Process Classifier (GPC) (Rasmussen 
and Williams, 2006, Marquand et al., 2010). While several MVPC algorithms are 
available, the SVM and GPC where chosen for this thesis as they have previously 
been shown to have good performance in neuroimaging problems owing to their 
ability to handle large dimensionality data in a computationally efficient manner when 
compared to other options (e.g. neural networks, random forests). I will then discuss 
potential ways for improving MVPC model performance through feature selection 
and parameter tuning, in addition to model validation and visualization methods. 
2.7.1 The Support Vector Machine 
The support vector machine (SVM) is among the most popular algorithms used for 
MVPC of neuroimaging data. SVMs benefit in their ability to train non-linear 
predictive models in high dimensional spaces that offer good generalization 
performance and computational efficiency. The SVM attempts to solve a supervised 
learning problem by optimally placing a boundary known as a hyper-plane (in cases 
with more than three dimensions) to separate given examples xi according to class 
labels f ∈ {+1,−1} (e.g. patients = +1 controls = -1). The SVM is referred to as a 
maximum margin classifier as it optimizes the placement of the hyper-plane such that 
the margin between the two classes is maximized (Figure 2.7). I will now briefly 
describe the SVM. More detailed coverage has been provided by Bishop (2007) and 




Figure	2.7,	The	 Support	Vector	Machine	 (Garcia,	 2016):	A)	 In	 this	2D	example	 the	 Support	Vector	
Machine	 (SVM)	 seeks	 to	 separate	 two	 classes	 (red	 squares	 and	 blue	 circles)	 using	 a	 hyper-plane	




The decision function for a linear SVM can be given as, 
(2.12) i j = k8j + d 
 
where w is a vector that is orthogonal to the hyper-plane that separates the two 
classes, x is an example data point and b is a constant offset term that controls the 
distance of the hyper-plane from the origin. For data points that lie on the hyper-plane 
f(x)=0. For other examples the sign of f(x) denotes the class f ∈ {+1,−1} of x such 
that xy+1 = f(x) > 0 and xy-1 = f(x) < 0. The SVM aims to maximize the margin 
between classes by finding, given perfect classification, the vector w with the smallest 
magnitude ||w||. This vector details the contribution of each data point in a feature set 
(e.g. vertex or voxel) towards classification and is known as the weight vector.  
 
Within training samples one or more samples may prevent clean separation between 
classes. This may be due to noise in the inputs (uncertainty in the location of samples) 
and/or outputs (mislabeling an sample) that cause a sample to be plotted on the 
“wrong side “of the decision plane. In cases where linear separation between cases is 
not possible the introduction of ‘slack variables’ can be used to ‘soften’ the margin. 
This can be achieved by introducing a trade off between maximizing the margin and 
the total number of acceptable miss classifications. This trade off introduces an 
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optimization problem, which can be viewed from either the primal or dual perspective 
(Boyd and Vandenberghe, 2004). The soft margin SVM in primal form can be given 
as, 
 (2.13) 						minimizep,q :		12 t Z + u v(wxy:  
 
  																																																	subject	to:		 f( tÅÇ( + d ≥ 1 − v(,v( ≥ 0, ) = 1,… , /	  
 
where we seek to minimize the term 	:Z t Z, which is achieved when the margin that 
separates between classes is maximized. In a hard margin scenario we impose the 
constraint f( tÅÇ( + d ≥ 1, such that the decision function output i Ç( = tÅÇ( +d multiplied by the label 1( (either +1 or -1) must be greater or equal to one, thus no 
sample can be closer than the margin marked by the f Ç = 1  and f Ç = −1 
contour lines. In 2.13 v( are non-negative slack variables, which loosen the constraint 
on the minimal distance (i.e. 1) that an example may fall from the margin, such that a 
distance of 1-v( is now acceptable. The trade-off between maximizing the margin and 
minimizing the number of classifications that violate the margin are controlled by a 
regularization parameter C. As C increases, priority is placed on reducing the number 
of misclassifications over maximizing the margin such that when C=∞ the SVM will 
have zero tolerance for these violations (i.e. ‘hard margin’ SVM).  
 
The optimization problem (2.12) can be solved it its duel form using the following 
Lagrange function,  
(2.14) Ü k, d, á, à, â = 12 ä Z + u v(O(y: − ã( f( k8j( + d − 1 + v(O(y: − å(v(O(y:  
 
where ã( ≥ 0, å( ≥ 0 for ) = 1,… , / are the Lagrange multipliers (the Lagrangian Ü 
is a scalar) that the function seeks to minimize with respect to maximizing w and b. 
The solution of (2.14) requires the resulting partial derivatives,  
(2.15) 
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ççkÜ k, d, á, à, â = 0, 
 ççd Ü k, d, á, à, â = 0. 
 
The first of these partial derivatives allows for the optimal weight vector to be 
expressed as a weighted combination of all examples x, with the class label yi 
determining the sign and the ã(’s determining the magnitude of the contribution of 
each example to the weight vector, such that 
(2.16) k = ã(f(j(O(y:  
 
The second partial derivative in (2.15) leads to the condition that the sum of the 
signed weights ã( and yi equal zero, such that 
(2.17) ã(f( = 0.O(y:  
 
Expressions (2.16) and (2.17) allow us to remove the primal variables w and b from 
the optimization problem outlined in (2.13), giving the dual form of (2.13) as 
(2.18) 																																		é2F)é)è6ê:	ë ã = ã(O(y: − 12 ã(ãíf(fíF(8FíOíy:O(y:  
 
		 				0ìdî631	14:	0 ≤ ã( ≤ u, ) = 1,… , /ã(O(y: f( = 0.  
 
The optimization problem (2.13) in dual form (2.18) now seeks to maximize an 
objective function of the support vector weights ã(. For these optimization problems 
the constraint that à( f(i j( − 1 + v( = 0 must be satisfied for each example xi by 
one of two ways. 1) When for a given example xi, ã( = 0 it is given that f(i Ç( ≥1 − v( and therefore xi is well classified. 2) When ã( > 0 it is given that f(i Ç( =
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1 − v( , therefore xi is either on the margin (f(i Ç( = 1, slack variable v( = 0) or 
within the margin (f(i Ç( = 1 − v( , slack variable v(  > 0) (Bishop, 2007). This 
highlights the sparse nature of SVM in that all the information relevant to the decision 
problem (i.e. w) is carried by the relatively few examples that fall on or within the 
margin (i.e. the support vectors).  
 
As training examples xi and xj only enter into the optimization problem (2.18) through 
their inner product it is possible to replace this inner product with a kernel function 
(K). This process, commonly referred to as ‘kernel trick’, allows mapping into a 
potentially higher dimensionality space in which a non–linear decision plane can be 
derived. The simplest form of K is a dot product between the input data and a test 
case, 
(2.19) ó j(, j = 	j(	 ∙ j 
 
For cases in which classes cannot be separated with a linear decision boundary (even 
with the aid of a soft margin) the resulting linear kernel K provides a feature space 
with higher dimensionality in which non-linear separation of the classes may be 
achievable. It is also possible to transform data from native space using non-linear 
kernels (e.g. the radial basis function). However, in cases where the number of 
features is larger than the number of observations non-linear kernels typically offer 
marginal if any improvement in classification accuracy (Hsu et al., 2003) and are thus 
not typically applied in neuroimaging problems.  
2.7.2 Gaussian Process Classifiers 
Pattern classification methods such as the SVM offer power tools to make binary 
predictions according to class labels. However, in the clinical setting having an 
estimate of confidence in a prediction is often just as important as the prediction itself. 
Probability theory offers a coherent way to manage uncertainty and can be introduced 
into prediction modeling though the application of Bayesian statistics. Bayes’ theorem 
describes the conditional probability of an event given another event is true, 
(2.20) G _ ! = G ! _ G(_)G(!)  
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here A and B are events, p(B)≠0. p(A) and p(B) are the probabilities of event A and B 
independent of each other. p(A|B) and p(B|A) represent conditional probabilities, i.e. 
the probability of A given B is true and vice versa (Kendall et al., 1968). Within 
MVPC the Gaussian process classifier (GPC) (Rasmussen and Williams, 2006) is one 
Bayesian method that can make probabilistic estimates as to class ownership. This 
ability gives GPC methods potential clinical benefits over the SVM, which is not a 
probabilistic prediction device.  
 
According to Rasmussen and Williams (2006), a Gaussian process (GP) can be 
viewed as an extension of a Gaussian probability distribution. Where as a Gaussian 
probability distribution describes finite dimensional variables, the GP extends the 
probability distribution to functions, which are infinite dimensional, under the 
constraint that any finite number of variables have a multivariate Gaussian 
distribution. Therefore a GP describes a distribution over functions that can be used 
for Bayesian inference. There are two complementary and equivalent views of GP 
inference, the ‘weight space’ and ‘function space’ views.  I will first introduce the 
function space view of GP inference and later discuss the weight space view in 
context of classification. In the view of GP function space a GP prior is placed over a 
set of interpolating functions f(x) the posterior distribution is computed according to 
Bayes rule. This distribution is then used to explain the relationship between 




Rasmussen	 and	 Williams,	 2006):	 A)	 Sample	 functions	 (dotted	 lines)	 selected	 from	 a	 zero-mean	
Gaussian	 process	 prior	 distribution	 are	 shown.	 B)	 After	 the	 introduction	 of	 training	 cases	 (black	
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When GP inference is posed as a binary classification problem we wish to predict the 
class probability for a test example x*, p(y = 1|x*,xi…n) given a set of training examples 
xi…n with associated class labels f ∈ {+1,−1}. In order to restrict the GP prior over 
functions f(x) (Figure 2.9 A) to give a binary output (i.e. f ∈ {+1,−1} ), f is 
‘squashed’ point wise through a response function (Figure 2.9 B). 
 
Figure	 2.9,	 The	 Gaussian	 Process	 Classifier	 (Rasmussen	 and	 Williams,	 2006):	 Here	 the	 Gaussian	
process	classifier	aims	to	separate	examples	xi…n	sampled	 from	two	classes	ô ∈ {+ö,−ö}.	A)	A	prior	
GP	distribution	of	f(x)	is	given	in	a	2-d	input	space.	In	order	to	limit	predictions	to	binary	classes	a	
response	function	is	used	to	squash	the	GP	distribution	of	f(x).	B)	Commonly	this	response	function	
takes	 the	 form	 of	 a	 logistic	 function,	õ ú = (ö + ùjû(−ú))7ö.	 C)	 The	 location	 of	 examples	 xi…n	 are	




The theory and implementation of GPC have been previously described by Ebden 
(2008) and are covered in detail by Rasmussen and Williams (2006). I will now 
briefly outline the GPC as described by Marquand et al. (2010).  
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The GPC is an extension of Gaussian process regression (GPR), which in the 
perspective of the weight space can be seen as a Bayesian extension of linear 




where w is a vector of weights, y is a target value, f is a function value, and ɛ N(0,σ2n 
) is a Gaussian noise term. Given input x the posterior distribution of these weights 
are computed by Bayes rule, 
(2.22) G k ü, ô, † = G ä † G(ô|ü,k, †)G(ô|ü, †)  
 
where X is a matrix of input examples xi…n with y, in the case of classification, being a 
vector of corresponding class labels, y = [y1 … ym]T, and † being a vector of hyper-
parameters. The term 	G ô ü, †  is itself a GP and is known as the normalizing 
constant or marginal likelihood, G ô ü, † =∫ G ô ü,k G k bk . Prediction for a 
particular test case x* in data set D comprising of examples xi and corresponding 
class labels f( is performed by averaging all possible values of w and weighting by 
their posterior probability, G i∗ §, †, j∗ = ∫ i∗ k, j∗, † G k §, † bk. Therefore, 
GP predictions are a weighted average of all possible linear models, under the prior 
constraints, based on the examples provided by X. 
 
In order to determine the posterior distribution, the spatial relationship of each 
example to all other examples is first described using a covariance function. There are 
several options for the form of this function (Rasmussen and Williams, 2006), the one 
used in this thesis being a linear covariance function, 
(2.23) ó = 1WZ üü• + d 
 
here l is a length parameter that controls the scaling of the latent function and b is a 
bias term that accounts for the offset from zero. To make predictions we make use of 
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the covariance between training examples and a test case, which are are stored in 
vector k*. For a regression problem, the posterior predictive distribution can then be 
calculated as, 
(2.24) G i∗ §, †, j∗ ~ß å, ®Z  å = ©∗8™7:ô ®Z = ´ j∗, j∗ − ©∗8™7:©∗ 
 
where u = ¨ + ®OZ. For regression problems this posterior predictive distribution is 
Gaussian. From this distribution we are interested in making a prediction of y* given 
y. This prediction can be viewed as analogous to the point predictions given by the 
SVM. However, here in GPR each prediction is accompanied by some degree of 
estimated variance,  
(2.25) ≠2. f∗ = 	ó∗∗ − ó∗ó7:ó∗8 
 
The degree of this variance translates to the confidence in the prediction.  
 
In the GPC problem a sigmoidal response function is used to constrain continuous 
regression predictions to a particular set of target classes. Effectively the response 
function is used to map the unconstrained latent function provided by GPR to a 
particular class label. Several response functions can be used to this purpose, here the 
cumulative Gaussian density or probit likelihood was used, 
(2.26) Φ F = :Z 6.i	( ØZ )+	:Z 
 
For binary classification the likelihood for a single data point can be given as G f( i( = Φ(f(, i(), which enables the posterior distribution over the latent function 
to be written as: 
(2.27) G ∞ §, † = 	ß(∞|0,ó)G § † 	 Φ(f(, i()±(y:  
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where K is the covariance function (2.23). Latent function values for training points 
are stored by f=[f1,…fm]T. ß(∞|+,ó) describes the prior over the latent function. The 
likelihood over training samples is factorized, as the class labels are independent 
given the latent function.  
 
For GP classification; exact inference of the posterior distribution is analytically 
intractable and is therefore approximated using a Gaussian, ≤ ∞ §, † = ß(∞|≥, Σ), 
which allows for calculation of the approximate posterior for a test case ≤ i∗ §, †, j∗ = ß(i∗|å∗, ®∗). Several approximation methods are available for this 
purpose. Here we employed an expectation propagation algorithm (Rasmussen and 
Williams, 2006), as it has been shown to have favorable results compared to other 
approximation methods (Kuss and Rasmussen, 2005, Nickisch and Rasmussen, 2008). 
These GPC based predictions are derived from integrating over the entire distribution 
for the latent function at a point for test case x* and therefore differ from the point 
based predictions provided by the SVM.  See Nickisch and Rasmussen (2008) for 
further details.  
 
In contrast to the SVM which seeks to optimize a margin between classes, ‘training’ 
of a GP models refers to finding the best functional form and hyper-parameters for the 
covariance function. Within this thesis this was achieved through maximizing the 
logarithm of the marginal likelihood. For GP regression problems this can be 
computed as, 
(2.28) </G ô ü, † = 12ô8™µ7:ô − 12 ln ™µ − /2 W/2∂ 
 
where ™µ  is the evaluation of C given hyper-parameters † . For classification the 
marginal likelihood is again approximated using EP. Here (2.28) allows the user to 
select the hyper-parameters among competing models for which the marginal 
likelihood is optimal. The marginal likelihood calculates the total probability of the 
data given the model hyper-parameter and represents a trade off between optimal fit 
and model complexity and thus provides a buffer against over fitting. 
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2.7.3 Model Performance and Validation for Multivariate Pattern 
Classification 
In supervised classification problems MVPC models learn to classify a group of 
training examples based on known class labels. These trained models are then applied 
to independent test examples for which class predictions are made. In order to 
accurately assess a model’s predictive performance it is important that test cases are 
not used in the training of a model. Ideally model performance is evaluated on 
completely independent test data. However, independent data is often not available 
for a variety of reasons. In neuroimaging this is commonly due to the expense of 
scanning individual subjects or challenges in recruiting large number of patients from 
a particular disease cohort.  
 
When independent test data is not available cross validation schemes may be used in 
order to estimate model performance. In k-fold cross validation, k number of cases are 
left out of model training, predictions are then made for the left out cases which act as 
the test data. The cross validation loop is then repeated n number of times such that all 
cases in turn are left out from the training phase and are used as test cases for the 
model. When k=1 this scheme is known as leave one out (loo) cross validation. By 
comparing the predictive class labels returned by either independent validation or 
cross validation to the known labels it is possible to estimate a MVPC model’s 
accuracy. Leave one out cross validation is an effective validation method for 
minimizing testing bias as this framework allows almost the entire training sample to 
be used to establish the model for each testing case. However, given loo methods test 
only a single case each fold this minimization of testing bias comes at the cost of 
increased variance in performance estimates. Due to the relatively small numbers of 
training samples within this thesis, loo cross validation was used throughout with the 
knowledge that this may increase variance in our model performance estimates. 
 
Model accuracy is defined as the percentage of test cases that are correctly classified. 
In addition to accuracy, models can be assessed by their sensitivity and specificity, 
(2.29) 
sensitivity = TP/(TP+FN) 
specificity = TN/(TN+FP) 
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here TP represents the number of true positive cases (e.g. patients classified as 
patients) and TN represents the number of true negatives (e.g. controls classified as 
controls). Conversely FP represents the number false positive cases (e.g. controls 
classified as patients) and FN represents the number of false negative cases (e.g. 
patients classified as controls). For some instances in the clinical setting a model’s 
sensitivity to catch a potential positive case may be valued over the possibility of 
making a false positive diagnosis. In other situations a model’s specificity for making 
an accurate diagnosis may be viewed as more important. 
 
Estimates of a model’s accuracy (or sensitivity and specificity) in themselves are not 
sufficient to tell if a model consistently performs above chance level. In order to test a 
MVPC model’s significance permutation testing can be performed. Here class labels 
are randomly permuted prior to model training and testing. This permutation is then 
repeated n number of time. Typically, n equals some order of thousands of 
permutation folds (e.g. n=1000, 10000, etc.). Across all folds the number of instances 
that the permuted model accuracy exceeds the original estimated accuracy is counted 
and then divided by the total number of permutations to give a p value for the 
classification model. As is convention model’s with a p-value of <0.05 are seen as 
statistically significant.  
 
2.7.4 Feature Extraction and Selection 
In MVPC the selection of data that is informative of the class labels often has more 
impact on model performance than the selection of one particular MVPC algorithm 
over another (e.g. SVM, GPC, etc.). In pattern classification (or regression) a 
particular characteristic of the data used to train a classification model is known as a 
feature or collectively as a feature set. Feature extraction is the process of extracting 
(i.e. calculating) a particular feature from a data set. For example, in this thesis feature 
extraction is the process of calculating surfaced based cortical measures from 
structural MRI data resulting in a vertex based feature set. 
 
Feature sets based on MRI data often contain several thousand features per example. 
Therefore, in order to increase the amplitude of signal with regards to the class label it 
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is often desired, although not necessary, to remove uninformative features. Broadly 
speaking feature selection can be performed in two ways, 1) through prior knowledge 
and expertise (e.g. selection of features from a region of interest known to be involved 
in a condition) or 2) through an automated feature selection algorithm (Mwangi et al., 
2014). Within parts of this thesis automated feature selection is performed through the 
application of a GLM to identify brain regions associated with a mean difference 
between classes. Data from vertices comprising these brain regions were then used for 
subsequent model training and testing.  
 
It is important to note that automated feature selection introduces a strong possibility 
of over fitting a predictive model to the training set. Thus, it is important that the 
parameters used to implement automated feature selection are not selected arbitrarily 
but are tuned using a nested cross validation procedure (Figure 2.10). This avoids bias 




out	 cross	 validation	 with	 a	 nested	 leave	 one	 out	 cross	 validation	 loop	 to	 tune	 model	 parameter	
values.	A)	Leave	one	out	validation	begins	by	excluding	one	case	that	will	act	as	testing	data	(blue	
square)	 from	the	 training	set	 (red	and	blue	squares	 in	shaded	box).	B)	From	the	 training	data	set	
nested	cross	validation	begins	by	C)	performing	leave	one	out	cross	validation	for	each	parameter	





Many ways of performing feature selection are available including both univariate 
(e.g. GLM) and multivariate approaches. When using a GLM to perform feature 
selection the uncorrected p-value threshold used to identify regions of interest 
represents one parameter that is tuned. Thus, for each cross validation fold a range of 
p-value thresholds are tested via nested cross validation. The p-value that returns the 
highest model accuracy is then used in training of the model for that cross validation 
fold. For this thesis, a GLM feature selection approach was used however such 
univariate approaches have the limitation of not taking into account relationships 
between data points. Thus, potentially informative data points may not be selected as 
they are tested for significance in isolation. Several other multivariate feature 
selection methods (e.g. recursive feature elimination, lasso) which may provide better 
results are available (for review see Mwangi et al. (2014)). However, due to time 
constraints in was beyond the scope of this project to extensively test all these 
methods.  
 
2.7.5 Model Visualization  
The spatial maps of MVPC models are inherently different than those provided by 
mass univariate methods such as the GLM. The GLM can be viewed as a forward 
model as it takes a known variable (e.g. class label) and highlights aspects of the data 
(e.g. brain regions) associated with the variable. This differs from backward models 
such as MVPCs that extract information from the data as it relates to a variable 
(Haufe et al., 2014).  
 
Commonly MVPC models are visualized through spatial mapping of the model’s 
weight vector. However, interpretation of these so call “discriminative maps” is made 
difficult by the fact that you cannot infer that values within w are directly related to 
the signal of interest (e.g. class label). For example, large weights may be associated 
with noise and small values the signal of interest. Despite limitations on 
interpretability several studies still report multivariate discriminative maps along with 
MVPC models. Thresholding discriminative maps based on a percentage of the 
maximum weight value has been proposed as one way of reducing noise and 
clarifying interpretation (Mourão-Miranda et al., 2005, Mourao-Miranda et al., 2006). 
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Other multivariate mapping methods have recently been proposed to calculate 
forward maps more in line with those generate by the GLM (Haufe et al., 2014). 
 
An alternative mapping method, known as ‘predictive mapping’ involves taking the 
dot product of each individual example (xi) with the corresponding weight vector (w), 
so that m =(j() ∙ k (Marquand et al., 2014). Predictive mapping has two advantages: 
1) it shows the total contribution to the prediction for each test point, i.e. the weights 
derived from the training data and from the test data point, and therefore 2) it can be 
used to determine the spatial distribution of informative regions for cases that were 
not learned as part of the primary decision problem. In other words, predictive 
mapping allows us to infer which aspects within a group of test cases underlie 


































Chapter 3: Grey to White Matter Percent Contrast as an in vivo 
Neuroimaging Feature in Autism Spectrum Disorder 
 
Autism spectrum disorder (ASD) is a condition that manifests during early 
development that is accompanied by differences in brain anatomy and connectivity 
(Lange et al., 2015, Ecker et al., 2015, Amaral et al., 2008). Several prior magnetic 
resonance imaging (MRI) studies of ASD have reported atypical measures of cortical 
anatomy such as folding, thickness, and surface area (Nordahl et al., 2007, Hyde et 
al., 2010, Ecker et al., 2013, Schaer et al., 2013). These in vivo findings are supported 
by postmortem reports of atypical cortical structure such as increased numbers of 
neuron cells, cortical minicolumns and instances of folding abnormalities in ASD 
(Casanova et al., 2006, Courchesne et al., 2011, Kemper, 1988).  
 
This chapter details a novel application of measures of tissue contrast in an attempt to 
quantify a specific aspect of neuropathology in ASD, namely poor definition of the 
grey-white matter boundary (Avino and Hutsler, 2010). This study was recently 
published in Cerebral Cortex (Andrews et al., 2017) and is included in its final 
published format in the pages that follow. Supplementary materials for this chapter 















Chapter 4: Clinical Testing of Multivariate Pattern 
Classification Models for Autism Spectrum Disorder 
4.1 Introduction 
Until recently, the majority of neuroimaging studies in mental health research have 
used so called mass-univariate methods which examine mean differences in brain 
measures between groups of individuals. However, these methods are not suited to 
make predictions for individual cases on the basis of patterns within the data (e.g. to 
predict group membership or clinical outcome), and thus offer limited translational 
value for clinical applications. Increasingly, “machine learning” methods such as 
multivariate pattern classification (MVPC) have been applied to clinical 
neuroimaging data to discriminate cases from controls. In brief, MVPC algorithms 
such as the Support Vector Machine (SVM) (Vapnik, 1995) or Gaussian Process 
Classifier (GPC) (Rasmussen and Williams, 2006) differentiate between two or more 
classes in the following way: 1) During a ‘training phase’ the model is initially 
established using well-defined samples to determine a mathematical criterion of a 
decision function that best distinguishes between the groups (e.g. ASD and controls). 
2) During the ‘testing phase’, the decision function is applied to predict the class or 
label of a new test example (e.g. an unseen data point). 
 
Several proof-of-concept studies having shown promise in classifying patients from 
controls across several psychiatric and neurodevelopmental conditions (Wolfers et al., 
2015, Arbabshirani et al., 2016). Within autism spectrum disorder (ASD), volumetric 
(Ecker et al., 2010b), morphological (Jiao et al., 2010, Ecker et al., 2010a), diffusion 
(Ingalhalikar et al., 2011, Ingalhalikar et al., 2010), and functional (Just et al., 2014) 
MRI brain measures have all been applied to discriminate individuals with ASD from 
typically developing (TD) controls at accuracies significantly above chance within the 
research setting (for review see Chapter 1.4.1). However, MVPC model performance 
(e.g. overall classification accuracy) is most often estimated using cross-validation 
methods within the same sample. To date, only two studies have evaluated ASD 
classification models on independent data sets acquired in the ‘research setting’ 
(Sabuncu and Konukoglu, 2014, Shen et al., 2017). These studies have reported 
modest overall accuracy in identifying individuals with ASD (59-72%) when 
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compared to the literature as a whole, which includes reports of several model 
performances ranging from 80 to upwards of 100% accuracy.  
 
To date no studies have tested classification models for ASD trained in the research 
environment on independent samples that are representative of the broader clinical 
population. This is important because several differences exist between research and 
clinical ASD cohorts. For example, individuals with ASD recruited within the 
research environment will generally be excluded if they have comorbid conditions, 
are taking certain medications, or fail to reach cut-offs on behavioural metrics such as 
the autism diagnostic interview (ADI) and/or autism diagnostic observation schedule 
(ADOS). In addition, low functioning ASD cases are often not included in imaging 
research. As such, many individuals who would qualify for a clinical ASD diagnosis 
would not meet inclusion criteria for research. As a result, the clinical phenotype 
between individuals with ASD in research and clinical samples is likely to differ to 
some degree.  
 
Furthermore, proof of concept classification studies report model performance when 
distinguishing individuals with ASD from typically developing (TD) controls. 
However, individuals in clinical populations who do not qualify for an ASD diagnosis 
usually would not be considered TD. Rather individuals who are referred for 
specialist ASD diagnostic services and found not to have the condition often qualify 
for a diagnosis of a different but related disorder (e.g. obsessive-compulsive disorder, 
social anxiety disorder, learning disability etc.) or have a subclinical behavioral 
presentation that would exclude them from qualifying as a TD control. Taking the 
above into account, training sets on which classification models are established are 
not necessarily exchangeable with the testing population of interest (i.e. clinical 
population).  
 
Thus, this study sought to (1) establish discriminative models for ASD within a 
research sample of TD controls and ASD adults, and then (2) test the efficacy of these 
models to identify ASD in an independent sample of individuals who had been 
referred to a specialist clinical service for ASD diagnosis. Two types of classification 
algorithms, i.e. the SVM and GPC were examined separately. The SVM and GPC 
were selected as they have both been successfully applied previously to neuroimaging 
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based classification problems (Ecker et al. 2010A, Ecker et al. 2010B, Marquand 
2010). These methods were applied to several different morphometric measures 
including volumetric as well as geometric features, which have previously been 
shown to be atypical in individuals with ASD (Ecker et al., 2010a, Sabuncu and 
Konukoglu, 2014, Jiao et al., 2010, Andrews et al., 2017). Based on previous reports 
we hypothesize that measures of cortical morphometry will be able to significantly 
discriminate ASD individuals from controls at accuracies above chance level within 
the research setting. However, given the inherent differences between our research 
training and clinical testing samples and previous findings of classification models 
showing reduced performance in the range of 10-15% when applied to independent 
testing sets (Sabuncu and Konukoglu, 2014), we expected a reduction in overall 
accuracy when predicting ASD diagnosis within the clinical sample.  
 
4.2 Methods 
4.2.1 Research Group Participant Demographics 
The research cohort included structural MRI data obtained in 27 male right-handed 
adults with ASD (Ages 18-38, 25±6.3yrs) and 27 matched TD developing controls 
(Ages 18-42, 28±6.1yrs), that were recruited by advertisement and assessed at the 
Institute of Psychiatry, Psychology and Neuroscience, London UK. Exclusion criteria 
included a history of major psychiatric disorder (e.g., psychosis), head injury, genetic 
disorder associated with autism (e.g., fragile-X syndrome, tuberous sclerosis), or any 
other medical condition affecting brain function (e.g., epilepsy). We excluded 
participants on antipsychotic medication, mood stabilizers, or benzodiazepines.  
All participants with ASD within the training set were diagnosed according to ICD-10 
research criteria. Diagnoses were confirmed using the Autism Diagnostic Interview 
(ADI-R; (Lord et al., 1994). All cases reached the diagnostic algorithm cutoffs for 
adults in the three domains of the ADI-R, although failure to reach cutoff in one 
domain by one point was permitted. Current symptoms were assessed using the 
Autism Diagnostic Observation Schedule (Lord et al., 2000) but were not used as 
inclusion criteria. Overall, intellectual ability was assessed using the Wechsler 
Abbreviated Scale of Intelligence (WASI) (Wechsler, 1999). All participants had a 
full-scale IQ score greater than 75. Group differences in age and full scale IQ were 
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assessed using a two-tailed independent samples t-test. All participants gave informed 
written consent in accordance with ethics approval by the National Research Ethics 
Committee, Suffolk, United Kingdom. 
Table 4.1. Participant Demographics (Research Sample) 
 ASD (n=27♂), TD Controls (n=27♂) 
Age, years 25 ± 6.3 (18-38) 28 ± 6.1 (18-42) 
Full-scale IQ, WASI 106 ± 13.0 (83 - 133) 110 ± 14.0 (77 - 130) 
ADI-R social 17 ± 5.8  (9 - 28) * 
ADI-R communication 12 ± 12.4  (8 - 24) * 
ADI-R repetitive behavior 4 ± 1.7  (1 - 8) * 
ADOS social + communication 11 ± 3.6  (7 - 21) * 
Note:	Values	given	as	Mean	±	(Range),	TD	controls	did	not	undergo	ADI	or	ADOS	assessment.		
 
There were no significant differences between individuals with ASD and TD controls 
within the training set in terms of age (t=1.703, p=0.095), full-scale IQ (t=.946, 
p=0.348), or total GM volume (t=.399 , p=0.691).  
 
4.2.2 Clinical Group Demographics 
In addition to the participants described above, 62 right handed male individuals who 
had received referrals for a specialist ASD assessment were recruited from the Autism 
Assessment and Behavioral Genetics Service at the Bethlem Royal Hospital, South 
London and Maudsley NHS Foundation Trust. All individuals within this sample 
were diagnosed according to ICD-10 research criteria. Of the 62 individuals, 14 did 
not receive an ASD diagnosis, 17 met ICD-10 criteria for ASD but not ADI-R or 
ADOS cutoffs (i.e. ‘clinical’ diagnosis for ASD), and 31 met ICD-10 and ADI-R 
and/or ADOS cutoffs for the condition (i.e. obtained a ‘research’ diagnosis of ASD). 
Individuals within this sample were representative of patients assessed in the clinical 
setting who often present with comorbid conditions. High rates of obsessive 
compulsive disorder (OCD), attention deficit disorder (ADD), phobias, depression, 
general and social anxiety disorders were observed across each subgroup within the 
clinical sample (Figure 4.2). 
Table 4.2. Participant Demographics (Clinical Sample) 
 No ASD (n=14) Clinical ASD (n=17) Research ASD 
(n=31) 
Age, years 34 ± 9.19 (20-45) 27 ± 5.67 (19-36) 29 ± 7.65 (18-44) 
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Full-scale IQ, WASI 120 ± 12.4 (96 - 136) 115 ± 16.1 (85 - 141) 111 ± 15.2 (83 - 
136) 
ADI-R social a 5 ± 5.3  (0 - 16) 7 ± 3.5  (2 - 13) 13 ± 6.9  (1 - 27) 
ADI-R communication a 5 ± 3.8  (0 - 11) 6 ± 3.2  (2 - 12) 10 ± 4.6  (2 - 21) 
ADI-R repetitive behavior a 2 ± 1.5  (0 - 5) 2 ± 1.4  (0 - 4) 4 ± 2.2  (0 - 8) 
ADOS social + 
communication b 
6 ± 2.4  (3 - 9) 7 ± 2.7  (2 - 12) 12 ± 3.25  (7 - 21) 
Percentage with  
Comorbid Condition  
69% (9/13) 71% (12/17) 58% (18/31) 




Within the clinical sample; individuals who did not receive an ASD diagnosis were 
significantly older than those with a clinical diagnosis of ASD (t=2.574, p=0.015) but 
not those with a research diagnosis of ASD (t=1.865, p=0.015). No significant 
difference in full scale IQ was observed between individuals with no ASD diagnosis 
and those with a clinical (t=1.017, p=0.318) or research diagnosis of ASD (t=1.930, 
p=0.060). Furthermore, individuals with clinical and research diagnoses did not 
significantly differ (p<0.05) in terms of age or FSIQ.  
 
In terms of ASD symptom severity as measured by the ADI-R and ADOS, individuals 
who received a clinical referral but did not meet ICD-10 criteria for an ASD diagnosis 
did not show a significant difference in any of the ADI-R subdomains or combined 
ADOS social and communication scores from individuals who met criteria for a 
clinical ASD diagnosis but did not reach ADI-R and ADOS cutoffs for a research 
diagnosis (p<0.05). Those with a research diagnosis showed statistically significant 
increases across all these measures compared to both the no ASD and clinical ASD 
groups (p<0.05). 
4.2.3 MRI Data Acquisition:  
All MRI scanning was conducted at the Institute of Psychiatry, Psychology and 
Neuroscience, King’s College London, UK, using a 3T GE Signa System (General-
Electric). A quantitative T1-mapping sequence (see Chapter 2.4; Deoni et al., 2008) 
was used to derive synthetic high-resolution structural T1-weighted inversion-
recovery images, with 1 × 1 × 1 mm resolution, a 256 × 256 × 176 matrix, repetition 
time = 1,800 ms, inversion time = 50 ms, flip angle = 20°, and field-of-view = 25 cm.  
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4.2.4 Cortical Surface Reconstruction 
The FreeSurfer software package (http://freesurfer.net/ ,v5.3.0) was used to derive 
models of the cortical surface for each T1-weighted image (see Chapter 2.5). In brief, 
a single filled white-matter volume was generated for each hemisphere after intensity 
normalization, the removal of extra cerebral tissue, and image segmentation using a 
connected components algorithm. A triangular surface tessellation was then generated 
for each white-matter volume by fitting a deformable template, resulting in a cortical 
mesh for the white and grey/pial (i.e., outer) surfaces with  150,000 vertices (i.e., 
points) per hemisphere. Prior to surface reconstruction a radiologist screened scans to 
exclude participants with clinically significant abnormalities or excessive motion 
artifacts. A secondary quality check was then performed to identify cortical surface 
reconstructions of insufficient quality (i.e. with visible reconstruction errors), which 
were excluded from the analysis and are not described here. Overall the drop out 
within the training set was equal between groups and was <10% of the total available 
sample. In order to avoid the introduction a subjective bias no further manual edits 
were performed.  
 
Each individual’s surface reconstructions were used to calculate vertex-wise measures 
of cortical morphometry, which included i) point-wise estimates of cortical volume 
(VOL), ii) cortical thickness (CT), iii) pial surface area (SA), iv) the local gyrification 
index (lGI), v) average convexity/concavity (SULC, i.e. sulcal depth), and vi) percent 
contrast of grey-white matter signal intensity (GWPC), where grey matter intensity 
was sampled at the grey-white matter boundary (i.e. 0% projection fraction) and 
contrasted with white matter intensity sampled at 1mm subjacent to the grey-white 
matter boundary. Further details on the calculation of these measures are provided in 
Chapter 2.5 (for CT, SA, lGI, and SULC) and the methods section of Chapter 3 (for 
GWPC). Prior to further statistical analyses, each morphometric feature (excluding 
lGI) was smoothed using a 15mm FWHM surface based Gaussian kernel. As lGI 
utilizes cortical SA measures sampled from a 15mm diameter spherical ROI, and is 
hence an inherently smooth feature, no additional smoothing was applied to measures 
of IGI.  
4.2.5 Pattern Classification 
Classification of individuals with ASD and TD controls was performed using two 
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pattern classification algorithms, the support vector machine (SVM) (Vapnik, 1995) 
and Gaussian process classification (GPC) (Rasmussen and Williams, 2006, 
Marquand et al., 2010). Whole brain vertex-wise measures of the six morphometric 
features described above were each used independently of each other as feature sets 
for classification. Details of SVM and GPC methods are provided in Chapter 2.7. In 
brief, SVMs operate by identifying a decision boundary (linear or non-linear) known 
as a hyperplane. The hyperplane separates the experimental classes with a maximum 
margin. Test cases are then classified as cases or controls depending on which side of 
the hyperplane they are projected to (Boser et al., 1992). GPC is a Bayesian 
classification method, which provides probabilistic predictions of class ownership. 
These predictive class probabilities make GPCs particularly well suited for clinical 
contexts where the probability of an individual having a particular condition (i.e. 
psychiatric disorder) is of primary interest. In brief, GPCs can be understood as a 
distribution over functions, with GP inference consisting of applications of Bayes’ 
rule to find the posterior function distribution that best approximates the training data.  
The performance of each SVM and GPC model within the research sample was 
assessed via leave one out cross validation (LOO-CV). Within each LOO-CV fold, 
data from all but one individual was used to train the classifier. The resulting pattern 
recognition model was then tested on the individual who was excluded from the 
training phase. This process was repeated S times (were S is the total number of 
subjects). Classification accuracy was then defined as the percentage of subjects 
correctly assigned to the ASD or control group. For each classification model 
prediction sensitivity (SE) and specificity (SP) were also calculated (see Chapter 
2.7.3). Model significance was then assessed via n=1000 permutations of the class 
labels to derive a null distribution of model accuracies by which to test significance 
against.  
Following the training phase, the established models that showed the highest overall 
accuracies within the research training sample were used to predict the class 
membership of individuals within the independent clinical sample. This sample 
contained both ASD positive (clinical or research criteria) and ASD negative cases, 
which for purposes of classification were labeled as analogous to TD controls in the 
training sample. Within the clinical sample, in addition to overall classification 
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accuracy, prediction accuracy within the ASD negative, clinical and research ASD 
subgroups was calculated.  
4.2.6 Classification Using Feature Selection 
In addition to the models above we retrained each classifier using a general linear 
model (GLM) based feature selection technique (see Chapter 2.7.4). This method 
sought to limit vertices used to train models to only those that had a significant mean 
difference between groups, and thus increase the amplitude of signal in the data with 
regards to the class labels (i.e. ASD/TD). For each cortical feature the main effect of 
group was identified by a regression of a GLM using only the training data. Here, we 
used diagnostic group as a categorical fixed-effects factor and age and full-scale IQ as 
continuous covariates: 
(3.6) 
Yi = β0 + β1 Group + β2 Age + β3FSIQ + εi 
 
where εi is the residual error at vertex i. A nested LOO-CV procedure was then 
applied to select the p-value used to threshold the vertex-wise statistical maps, such 
that only vertices with a statistically significant effect of group (β1) that exceeded this 
threshold were included as input features for classification.  
This nested LOO-CV procedure followed the following steps. i) For each LOO-CV 
fold across the research sample (S) one individual was left out to act as a test case, 
with the remaining individuals (S-1) acting as training data for that fold. ii) Within 
each of these LOO-CV folds a second nested LOO-CV loop was performed within the 
training data (i.e. S-1) for that particular fold. iii) For each of these nested LOO-CV 
folds another individual was left out and acted as a test case within the nested fold. iv) 
Using only the remaining training data within the nested fold, the above GLM was fit 
and the statistical maps for the main effect of group (β1) thresholded separately for a 
range of p-values (p> 0.4, 0.3, 0.2, 0.1, 0.05, 0.01, 0.001). v) Within the same nested 
training group, classification models were trained for each p-value using only vertices 
where the effect of group (β1) exceeded the significance threshold. vi) Model accuracy 
was estimated for each of these classifiers using LOO-CV within the nested loop. vii) 
The p-value threshold that yielded the highest classification accuracy within the 
nested LOO-CV loop was then selected and applied to the initial left out training 
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sample (S-1). viii) Thus, only vertices that showed a main effect of group that 
exceeded the p-value selected through nested LOO-CV to provide the highest overall 
accuracy were used to train the classifier within the initial training sample (S-1) to 
make a prediction on the initial left out test case.  
To apply this procedure within the independent clinical validation data set i) the p-
value threshold that yielded the highest estimated CV accuracy on average across all 
LOO folds in the research training set was selected. ii) This p-value threshold was 
then applied to statistical maps of the main effect of group across the entire research 
training set. ii) Vertices exceeding this statistical threshold were then used to retrain 
classifiers on the entire research training set. iv) These established models were then 
used to make predictions within the independent clinical data set. 
 
4.3 Results 
4.3.1 Classification of ASD and TD individuals in the research sample 
Using whole brain vertex wise morphometric measures SVM was not able to classify 
individuals with ASD from TD controls within the research sample at accuracies 
above what would be expected statistically by chance (VOL 50% Accuracy [48/52% 
SE/SP], p=0.56; CT 50% [48/52%], p=0.53; SA 54% [52/56%], p=0.11; lGI 41% 




Figure	 4.1:	 Support	 Vector	 Machine	 Predictions	 Within	 the	 Training	 Set:	 Class	 predictions	 for	
individuals	within	 the	 training	 set	derived	by	 leave	one	out	 cross	 validation	are	 shown	 in	 scatter	
plots	for	each	cortical	feature.	A	=	cortical	volume,	B	=	cortical	thickness,	C	=	surface	area,	D	=	local	
gyrification	index,	E	=	sulcal	depth,	D=	grey-white	matter	percent	contrast.	‘Projection	onto	Weight	
Vector’	 represents	 unthresholed	 SVM	 predictions,	 normalized	 between	 -1	 (TD)	 and	 1	 (ASD)	 for	
visualization.		
 
Similar model performance was achieved using GPC (VOL 52% [52/52%], p=0.41; 
CT 50% [48/52%], p=0.46; SA 57% [59/56%], p=0.13; lGI 41% [33/48%], p=0.81; 




When limiting the feature set to include only vertices that showed a significant group 
difference according to a traditional GLM both SVM (VOL 44% [37/52%]; CT 52% 
[52/52%]; SA 50% [56/44%]; lGI 41% [37/44%]; SULC 61% [67/56%] p=0.345; 
GWPC 48% [52/44%]; Figure 4.3) and GPC (VOL 50% [48/52%]; CT 54% 
Figure	 4.5:	 Gaussian	 Process	 Classification	 Predictions	 within	 the	 Training	 Set:	 Predictive	 class	





[48/59%]; SA 50% [56/44%]; lGI 43% [37/48%]; SULC 61% [59/63%], p=0.074; 
GWPC 56% [56/56%], p=0.197) Figure 4.4) overall classification accuracies 
remained modest.  
 
Figure	 4.3:	 Support	 Vector	Machine	 Predictions	within	 the	 Training	 Set	 using	 GLM	based	 Feature	
Selection:	 Class	 predictions	 for	 individuals	within	 the	 training	 set	 derived	 by	 leave	 one	 out	 cross	
validation	 are	 shown	 in	 scatter	 plots	 for	 each	 cortical	 feature.	 A	 =	 cortical	 volume,	 B	 =	 cortical	
thickness,	 C	 =	 surface	 area,	 D	 =	 local	 gyrification	 index,	 E	 =	 sulcal	 depth,	 D=	 grey-white	 matter	




Figure	 4.4:	 Gaussian	 Process	 Classification	 Predictions	 within	 the	 Training	 Set	 using	 GLM	 based	
Feature	 Selection:	 Predictive	 class	 probabilities	 for	 individuals	within	 the	 training	 set	 derived	 by	
leave	 one	 out	 cross	 validation	 are	 shown	 in	 density	 and	 scatter	 plots	 for	 each	 cortical	 feature.	




4.3.2 Predicting ASD Diagnosis within Clinical Sample 
The best performing classification models within the research training sample showed 
relatively modest overall classification accuracy (61%). While this is in line with a 
previous reports in large ASD cohorts using measures of CT (Sabuncu and 
Konukoglu, 2014), given the relatively small size of our training sample we were not 
able to show these results were statistically significant relative to chance. Thus, 
interpretation these classifiers ability to make predictions within the clinical testing 
set is made difficult as it is uncertain if this predictive value is reflective of biological 
differences between the groups. However, as an exploratory step we applied the best 
performing models (>55% overall accuracy) to make class predictions within the 
clinical sample.  
 
Across all SVM models, those trained on SULC measures with (61%, p=0.345) and 
without feature selection (56%, p=0.44) showed the highest classification accuracies 
within the research training sample. When these models were applied to the clinical 
sample they showed overall classification accuracies below chance levels with (39%) 
and without feature selection (39%), Table 4.5. These classifiers performed equally at 
or below chance level across all patient subgroups including those with no ASD 
diagnosis, a clinical, or a research diagnosis of ASD, Figure 4.3.  
 
 
Figure	 4.5:	 Support	 Vector	 Machine	 Predictions	 within	 the	 Testing	 Set:	 Class	 predictions	 for	
individuals	within	 the	 testing	 set	 are	 shown	 in	 scatter	 plots	 for	 SVM	 classifiers	 trained	 on	 vertex	
wise	 measures	 of	 sulcal	 depth	 both	 with	 (A)	 and	 without	 (B)	 GLM	 based	 feature	 selection.	






Table 4.3 Classification Accuracies within Subgroups of the Clinical Sample 
 Classification Accuracy 
Classifier Overall No ASD Clinical ASD Research ASD 
     
SVM SULC 24/62 (39%) 7/14 (50%) 6/17 (35%) 11/31 (35%) 
SVM SULC* 24/62 (39%) 6/14 (43%) 6/17 (35%) 12/31 (39%) 
     
GPC SA 25/62 (40%) 4/14 (29%) 11/17 (65%) 10/31 (32%) 
GPC SULC* 26/62 (42%) 7/14 (50%) 6/17 (35%) 13/31 (42%) 
GPC GWPC* 50/62 (81%) 12/14 (86%) 15/17 (88%) 23/31 (74%) 
	




Among GPC models trained within the research sample without GLM based feature 
selection, measures of SA were found to return the highest overall classification 
accuracy (57%, p=0.13), but showed below chance levels when applied to the clinical 
sample (40%), Figure 4.6. Two additional GPC models trained using feature selection 
on measures of SULC (61%, p=0.074) and GWPC (56%, p=0.197) showed overall 
classification accuracies above 55% within the research sample. When applied to the 
clinical sample the model based on measures of SULC showed overall accuracies 
bellow chance levels (42%), Figure 4.6. Accuracies for these models within the 
clinical subgroups are given in Table 4.3.  
 
Figure	 4.6:	 Gaussian	 Process	 Classification	 Predictions	 within	 the	 Testing	 Set:	 Predictive	 class	
probabilities	 for	 individuals	within	 the	 test	set	are	shown	 in	density	and	scatter	plots	 for	 the	GPC	
trained	 on	 measures	 of	 (A)	 surface	 area	 and	 (B)	 sulcal	 depth	 when	 using	 GLM	 based	 feature	
selection	(B).	
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However, the GPC trained on GWPC measures that were restricted to vertices that 
showed a significant effect of group (p value threshold of 0.05) within the training set 
showed a high overall accuracy (81%) within the clinical set, across all clinical 
subgroups (Table 4.3). However, we were unable to show this model performed 
above chance at a statistically significant level within the training set (57%, p=0.25). 
 
Figure	 4.7:	 Gaussian	 Process	 Classification	 Predictions	 within	 the	 Testing	 Set	 using	 measures	 of	




The first aim of this study was to establish predictive models for ASD based on 
different morphometric cortical features within a training set of TD controls and 
individuals with ASD acquired in a research setting. Secondly, this study aimed to test 
the ability of these classifiers to predict ASD within an independent sample of 
individuals who had been referred for a clinical ASD diagnostic assessment, thus 
representing a ‘real-world’ clinical setting. While previous reports suggest that 
measures of cortical structure can be used to classify ASD individuals (Ecker et al., 
2010a, Wee et al., 2014, Jiao et al., 2010, Hazlett et al., 2017, Sabuncu and 
Konukoglu, 2014), the current study was not able to replicate these findings in our 
research training sample. As an exploratory step, we applied the best performing 
classifiers within the research sample to make predictions as to ASD diagnosis within 
an independent clinical sample. In this context, one model showed the ability to 
discriminate individuals with and without ASD diagnoses at high overall accuracy 
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(81%). However, given this model’s performance in the research setting this result 
must be considered as preliminary and suggestive only.  
 
While a number of classifiers for ASD have been proposed and reported to show 
significant classification accuracies when discriminating individuals with ASD from 
TD controls within research settings, we were not able to replicate these results within 
our sample. A likely key contributor to this is the highly heterogeneous nature of the 
ASD phenotype. Within a heterogeneous cohort such as the ASD population, 
maximal classification accuracy based on measures of brain structure is likely to be 
rather modest. For example, classification studies reporting validation on independent 
ASD research samples have reported accuracies in the range of 59-72% (Sabuncu and 
Konukoglu, 2014, Shen et al., 2017). Whilst some of the accuracies we report here are 
in this range, we were not able to establish the statistical significance of these 
classifiers due to the small size of our research sample.  
 
When classifiers are trained on relatively small samples (i.e. n<100) drawn from a 
heterogeneous population (e.g. ASD) a high degree of variance in model performance 
is to be expected. Furthermore, cross validation methods that test a small number of 
cases for at each fold (i.e. n=1) may also increase variance in estimates of model 
performance. Such variance has been shown across classification studies in 
heterogeneous psychiatric and neurodevelopmental conditions along with a trend 
towards decreasing model performance with increasing training sample sizes (Wolfers 
et al., 2015) (Figure 4.8). Thus, the development of approaches that directly address 
phenotypic heterogeneity within ASD will be of critical importance for the successful 
delivery of classification methods that have translational value in clinical settings. 
Methods that seek to parse heterogeneity based on one particular source of variance 
(e.g. biological sex) could be of particular benefit and are a major theme in the 









less	 than	 100	 patients	 can	 be	 observed.	 ii)	 Classifier	 performance	 is	 also	 seen	 to	 decrease	 with	
increasing	numbers	of	patients	within	each	study,	which	 likely	 is	attributable	to	 increased	sample	
heterogeneity.	SCZ	=	schizophrenia;	BPD	=	bipolar	disorder;	MDD	=	major	depressive	disorder;	OCD	
=	 obsessive	 compulsive	 disorder;	 SAD	 =	 social	 anxiety	 disorder;	 PTSD	 =	 post-traumatic	 stress	
disorder;	 SP	 =	 specific	 phobia;	 ADHD	 =	 attention-deficit/hyperactivity	 disorder;	 ASD	 =	 Autism	
spectrum	disorder;	C	=	controls.	
 
When comparing the current results to previous ASD classification studies in small 
research samples that have reported good model performance (e.g. 70-100% 
accuracy) it is important to carefully note if and how feature selection has been 
applied. Broadly speaking, feature selection incorporates a variety of methods used to 
identify and include only features (e.g. MRI data points) that are informative to the 
classification problem at hand (Cuingnet et al., 2011, Chu et al., 2012, Mwangi et al., 
2014). While feature selection offers a valid way to increase signal within data to 
allow for better classification between groups, it also introduces the possibility of over 
fitting one’s model to the training set. To avoid over fitting it is essential to perform 
feature selection in a non-biased fashion such as through a nested LOO-CV 
framework like was conducted in the current study or to ensure so called ‘expert 
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based’ feature selection (e.g. ROI selection) is fixed a-priori. Ultimately, the gold 
standard test for over fitting is the application of a trained classifier to a completely 
independent test set. Thus, while previous studies reporting exceptional model 
performance through applications of feature selection in ASD are valuable for their 
ability to identify features that can distinguish cases from controls within individual 
research samples, testing of these models on independent research or clinical samples 
is required in order to establish their translational ability. 
 
Whilst our trained classifiers did not statistically exceed chance, as an exploratory 
step we applied our best performing models to predict ASD diagnoses within our 
independent clinical sample. This is based on the rationale that these classifiers may 
still have learned useful discriminating information, despite not exceeded chance 
owing to the small size of the training set. We found the majority of these models 
showed decreased overall classification performance within the clinical testing set. 
This result was expected based on previous reports that overall classification accuracy 
decreases when models are applied to independent samples (Sabuncu and Konukoglu, 
2014) and was likely further enhanced by the clinical nature of our testing sample, 
which introduces differences in both class frequencies (Hahn et al., 2013) and the 
clinical ASD phenotype between the research and clinical samples. 
 
One noteable exception to the above results was the GPC trained on measures of 
grey-white matter percent contrast (GWPC) taken at the grey-white matter boundary 
(Andrews et al. 2017) which showed high overall accuracy within the clinical sample 
(81%) and across all diagnostic sub-categories (74-88%). This is potentially of 
interest as this feature was designed with intent to investigate a particular aspect of 
ASD neuropathology, namely poor definition of the grey-white matter boundary 
(Avino and Hutsler, 2010) and thus may have increased sensitivity to detect the 
condition compared too more general measures of cortical morphology. However, 
interpretation of this finding is limited in light of our inability to show this model 
performed significantly above chance level within the research sample, or within the 
clinical sample via LOO-CV. The possibliity of this result being attributed to chance 
is further increased given the relatively large number of models trained within this 
study (n=24). If this model was found to identify individuals with ASD in a 
statistically significant fashion, correction for multiple comparisions would be 
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critically important before the results could be confidently attributed to a informative 
biological pattern in the data.  
 
It is important to note that if the above limitations can be addressed and an efficacious 
imaging biomarker for ASD is developed, the current high cost of MRI scanning 
makes the use of imaging as a population screening tool for ASD implausible at this 
time. However, MRI based screenings may still be able to offer benefits to 
populations at high risk for the condition. For example, within the current study ASD 
prevalence was found to be 77% among the sample of individuals referred for a 
clinical ASD assessment. This is important due to the fact that models trained on 
artificially balanced groups will suffer from high rates of false positives (type I errors) 
when applied to a general population with prevalence rates in the low single digits, 
regardless of initial model performance (i.e. high SE and SP). Accordingly, once a 
classification model has been established it is important to take into account any 
differences in class frequencies that may exist between training and test groups (Hahn 
et al., 2013). Taking the above factors into account, if an imaging based biomarker is 
to be successfully implemented targeting screening within appropriate high-risk 
populations with elevated ASD prevalence will be as equally as important as the 
identification of the biomarker in the first place. 
 
4.5 Conclusions 
Autism spectrum disorder (ASD) is a highly heterogeneous condition that poses 
several hurdles in the development of a MRI based biomarker for the condition. 
While a large body of evidence suggests that ASD is accompanied by changes in 
brain structure, the current study was not able to replicate previously reported findings 
that measures of cortical morphometry can identify individuals with ASD with 
significant accuracy in the research setting. Accordingly, we were not able to test the 
hypothesis that models trained within the research setting translate to clinical samples. 
Future classification studies would benefit by recruiting large scale ASD clinical 
samples that allow for the development of methodologies that directly address issues 
of heterogeneity in the condition though biological subtyping. This along with the 
identification of imaging features with increased sensitivity to detect ASD phenotypes 
















Chapter 5: Association Between the Probability of Autism 
Spectrum Disorder and Normative Sex-Related Phenotypic 
Diversity in Brain Structure 
 
Male preponderance is an understudied hallmark of autism spectrum disorder (ASD) 
and many other neurodevelopmental and psychiatric conditions. While some degree 
of this male preponderance is likely attributable to sex differences in the ASD 
phenotype and male biased diagnostic tools, it has been purposed that variance in 
biology attributable to normative sex differences may modulate ASD risk (Werling, 
2016).  
 
The following chapter details a study providing an initial ‘proof of concept’ for a 
novel use of multivariate pattern recognition to characterize normative phenotypic 
diversity associated with biological sex, and how this aspect of neuro-diversity is 
associated with probability for ASD. This study was recently published in JAMA 
Psychiatry (Ecker, et al 2017) and is included in its final published format in the 
pages that follow. Contributions to this publication by the current author included 
significant input on the study concept and design, data analysis and interpretation, and 
drafting of the manuscript. Supplementary materials for this chapter can be found in 














Chapter 6: Normative Sex-Related Phenotypic Diversity 
Across Multiple Measures of Brain Anatomy is Associated 
with Probability for Autism Spectrum Disorder 
 
This chapter represents a critical extension of the study detailed in chapter 5 regarding 
the association between sex-related phenotypic diversity in measures of cortical 
thickness (CT) and the probability for autism spectrum disorder (ASD). As has been 
noted by others (Cahill 2017) it is unknown if and how the previous results detailed in 
Chapter 5 (Ecker, et al 2017) will extend to other measures of neuro-anatomy. Here, 
we extended our initial findings to consider multiple aspects of brain anatomy 
including both volumetric and geometric cortical features in order to (i) provide a 
more comprehensive characterization of normative sex related differences in brain 
structure, (ii) determine how diversity in sex based neurophenotypes are associated 
with ASD probability, and (iii) estimate how much ASD prevalence in the general 
population might vary as a function of normative sex-related phenotypic diversity. 
 
This study is currently under review with The American Journal of Psychiatry and is 
presented in the pages that follow in its most recent format as of time of writing. 
Supplementary materials for this chapter are presented in Appendix IV, the current 
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Objective: Males are 2 to 5 times more likely to be diagnosed with Autism spectrum 
disorder (ASD) than females. The reasons for this bias are not fully understood. 
However, normative diversity in brain structure associated with biological sex is one 
possible mediator for ASD risk. The authors therefore examined the probability of 
ASD as a function of sex-related variability in multiple measures of brain anatomy.  
 
Method: 98 adults with ASD (49 males, 49 females) and 98 typically developing 
controls (51 males, 47 females) underwent structural MRI scanning. Measures of 
cortical morphometry (i.e. cortical thickness, surface area, the local gyrification index, 
and sulcal depth) were used to establish normative models of biological sex. These 
models were subsequently applied to males and females with ASD. Sample 
probabilities for ASD were calculated across features according to sex-based 
neuroanatomical phenotypes and extrapolated to estimate ASD risk within the general 
population.  
 
Results: Across morphometric features, females with ASD displayed a statistically 
significant neuroanatomical shift towards more male-typical presentations (p<0.001). 
Moreover, within both biological males and females sample probabilities for ASD 
increased with predicted probabilities for male-typical brain phenotypes. For 
biological females, this translated to an estimated variability in population prevalence 
ranging from 0.01 to 2.6% depending on having either a female- or male-typical 
neurophenotype.  
 
Conclusions: Male-typical neurophenotypes are associated with higher probability 
for having an ASD diagnosis than female-typical neurophenotypes across a range of 
neuroanatomical features. In addition to genetic and environmental factors, normative 
sex-related phenotypic diversity in brain structure should be considered when 
investigating risk and resilience for ASD.   
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6.2 Introduction 
Autism spectrum disorder (ASD) is a complex neurodevelopmental condition 
estimated to be 2-5 times more common in males than females (Lai et al., 2015, 
Fombonne, 2009). While the preponderance of males with ASD has partially been 
attributed to sex differences in clinical phenotypes (Szatmari et al., 2012, Bölte et al., 
2011, Dworzynski et al., 2012, Mandy et al., 2012, Solomon et al., 2012), etiological 
models propose that factors inherent to normative sex differences may modulate ASD 
liability (for review see (Werling, 2016)). However, it remains unknown what “male 
risk” and/or “female protective” factors may contribute to the male preponderance of 
ASD, and how these factors may affect the biological underpinnings of the condition.  
 
To identify potential sex-related risk (and protective) factors, we recently examined 
the probability of ASD as a function of normative sex-related phenotypic diversity in 
brain structure (Ecker et al., 2017). To do so, we initially developed a multivariate 
predictive model of biological sex based on differential patterns of brain structure in a 
sample of typically developing (TD) males and females. This model of normative sex 
differences was subsequently applied to males and females with ASD, which allowed 
us to (i) examine the probability of ASD along a phenotypic axis, ranging from the 
characteristic female to male brain phenotype, and (ii) identify patterns of sex-related 
neuroanatomical variability associated with low and high probability of ASD. In this 
previous study we reported that normative sex-related phenotypic diversity in brain 
structure significantly affects the risk of ASD in addition to biological sex alone, with 
male-typical neuroanatomical characteristics carrying a higher intrinsic risk for ASD 
than female-typical characteristics. This increased risk was predominantly driven by a 
phenotypic shift of the brain in females with ASD for a male-typical rather than 
female-typical presentation. Moreover, using a mapping approach that enabled us to 
estimate patterns of atypically at the level of each individual subject (Marquand et al., 
2014), we demonstrated that high and low risk of ASD is associated with particular 
patterns of neuroanatomical variability that included many of the brain regions where 
males typically differ from females on average (e.g. (Sowell et al., 2007, Im et al., 
2006)). Taken together, these findings highlight the need for considering normative 
sex-related phenotypic diversity in addition to genetic and environmental factors 
when estimating an individual’s risk for ASD. 
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However, in this prior ‘proof-of-concept’ study, our analysis was based exclusively 
on measures of cortical thickness (CT) as previous neuroimaging studies have shown 
CT to be highly variable between TD males and females (Sowell et al., 2007, Im et 
al., 2006), and significantly altered in individuals with ASD (Wallace et al., 2010, 
Ecker et al., 2013). Thus, as has been raised by others (Cahill, 2017), it is unknown 
whether or how our initial findings generalize to other morphometric features that 
have been reported to be atypical in ASD. These include vertex-wise estimates of 
surface area (SA; (Ecker et al., 2013)), the local gyrification index (lGI; (Ecker et al., 
2016, Schaer et al., 2013)), and sulcal depth (SULC; (Nordahl et al., 2007)). Here, we 
extended these findings to consider multiple aspects of brain anatomy including both 
volumetric and geometric cortical features in order to (i) provide a more 
comprehensive characterization of normative sex related differences in brain 
structure, (ii) determine how diversity in sex based neurophenotypes are associated 
with ASD probability, and (iii) estimate how much ASD prevalence in the general 
population might vary as a function of normative sex-related phenotypic diversity. 
We expect that our initial finding of a phenotypic shift of the brain in ASD females 
towards a more male-typical neurophenotype generalizes to other morphometric 
features, and for sex differences in cortical morphometry to be associated with 







98 right-handed adults with ASD (49 males and 49 females) and 98 age and IQ 
matched TD controls (51 males and 47 females) aged 18-42 years were recruited by 
advertisement and assessed at the Institute of Psychiatry, Psychology and 
Neuroscience (IoPPN), London, and the Autism Research Centre, Cambridge. 
Approximately equal ratios of cases to controls, and males to females, were recruited 
within sites (Table 6.1). Exclusion criteria included a history of major psychiatric 
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disorder (e.g. psychosis), head injury, genetic disorder associated with ASD (e.g. 
fragile-X syndrome, tuberous sclerosis), or any other medical condition affecting 
brain function (e.g. epilepsy). We also excluded participants on antipsychotic 
medication, mood stabilizers or benzodiazepines. 
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Table 6.1. Participant Demographics and Global Brain Measures 
  ASD (n = 98) TD Control (n = 98) 
   
Male Participants (n = 100) n = 49 n = 51 
   
Age [years] 26.16 ± 7.2 (18 - 41) 27.22 ± 5.58 (18 - 42) 
Full-scale IQ (WASI) 112.61 ± 12.27 (89 - 135) 114.67 ± 10.88 (93 - 137) 
Verbal IQ 110.51 ± 13.01 (83 - 137) 109.86 ± 11.03 (88 - 137) 
Performance IQ 112.00 ± 13.65 (85 - 138) 116.74 ± 10.90 (93 - 133) 
ADI-R Social 17.57 ± 5.50 (10 - 28) - 
ADI-R Communication 13.86 ± 4.16 (8 - 24) - 
ADI-R Repetitive Behavior 4.96 ± 2.37 (1 - 10) - 
ADOS Social + Communication 9.43 ± 4.39 (1 - 21) - 
ADOS Stereotypic Behaviour 1.27 ± 1.27 (0 - 5) * - 
Mean Cortical Thickness [mm] 2.35 ± 0.10 2.33 ± 0.10 
Mean Surface Area 0.7680 ± 0.71 0.7683 ± 0.05 
Mean local Gyrification Index 3.04 ± 0.12 3.04 ± 0.10 
Mean Sulcal Depth 0.0341 ± 0.007 0.0356 ± 0.006 
Total Grey Matter Volume [litre] 0.76 ± 0.08 0.76 ± 0.05 
Total Intracranial Volume [litre] 1.59 ± 0.21 1.58 ± 0.17 
   
Female Participants (n = 96) n = 49 n = 47 
   
Age [years] 27.60 ± 7.12 (18 - 48) 27.60 ± 7.31 (19 - 52) 
Verbal IQa 116.60 ± 12.15 (76 - 144) 117.83 ± 8.81 (96 - 135) 
Performance IQa 110.56 ± 14.50 (67 - 138) 114.38 ± 8.26 (96 - 128) 
Full-scale IQ (WASI) 114.88 ± 12.36 (84 - 136) 118.38 ± 7.32 (99 - 129) 
ADI-R Social 16.32 ± 4.24 (10 - 26) - 
ADI-R Communication 12.43 ± 3.96 (7 - 22) - 
ADI-R Repetitive Behavior 4.36 ± 1.98 (1 - 9) - 
ADOS Social + Communication 7.71 ± 5.28 (0 - 19) - 
ADOS Stereotypic Behaviour 0.75 ± 0.97 (0 - 3) * - 
Mean Cortical Thickness [mm] 2.32 ± 0.11 2.34 ± 0.10 
Mean Surface Area 0.6895 ± 0.05 0.6865 ± 0.06104 
Mean local Gyrification Index 2.95 ± 0.09 2.96 ± 0.10 
Mean Sulcal Depth 0.0378 ± 0.008 0.0380 ± 0.007 
Total Grey Matter Volume [litre] 0.67 ± 0.06 0.68 ± 0.06 




thickness,	 total	grey	matter	volume,	or	total	 intracranial	volume	(p<0.05,	 two-sided).	ADI-R	values	
based	 on	 49	males	 and	 44	 females	 with	 ASD.	 ADOS	 values	 based	 on	 49	males	 and	 48	 females.	 *	




All participants with ASD were diagnosed according to International Statistical 
Classification of Diseases, 10th Revision (ICD-10) research criteria. Clinical 
diagnoses were confirmed using the Autism Diagnostic Interview Revised (ADI-R; 
(Lord et al., 1994)(19)) or the Autism Diagnostic Observation Schedule (ADOS; 
(Lord et al., 2000)). All ADI-R diagnosed participants reached algorithm cut-offs in 
the three domains of the ADI-R, although failure to reach cut-off in one domain by 
maximally two points was permitted. Due to reliable informants being unavailable, 
we were unable to obtain ADI-R diagnostic data from five females with ASD, for 
whom diagnostic status was confirmed using ADOS-G cut-offs for ASD. In all other 
participants, ADOS-G scores were used to assess the severity of current symptoms 
and were not used as an inclusion criterion. One female with ASD fell short one point 
on the ADI-R communication and repetitive domain but met ADOS-G criteria. 
Overall intellectual ability was assessed using the Wechsler Abbreviated Scale of 
Intelligence (Wechsler, 1999)(21). All participants had a full-scale IQ greater than 80 
and gave informed written consent in accordance with ethics approval by the National 
Research Ethics Committee, Suffolk, UK. 
 
6.3.2 Structural MRI Data Acquisition 
Scanning took place at the IoPPN, London, and the Addenbrooke’s Hospital, 
Cambridge, using matched 3T GE Signa systems (General-Electric, Milwaukee, 
USA). A quantitative T1-mapping sequence was used to ensure standardization of 
structural MRI scans across scanner platforms (Deoni et al., 2008, Ecker et al., 2012), 
which resulted in high-resolution structural T1-weighted inversion-recovery images, 
with 1x1x1mm resolution, a 256x256x176 matrix, TR=1800ms, TI=50ms, FA=20’’, 
and FOV=25cm. 
 
6.3.3 Cortical Reconstruction using FreeSurfer 
FreeSurfer v5.3.0 software (http://surfer.nmr.mgh.harvard.edu/) was used to derive 
tessellated models of the cortical surface for each T1-weighted image. These well-
validated and fully automated procedures have been extensively described elsewhere 
(e.g. (Dale et al., 1999, Fischl et al., 1999, Ségonne et al., 2004, Jovicich et al., 2006, 
Fischl and Dale, 2000)). Resulting surface models were visually inspected for 
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reconstruction errors. Surface reconstructions with visible inaccuracies were further 
excluded from the statistical analysis and are not described in this study. Dropout 
rates were equal across groups and were <10% of the total sample.   
From each individual’s surface reconstructions four separate vertex based 
morphometric cortical features were calculated. (i) Cortical thickness (CT), i.e. the 
closest distance between corresponding vertices between the grey-white matter and 
gray matter-cerebrospinal fluid boundaries (Fischl and Dale, 2000); (ii) vertex-wise 
estimates of pial (i.e. grey matter) surface area (SA) (Winkler et al., 2012). And 
measures of cortical geometry including (iii) the local gyrification index (lGI) (Schaer 
et al., 2008) and (iv) sulcal depth (SULC, i.e. average convexity, the depth/height of 
each vertex above the average cortical surface). Prior to further analysis all features 
(excluding lGI) were smoothed using a 15mm surface-based FWHM Gaussian kernel. 
As lGI utilizes SA values sampled within spherical regions on interest with a 15mm 
diameter, no additional smothing was performed for this measure.  
 
6.3.4 Gaussian Process Classification 
Gaussian Process Classification (GPC) (Rasmussen and Williams, 2006, Marquand et 
al., 2010) models were employed to discriminate biological sex among TD 
participants on the basis of each of the four cortical features (i.e. CT, SA, lGI, SULC) 
separately. These classifiers provide a predictive class probability (yp) for each 
individual ranging from 0 to 1 for the characteristic female to male brain phenotype, 
with yp=0.5 serving as the binary cut-off between classes. The overall classification 
accuracy of each model was estimated using leave-one-out cross validation and tested 
for significance by repeating the cross-validation procedure n=1,000 times after 
randomly permuting the class labels. Subsequently, we applied these four classifiers 
for biological sex in TD participants to predict the sex of males and females with 
ASD. The resulting classification accuracies for the ASD cases were tested for 
statistical significance using permutation testing as outlined above.  
To visualize the patterns of brain regions representative of normative sex differences, 
we present spatial representations of the maximum a-posteriori estimate of each 
model’s weight vector (w), which is indicative of the regional contribution to the 
overall prediction of biological sex (Marquand et al., 2010). For each classifier, w was 
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derived by training the GPC on all TD individuals. As individuals with ASD were not 
included in the initial training of the classifiers they do not contribute to w, thus we 
used a  “predictive mapping” approach (Marquand et al., 2014) to determine which 
cortical features are driving sex related differences in ASD among groups of males 
and females with high and low probability for ASD. Here, groups of high and low 
ASD probability were determined according to predicted class probabilities, with 
yp>0.5 (i.e. male-typical phenotype) representing high and yp<0.5 (i.e. female-typical 
phenotype) representing low probability. For each test example i in both male (and 
female) high (and low) probability groups j, we calculated the element-wise (i.e. 
Hadamard) product of each individuals data (xij) and the corresponding weights (w), 
so that (xij).*k (Marquand et al., 2014). For each group (i.e. male and female, high 
and low ASD probability) brain regions contributing the most to the classification 
were summarized by taking the mean of the (xij).*k values at each vertex.  
 
6.3.5 Estimating ASD Probability 
To examine how normative sex based phenotypic diversity in brain structure is 
associated with probability for ASD we first calculated the mean of each individual’s 
predictive class probabilities across the four classification models. This provided a 
single class probability for each individual that takes into account normative sex 
variability across all four cortical features. We then converted the continuous axis of 
class probabilities into a set of discrete bins (e.g., from 0 to 1 in steps of 0.125). 
Within each bin, the sample probability of ASD was calculated as the ratio of the 
number of individuals with ASD relative to the total number of individuals within the 
bin. Confidence intervals for these sample probabilities were determined using an 
exact binomial test implemented in R Project for Statistical Computing 
(https://www.r-project.org). Furthermore, these data allowed us to estimate the 
population prevalence of ASD given a male- or female-typical neuroanatomical 
phenotype in addition to being biologically male or female. Details of these methods 
are provided in the supplementary materials. In brief, using Bayes theorem, we 
combined our sample prevalence estimates with previously published prevalence rates 
of ASD for biological male and female individuals in the general population (i.e., 
1:42 for male and 1:189 for female individuals; (Baio, 2014)). In this way, we were 
able to estimate the population prevalence of ASD diagnosis (D = 1) given an 
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individual’s predicted neuroanatomical sex phenotype (M) and biological sex (S), that 
is ℙ(D = 1 | M, S). 
 
6.3.6 Vertex-wise between-group comparison of cortical measures 
Vertex-wise statistical analyses of each cortical feature were conducted using the 
SurfStat toolbox (www.math.mcgill.ca/keith/surfstat/) for MATLAB (R2014a, The 
Mathworks, Massachusetts). For the comparisons between TD males and females, 
parameter estimates were obtained by regression of a GLM at each vertex i with 
biological sex and center as categorical fixed-effects factors, and total grey matter 
(GM) volume as a continuous covariate. To examine whether the neuroanatomy of 
ASD is significantly modulated by biological sex, we also included a main effect of 
diagnostic group and a group-by-sex interaction, i.e. 
 
Yi = β0 + β1 Group + β2 Sex + β3 (Group x Sex) + β4 GMtotal + β5 Center + εi, 
 
where εi is the residual error. Additionally, total SA was used as a continuous 
covariate for analyses of SA. Effects of interest were estimated from the coefficients 
β1-3 normalized by the corresponding standard error. Corrections for multiple 
comparisons were performed using a ‘random field theory’ (RFT)-based cluster 
analysis for non-isotropic images at a cluster-threshold of p<0.05 (two-tailed) 
(Worsley et al., 1999).  
6.4 Results 
6.4.1 Participant Demographics and Global Brain Measures 
There were no significant differences between all individuals with ASD and TD 
controls in age (t(194)=-0.53, p=0.598), full-scale IQ (t(194)=-1.72, p=0.086), mean 
CT (t(194)=0.08, p=0.936), mean SA (t(194)=0.03, p=0.976), mean lGI (t(194)=0.24, 
p=0.810), mean SULC (t(194)=0.67, p=0.499), and total GM volume (t(194) = -0.20, 
p=0.839). There were also no significant differences between males and females in 
age (t(194)=-0.93, p=0.356), full-scale IQ (t(194)=-1.87, p=0.063), mean CT 
(t(194)=0.95, p=0.344), or mean SULC (t(194)=-2.80, p=0.006) across diagnostic 
groups. As expected, total grey matter volume was significantly larger in males than 
in females (t(194)=9.11, p<0.001). Furthermore, across the entire sample males 
	 151	
showed significantly greater mean SA (t(194)=9.43, p<0.001) and mean lGI 
(t(194)=5.56, p<0.001) than females. There were no significant differences in any of 
these measures between TD and ASD males, or between TD and ASD females 
(p<0.05, 2-tailed). 
 
6.4.2 Prediction of Biological Sex Based on Normative Variability in 
Cortical Morphometry 
Across all four vertex based cortical features GPC was able to separate male from 
female TD controls at cross validated accuracies significantly above what would be 
expected by chance (SA 78%, p<0.001; CT 71%, p<0.001; SULC 74%, p<0.001; lGI 
77%, p<0.001). Using each classifiers predictive class probabilities for individuals we 
were able to represent normative sex based variability in brain phenotypes along a 
singular phenotypic axis, ranging from the female- to male-typical neurophenotype 
(Figure 1). For each morphological measure, the GPC model weights (w) followed a 
spatial pattern similar to the distribution of group differences observed between TD 
males and females as determined via a conventional GLM (Figure 6.1, Supplementary 









6.4.3 Prediction of Biological Sex Among Individuals with ASD 
When predicting biological sex for individuals with ASD we found that females with 
ASD were more frequently allocated to the male rather than the female class in all 
four models (SA 71%, p=0.002; CT 80%, p=0.002; SULC 65%, p=0.009; lGI 78%, 
p=0.001). Females with ASD were significantly allocated to the male class more 
frequently than would be expected based on the typical rates of misclassification for 
female controls (SA χ2=26.41, p<0.001; CT χ2=22.15, p<0.001; SULC χ2=13.65, 
p<0.001; lGI χ2=26.01, p<0.001). Furthermore, the mean across the predicted class 
probabilities for ASD females was significantly increased in females with ASD 
relative to female controls, indicating a shift towards male-typical morphological 
patterns in the brain (SA t=6.158, p<0.001; CT t=6.13, p<0.001; SULC t=4.44, 
p<0.001; lGI t=6.85, p<0.001). Across all four models there were no significant 
differences (p<0.05) between the predicted class probabilities for TD and ASD males, 
or between males and females with ASD. 
 
6.4.4 ASD Probability as a Function of Normative Sex Variability in 
Cortical Morphometry 
Within our sample we found that the number of individuals with ASD significantly 
increased along the female to male phenotypic axis (i.e. from female to male) as 
defined by predicted class probabilities. This effect was predominantly driven by the 
shift of females with ASD towards a more male-typical neuroanatomical brain 
phenotype (See Figure 6.2, Supplementary Figure 2). When these sample probabilities 
were combined with previously reported ASD prevalence rates in the general 
population among males (1/43, i.e. 2.3%) and females (1/190, i.e. 0.5%) (Baio, 2014), 
we found that biological females with male-typical brain morphology (0.1% estimated 
prevalence) were twenty six times more likely to have ASD compared to biological 
females with female-typical neuroanatomical phenotypes (2.6% estimated 
prevalence). Biological males with male-typical brain morphometry showed an 
estimated population prevalence of 2.4% in line with previously reported rates. 
However, males with female-typical phenotypes showed a reduced prevalence 
estimate for ASD (1.9%) indicative of a ‘female protective effect’ in relation to brain 










Predictive maps identifying patterns of neuroanatomical variability associated with 
high and low probability of ASD across sexes are shown in Figure 6.3. While a 
similar set of brain regions conferred high (and low) probability for ASD in men and 
women within features, certain brain regions were unique to or differed in sign 
between particular risk groups and sexes. For example, negative predictive mapping 
values for CT in the left parahippocampal gyrus and SULC in the superior temporal 
gyrus were observed across all males and high-probability females, while low 
probability females showed positive values in these regions. For predictive mapping 
measures of SA and lGI, regions of the inferior and superior temporal gyri appear to 
show a sex-specific relationship with high probability males showing negative values 
compared to positive values amongst females and low probability males. This 
indicates that morphometric measures in particular brain regions that are important for 
classifying sex differences differ between individuals with high and low risk for ASD 
and may be sex-specific. 
Figure	 6.2	 Probability	 for	 ASD	 as	 a	 Function	 of	 Normative	 Sex-Related	 Phenotypic	 Variability	 in	 Brain	
Morphology:	Probability	estimates	for	ASD	across	eight	discrete	bins	along	the	axis	of	probabilistic	class	
predictions	 for	 biological	 sex	 are	 plotted	 for	 (A)	 biological	 females	 and	 (B)	 males.	 Each	 individual’s	
probabilistic	class	prediction	was	calculated	as	the	mean	prediction	across	all	four	classification	models.	




 Figure	 6.3	 Prediction	Maps	 for	High	 and	 Low	 ASD	 Probability	Males	 and	 Females:	 Prediction	maps	 highlighting	 brain	 regions	most	 relevant	 to	
classifying	biological	sex	among	high	and	low	risk	males	and	females	are	shown	for	each	cortical	feature,	(A)	cortical	thickness	(CT),	(B)	surface	area	





6.4.5 Cortical Morphometry in ASD is Modulated by Biological Sex  
Lastly, we used a conventional GLM to test for significant between-group differences 
and diagnosis-by-group interactions in the four examined morphometric features. 
Overall, we found that measures of CT, SA, and lGI in ASD were significantly 
modulated by biological sex (Figure 6.4, also Supplementary Figure 3). Such group-
by-sex interactions therefore need to be taken into account when interpreting main 
effects of group. Significant group-by-sex interactions in measures of CT were 
observed across the temporal lobe, including the fusiform and parahippocampal gyri. 
Across this cluster the degree of CT abnormality in females with ASD exceeded those 
of males, despite no differences in measures of ASD symptom severity (9). 
Additionally, group-by-sex interactions were observed for measures of SA and lGI in 
the medial orbital frontal cortex showing decreases in females with ASD and 
increases in males with ASD. Statistical details of these clusters are provided in 












The present study builds upon a previous ‘proof-of-concept’ suggesting that 
probability of ASD increases significantly from a characteristic female to male 
neuroanatomical brain phenotype (Ecker et al., 2017). In this prior study, which 
examined measures of cortical thickness (CT) only, the increase in ASD probability 
was predominantly driven by a phenotypic shift of the brain in females with ASD 
towards a male-typical neurophenotype (Ecker et al., 2017). In the current study, we 
show that this phenotypic shift is not restricted to measures of CT, but generalizes to 
other cortical features including vertex-wise estimates of surface area (SA), the local 
gyrification index (lGI), and sulcal depth (SULC). The findings of the present study 
therefore not only support our original report in suggesting that male-typical 
neuroanatomical characteristics carry a higher probability for ASD than female-
typical characteristics, but further show this effect to be broadly and consistently 
related across multiple measures of cortical morphometry. 
 
The extension of our approach to include multiple morphometric features is of crucial 
importance as there is evidence to suggest that different cortical features are 
etiologically and phenotypically distinct. For example, it has been shown that 
measures of CT and SA (i) are mediated by different sets of genes (Panizzon et al., 
2009), (ii) have different developmental trajectories (Ecker et al., 2014), and (iii) 
represent distinct aspects of the cortical architecture (Rakic, 1995). Therefore, the 
observation that the phenotypic shift of the brain in ASD females is consistent across 
morphometric features may indicate the existence of a common underlying 
mechanism, such as atypical cortical neurogenesis and migration (Casanova, 2014), 
that steers multiple aspects of brain anatomy towards a similar phenotypic endpoint 
overall. Yet, the neuroanatomical patterns associated with the prediction of biological 
sex, and the patterns carrying high/low ASD probability in males and females, 
differed in sign and regional distribution between the cortical features. Thus, while 
there may be a common etiology for the phenotypic differences in brain anatomy in 
ASD within the sexes, our findings are consistent with the notion that sex 
differentiation mechanisms in the brain have region specific effects (for review see 
(McCarthy, 2017, McCarthy and Konkle, 2005)). Therefore, differences in these 
neuroanatomical patterns associated with high probability for ASD may be beneficial 
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in identifying brain regions where sexual differentiation may contribute to male 
preponderance in ASD. 
 
Moreover, we established that the neuroanatomy of ASD in some regions of the brain 
is modulated by biological sex by examining sex-by-diagnosis interactions for 
multiple cortical features. This suggests that in these brain regions (i) there are not 
only quantitative differences in the degree of neuroanatomical abnormality between 
males and females with ASD and their respective normative population, but also that 
(ii) ASD potentially interacts with sexually-differential neurobiological phenotypes to 
give rise to qualitative differences in brain anatomy between males and females with 
the condition. This is also relevant in view of a recent genetic study, suggesting that 
while ASD risk genes are expressed at similar levels in males and females, the impact 
of these genes is likely modulated by their interactions with sex-differential processes 
(e.g. in cortical microglia and/or astrocytes) that may play a critical role in setting 
males at a greater risk for ASD (Werling et al., 2016). An individual’s risk or 
probability of ASD is therefore not only dependent on genetic load itself, but also on 
naturally occurring sex-differential biological pathways. 
 
With respect a biological organ as complex as the brain it has been suggested that on 
a phenotypic level, the brain should be considered a ‘mosaic’ of regions that differ 
between degrees of relative maleness or femaleness, or not at all (i.e. unisex), 
resulting in a potentially infinite variety of brain phenotypes both within and between 
sexes (McCarthy, 2017, McCarthy and Konkle, 2005). In order to identify an 
individual’s position on such a multi-dimensional ‘spectrum’ of sex-related 
phenotypic variability, it is important to develop analytical frameworks that can 
accommodate inter-individual phenotypic diversity within and across the binary 
categories dictated by biological sex, such as the probabilistic multivariate pattern 
classification approach utilized in the present study (see also (Ecker et al., 2017)). In 
this way we were able to estimate an individual’s risk of ASD based on phenotypic, 
rather than biological sex and in doing so demonstrated that an individual’s 
probability for developing ASD may vary from as much as 0.1 to 2.6% in the general 
population depending on having a female- or male-typical neuroanatomical 
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phenotype, in addition to being biologically male or female. Our approach to 
modeling normative sex-related phenotypic diversity may therefore be extended to 
various additional phenotypic features in the future, and to contribute to the 
development of multivariate disease liability models for complex neurobiological 
phenotypes. 
 
Despite the advantages of the current approach over the original proof-of-concept 
study, a number of limitations remain. Most importantly, it is crucial to highlight that 
while we were able to show a statistical association between normative sex-related 
phenotypic diversity in brain structure and ASD probability, this relationship should 
not be interpreted as being ‘causal’. Future studies will be needed to uncover the 
genetic and/or neurobiological mechanisms underpinning this relationship (e.g. 
(Baron-Cohen et al., 2015, Werling et al., 2016, Lai et al., 2017)). Second, due to the 
limited range of clinical/behavioral measures acquired in the current study, we were 
unable to determine the functional relevance of our findings. In the future it will be 
crucial to identify how diversity in normative sex-related morphometric phenotypes 
relates to sex-differences in general cognitive and/or behavioral profiles (Miller and 
Halpern, 2014, Hyde, 2016), or to different clinical ASD phenotypes (Szatmari et al., 
2012, Bölte et al., 2011, Solomon et al., 2012, Mandy et al., 2012). Last, our study 
was based on a sample of adults with ASD without learning disability using a cross-
sectional study design. The fact that our sample is not representative of the entire 
ASD population limits the generalizability of our sample probability estimates for 
ASD to the general population. Furthermore, our population estimations are based on 
previously reports of male preponderance in ASD being roughly a 4:1 male to female 
ratio (Baio, 2014), however other studies have shown this ratio may actually to be 
closer to 2:1 (Werling, 2016). The nature of our sample means further studies will 
thus be required to (i) replicate our findings in other subgroups on the autism 
spectrum (e.g. in children and adolescents, or individuals with a learning disability), 
and (ii) to identify how stable (or variable) our neuroanatomical indicators of 
biological sex are across different stages of development. 
	 161	
6.6 Conclusions 
Taken together, our findings suggest that the male-typical neurobiological brain 
phenotype carries a higher probability for ASD than the female-typical phenotype 
across the binary categories dictated by biological sex, and across a range of 
neuroanatomical features that include both volumetric as well as geometric measures. 
In addition to genetic and environmental factors, multiple morphometric features 
characteristic of normative phenotypic diversity in brain structure should therefore be 
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Chapter 7: General Discussion 
 
The studies that comprise this thesis employed structural magnetic resonance imaging 
(MRI) and novel analytical frameworks to address three overarching aims, namely i) 
developing novel neuroimaging features that are informative (e.g. of diagnostic or 
prognostic value) for the condition, ii) evaluating the efficacy of structural 
neuroimaging features to identify ASD cases within the clinical setting, and iii) 
investigating the role of normative sex differences in brain structure and their 
influence on the probability for ASD. Collectively these studies share the broader goal 
of advancing the field of neuroimaging research in a direction that provides real world 
translational value for ASD individuals and stakeholders. First, the present chapter 
aims to summarize the key findings of each of the four studies that were presented in 
this thesis. Second, possible interpretations of these results are provided, particularly 
with regards to moving neuroimaging studies in ASD closer to the development of 
translational imaging tools. Last, strengths and limitations of the presented studies 
will be discussed, followed by final conclusions.  
 
7.1 Summary and Key Findings 
7.1.1 Study 1: Tissue Contrast as a Novel Imaging Marker in Autism 
Spectrum Disorder 
The aim of this study was to determine if previous post-mortem reports of poor 
definition of the grey–white matter boundary in autism spectrum disorder (ASD) 
(Avino and Hutsler, 2010) could be detected using a whole brain in vivo MRI 
approach. To accomplish this, we used a novel application of tissue signal intensity 
contrast measures sampled at and around the grey-white matter boundary (Salat et al., 
2009, Andrews et al., 2017). As hypothesized, we determined that individuals with 
ASD had significantly less well-defined grey-white matter percent contrast (GWPC) 
across the grey-white matter boundary. This effect appeared to be largely driven by an 
increase in grey matter signal intensities in individuals with ASD. Taken together, our 
findings suggest that measures of GWPC sampled across cortical layers may serve as 
an in vivo proxy measure for irregular microstructural organization of the cortex in 
ASD. 
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7.1.2 Study 2: Clinical Validation of Multivariate Pattern Classification 
Models for Autism Spectrum Disorder 
This study sought to first establish predictive models for the broader ASD phenotype 
based on measures of cortical neuroanatomy within a well-defined sample consisting 
of typically developing (TD) and ASD male adults acquired in the research setting. 
The second and primary aim of this study was to test the efficacy of these 
classification models to identify individuals with ASD within an independent clinical 
sample. Two different well established pattern classification algorithms, namely the 
support vector machine (SVM; Vapnik, 1995) and Gaussian process classifier (GPC; 
Rasmussen and Williams, 2006, Marquand et al., 2010), were used to establish 
classifiers based on the research sample utilizing measures of either cortical volume, 
thickness (CT), surface area (SA), the local gyrification index (lGI), sulcal depth 
(SULC), or grey-white matter percent contrast (GWPC). Based on previously 
reported findings (Ecker et al., 2010, Jiao et al., 2010) we hypothesized that these 
structural measures are able to discriminate individuals with ASD and TD controls 
significantly above chance levels. However, given differences in inclusion criteria 
between our research training and clinical testing samples, and based on previous 
findings of classification models showing reduced performance in the range of 10-
15% when applied to independent testing sets (Sabuncu and Konukoglu, 2014), we 
expected a reduction in overall accuracy when predicting ASD diagnosis within the 
clinical sample.  
 
While some classifiers showed modest classification accuracies (61%) within the 
research sample, we were not able to establish the statistical significance of these 
classifiers due to the small size of our training set. However, in an exploratory 
analysis we applied our best performing models to predict ASD diagnoses within the 
independent clinical sample. We established that the majority of these models showed 
decreased overall classification accuracies within the clinical testing set. One noteable 
exception to this was the GPC utilizing measures of grey-white matter percent 
contrast (GWPC) sampled at the grey-white matter boundary (Andrews et al. 2017), 
which showed high overall accuracy within the clinical sample (81%). However, 
given this model’s initial performance in the research setting this result must be 
considered as preliminary at best. 
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7.1.3 Studies 3 and 4: Association of Normative Sex-Related Phenotypic 
Diversity in Brain Structure with Probability for Autism Spectrum 
Disorder 
These two studies sought to directly investigate possible biological underpinnings of 
male preponderance in ASD (Lai et al., 2017, Werling, 2016). The aims of these 
studies were three-fold; i) to provide a phenotypic characterization of normative sex 
related diversity in brain structure, ii) to determine how diversity in sex based 
neurophenotypes is associated with probability for ASD, and iii) to estimate 
variability in ASD prevalence in the general population as a function of normative 
sex-related phenotypic diversity in brain structure. To accomplish this, we first 
established normative predictive models in male and female TD individuals for the 
binary classes dictated by biological sex. In study 3, we report initial findings using 
measures of CT (Ecker et al., 2017), and in study 4 we extended the analytical 
framework to include measures of SA, lGI, and SULC. The use of GPC (Rasmussen 
and Williams, 2006, Marquand et al., 2010) allowed us to effectively represent the 
diversity of sex based neurophenotypes along a singular axis dictated by predictive 
class probabilities ranging from the female- to male-typical neurophenotype. Once 
established, these normative models were applied to males and females with ASD.  
 
In both studies we found that sample probabilities for ASD increased with predicative 
probabilities for the male-typical class. This was largely due to a statistically 
significant shift towards more male-typical neurophenotypes in females with ASD 
across all cortical measures. We then extrapolated sample probabilities for ASD 
among individuals with female- and male-typical neurophenotypes to estimate their 
association with ASD prevalence within the general population. Based on previous 
population prevalence estimates (Baio, 2014), we demonstrate that biological females 
with more male-typical brain morphology (2.6% estimated prevalence) are 26 times 
more likely to have ASD compared to biological females with female-typical 
neuroanatomical phenotypes (0.1% estimated prevalence). Biological males with 
male-typical brain morphometry showed an estimated population prevalence of 2.4%, 
which is in line with previously reported rates. In addition, males with female-
typical phenotypes showed a reduced prevalence estimate for ASD (1.9%). Taken 
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together, these results support the notion that there is differential liability for ASD 
between the sexes, which increases from a female to male phenotypic presentation of 
the brain, and is also indicative of a ‘female protective effect’ for ASD in terms of 
brain anatomy.  
 
7.2 Discussion 
7.2.1 The Development of Imaging Features for Autism Spectrum 
Disorders 
The past decade has seen several advances in the development of structural MRI 
features to study the neuroanatomical underpinnings of ASD. Studies continue to 
move away from investigating relatively unspecific, gross-anatomical measures, such 
as total brain volume, to using more advanced metrics that represent particular aspects 
of neuroanatomical structure and development (Ecker et al., 2015). For example, 
surface based morphometry (SBM) measures of CT and SA have been shown to be i) 
mediated by different sets of genes (Panizzon et al., 2009), ii) have different 
developmental trajectories (Ecker et al., 2014), and iii) represent distinct aspects of 
the cortical architecture (Rakic, 1995). Thus, these measures are well suited to explore 
etiological theories for ASD, which suggest that the condition arises from atypical 
neuronal proliferation, migration, and maturation (Casanova, 2014). The development 
of novel neuroimaging features that map onto specific aspects of the ASD phenotype 
thus offers the potential for both greater insight into the biological underpinnings of 
ASD, and the possibility for such features to act as imaging biomarkers.  
 
One neuropathological finding that remained relatively underexplored in vivo is 
atypical cell patterning at the grey-white matter boundary in ASD (Avino and Hutsler, 
2010). The current thesis presented a novel in vivo approach to quantify this specific 
neuroanatomical feature (Andrews et al., 2017). This was done with the purpose of 
investigating a critical aspect of neurodevelopment believed to contribute to poor 
grey-white matter boundary integrity in ASD, namely the formation and resolution of 
the cortical subplate (Hoerder-Suabedissen and Molnár, 2015). During 
neurodevelopment, cells within the subplate are critical for establishing proper 
cortical structure and connectivity by guiding both migrating neurons and innervating 
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cortico-cortico and thalamo-cortical axons (Allendoerfer and Shatz, 1994). Thus, 
disruptions to subplate development and apoptosis may contribute to both atypical 
cortical structure and connectivity observed within ASD (Hutsler and Avino, 2015).  
 
The importance of the subplate in establishing inter-cortical connectivity is supported 
by reports suggesting that this structure is thicker within highly connected cortical 
association areas (Kostovic and Rakic, 1990). This has recently been linked to the 
downward dispersion of subplate cells resulting from a high degree of axonal 
innervation in these regions (Duque et al., 2016). Within the current study, significant 
increases in grey matter signal intensity in ASD were largely localized to association 
areas that underpin social processing and wider socio-cognitive functioning, including 
regions of the temporal lobe, the temporal parietal junction, and fusiform gyrus. Thus, 
the increased signal intensities in adults with ASD in these regions may reflect the 
consequences of an atypical formation of cortical connections during early brain 
development, potentially resulting in increased myelination and hyper local 
connectivity (Belmonte et al., 2004). 
 
Moreover, our examination of grey-white matter percent tissue contrast (GWPC) at 
the grey-white matter boundary represents a direct attempt to quantify a specific 
neuropathological mechanism in ASD (i.e. poor delineation of this boundary). 
Accordingly, this feature is likely to have greater effects sizes within ASD individuals 
than other, more general measures of cortical morphometry. This is of key importance 
for translational studies seeking to use brain imaging features to make prognostic or 
diagnostic predictions within ASD. For example, in the context of pattern recognition 
it has been shown that the best predictor of successful classification of ASD is not the 
particular algorithm used but training models on imaging features with significant 
effects sizes in the condition (Sabuncu and Konukoglu, 2014). Thus, measures such as 
GWPC that map onto particular aspects of ASD neuropathology are likely to be 




7.2.2 The Development of Diagnostic Imaging Tools for Autism 
Spectrum Disorder 
Increasingly, through applications of multivariate pattern classification, studies have 
provided proof of concept evidence that individuals with ASD can be identified with 
high accuracy in the research setting based on neuroimaging features (Ecker et al., 
2010, Ingalhalikar et al., 2011, Just et al., 2014). The implementation of predictive 
models for ASD would offer significant benefits to patients and stakeholders. Such 
benefits could come through early identification of the condition allowing for 
intervention and treatment to begin at a younger age. Furthermore, this would provide 
clinicians biologically based evidence when making a diagnosis of ASD, which 
currently is reliant solely on behavioral assessments. However, to date no studies have 
tested classification models for ASD trained in the research environment on 
independent samples that are representative of the broader clinical population. This is 
important because inclusion criteria for participation in ASD research are likely to 
introduce several phenotypic differences between research and clinical ASD cohorts. 
 
Within the current study, our best performing classifiers for ASD in the research 
setting showed modest overall accuracies (61%). While this is within the range of 
previous models tested on independent samples (Sabuncu and Konukoglu, 2014, Shen 
et al., 2017), we were not able to establish the statistical significance of these 
classifiers due to the small size of our research sample. However, as an exploratory 
step we applied the best performing classifiers within the training set to predict ASD 
within the clinical sample. We found a GPC based on measures of grey-white matter 
percent contrast (GWPC) taken at the grey-white matter boundary (Andrews et al., 
2017) to have high overall accuracy within the clinical sample (81%) across all 
diagnostic sub-categories (74-88%). This preliminary result supports the concept that 
features developed to map onto particular aspects of ASD neuropathology have an 
increased sensitivity to detect the condition. However, given that we could not show 
this model performed significantly better than chance within the research setting 
(p=0.197), this finding must be considered as suggestive only. 
 
A major impediment to classifying individuals with ASD at high accuracy is the 
highly heterogeneous nature of the phenotype. As a result, maximal classification 
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accuracy based on brain structure across the ASD population is likely to be modest. 
Thus, the development of approaches that directly address phenotypic heterogeneity 
within ASD will be of critical importance for the successful delivery of classification 
methods that have translational value in clinical settings. Several individual variables 
including exogenous factors and genetic disposition may contribute to 
neuroanatomical variance in ASD. One variable that has been shown to have strong 
associations with ASD is biological sex (Lai et al., 2017, Werling, 2016). 
Accordingly, a major theme of this thesis dealt with identifying how normative 
variance in brain structure associated with biological sex is associated with 
probability for ASD. 
 
7.2.3 Neuro-Diversity Associated with Biological Sex and Probability for 
Autism Spectrum Disorder 
It has been suggested that on a phenotypic level, the brain should be considered a 
‘mosaic’ of regions that differ between degrees of relative maleness or femaleness, or 
not at all (i.e. unisex), resulting in a potentially infinite variety of brain 
phenotypes both within and between the sexes (McCarthy, 2017). The studies 
presented in this thesis employed a multivariate classification approach that allowed 
us to represent diversity in sex based neurophenotypes along a continuum ranging 
from typically male to female. This ‘more nuanced’ approach to investigating sex 
differentiation in the brain represents a key advancement as it can accommodate the 
long-standing notion that both males and females are subject to various degrees of 
masculinization and feminization (Whalen, 1974).  
 
Through this normative modelling approach we were able to estimate an individual’s 
probability of ASD based on phenotypic, rather than biological sex. Using this 
approach, we demonstrated that an individual’s probability for developing ASD can 
vary from 0.1 to 2.6% in the general population depending on having a female- or 
male-typical neuroanatomical phenotype, while being biologically male or female. 
Thus, these phenotypic measures that represent variable degrees of sexual 
differentiation in individuals, may serve as an important factor in future multivariate 
disease liability models for complex neurobiological phenotypes such as ASD.  
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Moreover, we established that the neuroanatomical patterns associated with prediction 
of biological sex differed in region and sign between the sexes, and individuals with 
female- and male-typical neurophenotypes. This finding is consistent with the idea 
that sex-dependent mechanisms have region specific effects in the brain, and that the 
neuroanatomical patterns associated with high and low probability for ASD may be 
used to identify brain regions where sexual differentiation contributes to male 
preponderance in ASD prevalence. Given the significant association between 
biological sex and ASD prevalence, these findings contribute to ongoing research 
efforts into the etiological underpinnings of ASD, and potentially other mental health 
disorders with sex differences in prevalence (Cahill, 2017).  
 
7.3 Strengths of the Current Studies 
The studies that comprised this thesis have a number of benefits. First, to the best of 
our knowledge, we present the first study to investigate grey-white matter boundary 
integrity in vivo in ASD. In doing so we established a novel imaging feature in the 
form of percent contrast of grey-white matter signal intensity (GWPC) taken at and 
around the grey-white matter boundary. Given that GWPC potentially maps onto a 
specific neuropathological feature in ASD, the measure is likely to be particularly 
useful to future ASD researchers as it has large effect sizes (i.e. ‘biological footprint’) 
in the condition in comparison to many other cortical morphometric features. Second, 
through collaboration with the Autism Assessment and Behavioural Genetics Service 
at the Bethlem Royal Hospital, South London and Maudsley NHS Foundation Trust, 
we were able to recruit a highly representative sample of ASD individuals within the 
clinical setting. Several neuroimaging studies have sought to develop a diagnostic 
imaging biomarker for ASD within the research setting. However, inherent 
differences in the clinical phenotype between research and clinical ASD samples are 
likely to exist (see Chapter 4.1). Therefore, the recruitment of a clinical sample such 
as the one presented in the current study is of critical importance for testing the 
translational value of classifiers established in the research setting. Third, this thesis 
presents the first proof of concept studies linking normative variability in brain 
structure associated with biological sex to the probability for ASD. A particular 
strength of these studies was the use of Bayesian pattern recognition methods to 
effectively represent biological sex along a continuum. This nuanced approach 
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allowed us to move beyond simple binary sex categories and more fully capture the 
spectra of neurodiversity associated with differentiation between the sexes 
(McCarthy, 2017).  
 
7.4 Limitations 
Collectively, the presented studies face limitations common to several structural 
neuroimaging investigations in ASD. The high cost of MRI along with the significant 
amount of time, energy, and expertise needed to recruit patients to participate in 
imaging research presents inherent limitations on sample sizes. Furthermore, the 
nature of MRI acquisition also hinders the collection of samples that accurately reflect 
the entire spectrum of ASD phenotypes. Often, individuals with particularly severe 
ASD symptoms and/or comorbid learning disability are unable or unwilling to 
conform to the requirements that MRI acquisition demands, namely lying motionless 
within a confined noisy space for an extended period of time. Consequentially, so 
called ‘low functioning’ individuals with ASD are nearly absent within the 
neuroimaging literature.  
Despite these limitations, however, our studies investigating tissue contrast and the 
association between biological sex and ASD probability benefit from relatively large 
sample sizes (n ~100), which is above what has been shown to be required for the 
identification of subtle group differences in cortical measures (n=50, Pardoe et al., 
2013). Furthermore, inclusion of nearly 50 females with ASD represents one of the 
largest imaging samples of females with the condition reported to date. However, the 
recruitment of adult samples introduces limitations when studying a 
neurodevelopmental condition such as ASD that likely originates during early 
prenatal stages of life (Bauman and Kemper, 2005). The developmental trajectories of 
the variety of structural neuroimaging measures within this study are yet to be firmly 
established, but are likely to non-linear and complex (Ecker et al., 2014). Thus, it 
remains uncertain if, and how, the current results identified within adults will translate 
to infants, toddlers, adolescents, and elders with ASD. Ultimately, future longitudinal 
studies that recruit participants during the first stages of life (e.g. fetal and/or 




The current studies utilized state of the art MRI methods for investigating cortical 
structure in vivo within a clinical population. While these methods offer many 
improvements over more traditional MRI methods, such as voxel based morphometry 
(VBM), they are still limited in several ways. The current high end resolution of 3T 
structural MRI scans is roughly 1mm3. It has been estimated that a 1mm3 volume in 
the cerebral cortex may contain upwards of 630,000 neuron cells and as many as four 
times that number of glial cells (Lent et al., 2012). Therefore, the current resolution 
offered by structural MRI does not allow for the investigation of fine aspects of 
neuro-biology such as cell patterning of individual cortical layers, and is thus limited 
to gross volumetric and geometric measures. Accordingly, one of the greatest 
limitations of structural neuroimaging studies remains a lack of understanding of the 
underlying biological mechanisms that contribute to imaging measures. For example, 
atypical CT measures in ASD may reflect gross numbers of neuronal cells within the 
cortical sheet (Courchesne et al., 2011), degrees of dendritic arborization (Tang et al., 
2014), or myelination processes (Sowell et al., 2004). Adding to the complexity, it is 
likely that each of these variables contribute to CT to different degrees and kind 
across individuals and developmental stages. Future research is thus required to 
investigate the specific cytoarchitectural abnormalities underlying ASD. 
 
7.5 Future Directions 
7.5.1 Large Scale Studies and Heterogeneity  
The use of MRI techniques to investigate ASD is a relatively novel and rapidly 
growing field. In this context, it is perhaps unsurprising that many of the limitations 
outlined above remain to be addressed. Ongoing efforts such as the Autism Brain 
Imaging Database Exchange (ABIDE), Infant Brain Imaging Study (IBIS), Autism 
Phenome Project (APP) and European Autism Interventions Study (EU-AIMS) are 
currently recruiting and scanning large numbers of individuals with autism across the 
full spectrum of impairment, and at the earliest stages of neurodevelopment. The 
collection of large scale, high quality, imaging data sets that accurately reflect the 
phenotypic heterogeneity observed in the broader ASD population will be invaluable, 




Moreover, current efforts to better understand the biological underpinnings of ASD 
and develop both efficacious treatments and biomarkers for the condition are hindered 
by the diversity of clinical phenotypes incorporated under ASD diagnostic criteria. 
Thus, the stratification of the ASD phenotype into biologically more homogeneous 
subtypes is of critical importance for advancing studies of ASD etiology, and efforts 
towards developing imaging tools for translational applications. Recent applications 
of normative models that seek to identify deviations in particular behavioral measures 
within individuals from a population distribution represent a critical advancement in 
this area of research (Marquand et al., 2016). These methods appear to be particularly 
well suited for parsing ASD through their ability to infer how certain atypical 
behaviors map onto biology and thus identify homogenous biological subtypes in 
ASD associated with degrees of variation in behavioral measures when compared to a 
healthy cohort.   
7.5.2 Development and Implementation of Multi-Modal Methods  
Increasingly, neuroimaging studies of ASD incorporate several different imaging 
features and modalities. Such multimodal imaging studies are extremely valuable 
because different imaging sequences (e.g. diffusion, functional, structural) can be 
used to capture unique aspects of neuropathology in ASD. However, standard practice 
for multimodal studies still involves investigating features in a parallel (i.e. unimodal) 
fashion. Thus, interpretation of the relationship between results in different modalities 
is conducted in a post-hoc manner. In order to determine the inter-relationships 
between different imaging measures, and to take full advantage of the unique 
strengths that each modality offers, so-called multimodal ‘fusion methods’ are 
required. For example, linked independent component analysis can be used to identify 
components comprised of shared variance across multiple imaging features, 
regardless of differences in spatial dimensions between them (Groves et al., 2012). 
Such methods have already shown the ability to identify multimodal components 
associated with particular behaviors associated with ADD (Francx et al., 2016), and 
thus may offer value in efforts to parse the heterogeneity of ASD.  
 
7.5.3 Linking Imaging with Biology  
Lastly, the development of surface based morphometry measures that represent 
distinct aspects of cortical architecture and etiology has provided unique insights into 
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the potential underlying biological mechanisms driving differences in these measures 
in individuals with ASD. However, there is a critical need for establishing concrete 
links between macroscopic imaging measures and microscopic biology within 
individuals. Recent advancements in the use of cellular models based on patient-
specific induced pluripotent stem cells (iPSCs) offer particular promise to address this 
relationship. Through a typical biopsy (e.g. skin, hair ect.), this technology allows for 
the delivery of in vitro neuron cells from particular patients (Takahashi and 
Yamanaka, 2006, Takahashi et al., 2007). Accordingly, many of the developmental 
events believed to be atypical in ASD can be recapitulated and observed in the culture 
dish (Marchetto and Gage, 2012) and then related to neuroimaging measures, all 
within the same individual in a safe, in vivo, minimally invasive fashion. 
 
7.5 Conclusion 
The studies that comprise this thesis highlight advances in the field of structural 
neuroimaging research in autism spectrum disorder (ASD) in areas of feature 
development, clinical translation, and efforts to understand the modulating role of 
biological sex on the prevalence of ASD. Here we first introduced a novel in vivo 
feature based on tissue contrast to measure atypical cortical microstructure that has 
previously been reported in histological studies. Second, we trained classification 
models for ASD in the research setting and then tested the ability of these models to 
make diagnostic predictions within a representative clinical ASD sample. Last, we 
established normative models of phenotypic diversity in brain structure associated 
with biological sex in a sample of typically developing (TD) males and females, 
which we subsequently applied to males and females with ASD to identify the 
association between sex based neurophenotypes and ASD probability. Taken together, 
the body of work presented within this thesis constitutes an important step forward 
toward establishing translational imaging tools for ASD that may one day be applied 
in the clinical setting. However, future studies will be required to address the large 
degree of phenotypic heterogeneity in ASD, develop methods that can take full 
advantage of multimodal imaging data, and identify the biological underpinnings of 


















 	  
	 182	
Appendix I: ICD-10 Criteria for "Childhood Autism" 
 
A. Abnormal or impaired development is evident before the age of 3 years in at least one 
of the following areas: 
 
1. receptive or expressive language as used in social communication; 
 
2. the development of selective social attachments or of reciprocal social interaction; 
 
3. functional or symbolic play. 
 
B. A total of at least six symptoms from (1), (2) and (3) must be present, with at least two 
from (1) and at least one from each of (2) and (3) 
 
1. Qualitative impairment in social interaction are manifest in at least two of the following 
areas: 
 
a. failure adequately to use eye-to-eye gaze, facial expression, body postures, and gestures to 
regulate social interaction; 
 
b. failure to develop (in a manner appropriate to mental age, and despite ample 
opportunities) peer relationships that involve a mutual sharing of interests, activities and 
emotions; 
 
c. lack of socio-emotional reciprocity as shown by an impaired or deviant response to other 
people’s emotions; or lack of modulation of behavior according to social context; or a weak 
integration of social, emotional, and communicative behaviors; 
 
d. lack of spontaneous seeking to share enjoyment, interests, or achievements with other 
people (e.g. a lack of showing, bringing, or pointing out to other people objects of interest to 
the individual). 
 
2. Qualitative abnormalities in communication as manifest in at least one of the following 
areas: 
 
a. delay in or total lack of, development of spoken language that is not accompanied by an 
attempt to compensate through the use of gestures or mime as an alternative mode of 
communication (often preceded by a lack of communicative babbling); 
 
b. relative failure to initiate or sustain conversational interchange (at whatever level of 
language skill is present), in which there is reciprocal responsiveness to the communications 
of the other person; 
 
c. stereotyped and repetitive use of language or idiosyncratic use of words or phrases; 
 
d. lack of varied spontaneous make-believe play or (when young) social imitative play 
 
3. Restricted, repetitive, and stereotyped patterns of behavior, interests, and activities are 
manifested in at least one of the following: 
 
a. An encompassing preoccupation with one or more stereotyped and restricted patterns of 
interest that are abnormal in content or focus; or one or more interests that are abnormal in 
their intensity and circumscribed nature though not in their content or focus; 
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b. Apparently compulsive adherence to specific, nonfunctional routines or rituals; 
 
c. Stereotyped and repetitive motor mannerisms that involve either hand or finger flapping or 
twisting or complex whole body movements; 
 
d. Preoccupations with part-objects of non-functional elements of play materials (such as 
their oder, the feel of their surface, or the noise or vibration they generate). 
 
C. The clinical picture is not attributable to the other varieties of pervasive 
developmental disorders; specific development disorder of receptive language (F80.2) 
with secondary socio-emotional problems, reactive attachment disorder (F94.1) or 
disinhibited attachment disorder (F94.2); mental retardation (F70-F72) with some 
associated emotional or behavioral disorders; schizophrenia (F20.-) of unusually early 
onset; and Rett’s Syndrome (F84.12). 
 
World Health Organization. (1992). International classification of diseases: Diagnostic 




Appendix II: Chapter 3 Supplementary Materials 
 
Chapter 3 Supplementary Methods 
 
Surface deformation procedure to place the grey-white matter boundary (i.e. white matter 
surface) 
Within this study we refer to the white matter surface (i.e. the surface that defines the 
transition from grey to white matter) as the grey-white matter boundary. The surface 
deformation procedure that places the white matter surface has previously been described by 
Dale et al. (1999) and is detailed bellow.  
 
First white matter voxels are labeled through a segmentation procedure. Contiguous white 
matter voxels are identified through a connected components algorithm resulting in a filled 
white matter labeled volume. This volume is then tessellated using two triangles to define 
each voxel composing the surface of the white matter volume. Deformation of this “jagged” 
white matter tessellation to the grey-white matter boundary is accomplished by a 
minimization of an energy functional. The first two terms of this energy functional act to 
smooth the surface and regularize the tessellation by introducing a spring like property to the 
surface. This spring property is decomposed into two terms given as, 
 








where N1(i) denotes the set of nearest neighbors of the ith vertex, V is the total number of 
vertices in the tessellation, n(i) is the unit normal vector to the surface at the ith vertex, 
[e0(i),e1(i)] is an orthonormal basis for the tangent plane at the ith retex, and xk regers to the 
(x,y,z) position of the kth vertex in the tessellation. The term Ji results in the redistribution of 
vertices to regions where they are needed, encouraging a uniform spacing of vertices without 
requiring prohibitive numbers of elements. The term Jn imposes a smoothness constraint on 
the surface deformation by penalizing nodes that distance themselves from the direction 
normal to surface from its neighboring nodes. The third term of the energy functional is based 




J; = 12V (T4-56 i − I(x-))0  
 
where T(i) is the mean white matter value of border voxels within a 5mm neighborhood of 
each vertex, within the segmented white matter volume. The value of I(x) is computed on a 
subvoxel basis using trilinear interpolation. The placement of the grey-white matter boundary 
is achieved by minimizing an energy function that is a weighted sum of the three terms 
presented above, 
 J = J7 + 	λ"J" + 	λ;J; 
 
where the coefficients λ"  and λ;  specify the strength of the smoothness and regularization 
constraints in relation to the intensity term. The gradient of this functional defines the 
movement of the surface tessellation such as the movement of the kth vertex is given by the 
negative of the directional derivative with respect to xk,, 
 − ∂J∂,B = λ; T k − I DB ∇I ,B + (λ" ( k ∙ ,/ + 89(k) ∙ ,/ + 86(k) ∙ ,/)/∈23(B)  
 
where the volume gradient ∇I ,B  is computed using a Gaussian blurred (σ = 1) version of 
the MRI volume.  
 
These automated methods for determining the grey-white matter boundary have been 
previously validated using scans of postmortem brains and have found FreeSurfer based 
measures of cortical thickness to be on average only 0.077mm different than manual 
measures performed on dissected tissue samples (Rosas et al. 2002). Within group systematic 
errors in the placement of the grey-white matter boundary using these methods would result 
in whole brain differences in cortical thickness that are not observed in our study. These 
findings thus indicate a high degree of accuracy for FreeSurfer in placing the white matter 







Supplementary Figure 1, Regions of decreased cortical thickness (CT) in autism 
spectrum disorder (ASD): A.) Between group differences in CT (uncorrected). B.) 
Individuals with ASD showed significantly decreased CT (RFT p<0.5) bilaterally in the 
parahippocampal, fusiform, and lingual gyri (highlighted in blue). See supplementary Table 1 




Supplementary Figure 2, Sex differences in grey-white matter signal intensity percent 
contrast (GWPC): Regardless of diagnosis males showed significantly greater GWPC (RFT 
p<0.5) compared to females across all grey matter sampling depths (a). These increases are 
highlighted in red and include predominantly fronto-parietal regions of the left hemisphere, 




Supplementary Figure 3, Regional differences in grey-white matter signal intensity 
percent contrast (GWPC) and grey matter intensities (GMI) in Autism Spectrum 
Disorder (ASD) (5mm FWHM smoothing kernel): Between group differences in (A) 
GWPC and (B) GMI intensities are shown when GMI was sampled at the grey-white matter 
boundary (i.e. white matter surface, projection fraction 10%) and a projection fraction of 30% 
into the cortical sheet. Individuals with ASD showed (A) significantly decreased GWPC 
(RFT p<0.5), indicating less definition between grey and white matter, in several regions 
highlighted in blue. In several of these regions (B) increases in GMI, highlighted in red were 
also observed. These results using a 5mm FWHM smoothing kernel were largely similar to 
those using a 10mm FWHM smoothing kernel (Figures 2 and 3, Table 2). For statistical 




Supplementary Table 1 
      Talairach   
Cluster Region Labels Hemisphere BA(tmax) No vertices x y z tmax pcluster 
 
1 parahippocampal gyrus, 
entorhinal cortex, 
fusiform gyrus, inferior 
temporal gyrus, lingual 
gyrus  
L 19 6191 -17 -48 -3 -4.46 4.89 x 10-6 
2 parahippocampal gyrus, 
fusiform gyrus, lingual 
gyrus 
R 36 3728 21 -42 -5 -3.35 1.73 x 10-4 
 
 
Supplementary Table 1, Clusters of Decreased Cortical Thickness in Autism Spectrum 
Disorder (ASD): Broadmann area (BA), left (L), right (R), Vertices indicates the number of 
vertices within the cluster, tmax represents the maximum t-statistic within the cluster located at 
















Supplementary Table 2, Clusters of Increased Grey-White Matter Signal Intensity Percent Contrast (GWPC) in Males: Broadmann area 
(BA), left (L), right (R), Vertices indicates the number of vertices within the cluster, tmax represents the maximum t-statistic within the cluster located 
at the x y z Talairach coordinates listed, pcluster is the cluster corrected p value.  
 
Supplementary Table 2 
 
          Talairach     
  Cluster Region Labels Hemisphere BA(tmax) No. vertices x y z tmax pcluster 
 
          1 precentral gyrus, frontal pole, pars opercularis, pars orbitalis, pars 
triangularis, rostral middle frontal gyrus, superior frontal gyrus 
L 44 11867 -49 10 6 5.35 4.38 x 10-6 
2 inferior parietal cortex, lateral occipital cortex, lingual gyrus, middle 
temporal gyrus, superior parietal cortex 
R 7 10199 39 -63 44 4.82 4.38 x 10-6 
3 middle temporal gyrus, inferior parietal cortex, lateral occipital cortex, 
postcentral gyrus, superior parietal cortex, supramarginal gyrus 
L 19 9991 -38 -78 25 4.49 4.38 x 10-6 
4 precuneus, inferior temporal gyrus, isthmus-cingulate cortex, lateral 
occipital cortex, lingual gyrus, pericalcarine cortex, superior parietal 
cortex 
L 7 9359 -6 -67 41 4.53 4.38 x 10-6 
5 postcentral gyrus, paracentral lobule, precentral gyrus, precuneus 
cortex, superior parietal cortex 
R 3 7611 36 -30 61 4.54 4.38 x 10-6 
6 parahippocampal gyrus, entorhinal cortex, fusiform gyrus, inferior 
temporal gyrus  
R 36 4001 34 -27 -15 3.42 1.16 x 10-3 
7 lateral orbital frontal cortex, medial orbital frontal cortex, rostral 
anterior cingulate cortex 
L 47 3563 -24 12 -16 5.71 1.14 x 10-3 
8 superior frontal gyrus R 6 3139 9 20 54 4.59 8.45 x 10-4 
9 lateral orbital frontal cortex, medial orbital frontal cortex R 47 2824 26 10 -14 5.29 1.06 x 10-2 
10 middle frontal gyrus, precentral gyrus L 9 2246 -37 32 25 4.31 1.81 x 10-3 





Supplementary Table 3 
      Talairach   
Measure Cluster Region Labels Hemisphere BA(tmax) Vertices x y z tmax pcluster 
Grey-White Matter 
Percent Contrast 
          
 1 fusiform gyrus, lingual gyrus, parahippocampal gyrus L 36 4027 -27 -39 -7 -3.66 1.33 x 10-5 
 2 parahippocampal gyrus, fusiform gyrus, lingual gyrus R 20 3447 33 -35 -18 -3.8 1.33 x 10-5 
 3 medial orbital frontal cortex, rostral anterior cingulate cortex, 
superior frontal gyrus 
L 10 2342 -10 39 -4 -3.68 1.45 x 10-5 
 4 insula, lateral orbital frontal cortex R 47 1671 26 18 -14 -4.02 1.76 x 10-4 
 5 posterior-cingulate cortex, isthmus-cingulate cortex, lingual 
gyrus, precuneus cortex 
L 30 1348 -19 -53 9 -3.72 3.52 x 10-4 
 6 insula, lateral orbital frontal cortex L 13 1267 -30 19 -2 -3.58 1.05 x 10-3 
 7 middle temporal gyrus, superior temporal gyrus R 21 1068 55 -13 -17 -3.74 1.01 x 10-2 
 8 insula L 13 1132 -38 -4 16 -2.97 4.43 x 10-2 
 9 supramarginal gyrus R 13 926 -45 -32 23 -4.13 1.24 x 10-2 
Grey Matter Signal 
Intensity 
          
 1 insula, lateral orbital frontal cortex, superior temporal gyrus R 38 4370 37 0 -12 4.01 7.28 x 10-6 
 2 banks superior temporal sulcus, inferior parietal cortex, middle 
and superior temporal gyrus 
L 21 4021 -50 -26 -2 3.64 7.89 x 10-6 
 3 banks superior temporal sulcus, inferior parietal cortex, inferior, 
middle, and superior temporal gyri 
R 41 3735 46 -36 7 2.95 1.05 x 10-5 
 4 fusiform gyrus, lingual gyrus, parahippocampal gyrus  R 30 3522 18 -38 -6 3.90 7.40 x 10-6 
 5 isthmus-cingulate cortex, precuneus cortex L 29 2694 -14 -49 7 3.38 3.39 x 10-5 
 6 fusiform gyrus, inferior temporal gyrus, lingual gyrus L 19 2410 -29 -56 -3 3.56 2.22 x 10-4 
 7 medial orbital frontal cortex, rostral anterior cingulate cortex, 
superior frontal gyrus 
L 32 2165 -11 42 2 3.40 2.96 x 10-4 
 8 postcentral gyrus, superior parietal cortex L 2 1868 -46 -23 43 3.56 1.66 x 10-2 
 9 insula, lateral orbital frontal cortex L 13 1654 -30 18 -2 3.79 4.09 x 10-3 
 10 paracentral lobule, superior parietal cortex,  L 5 1458 -16 -35 50 3.11 4.85 x 10-2 
 11 superior temporal gyrus L 21 1228 -45 -9 -13 2.78 2.73 x 10-2 
 12 inferior temporal gyrus L 20 1085 -48 -10 -23 3.47 3.34 x 10-2 
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Supplementary Table 3, Significant Reductions in Grey-White Matter Signal Intensity Percent Contrast (GWPC) and Increases in Grey 
Matter Intensity (GMI) in ASD (FWHM 5mm): Broadmann area (BA), left (L), right (R), Vertices indicates the number of vertices within the 
cluster, tmax represents the maximum t-statistic within the cluster located at the x y z Talairach coordinates listed, pcluster is the cluster corrected p 
values
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Appendix IV: Chapter 6 Supplementary Materials 
 
 
Supplementary Figure 6, Morphological Differences Between Typically Developing (TD) Females and Males 
as Identified Using a General Linear Model: Sex differences between TD males and females for (A) cortical 
thickness, (B) surface area, (C) the local gyrification index, and (D) sulcal depth. Uncorrected t-maps are shown in 
the left panel, random field theory cluster corrected (p<0.5) maps are shown in the right panel.   
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Supplementary Figure 3. Probability for ASD as a Function of Normative Sex-Related Phenotypic Variability in Brain Morphology: 
Probability estimates for ASD across eight discrete bins along the axis of predictive class probabilities for biological sex are plotted for (A) cortical 
thickness, (B) surface area, (C) the local gyrification index, and (D) sulcal depth for biological females and males (left and right panel respectively). 
For each model (excluding local gyrification index measures in biological males) probability for ASD was seen to increase along with increasingly 
male-typical class predictions. This relationship was particularly apparent in females due to the statistically significant shift in females with ASD 






















































































Supplementary Figure 2, Group x Sex Interaction Effects Identified Using a General Linear Model: Uncorrected t 
maps of group x sex interaction effects are shown in the left panel for (A) cortical thickness, (B) surface area, (C) the local 
gyrification index, and (D) sulcal depth. Significant clusters after random field theory (RFT) correction (p<0.05) are 
shown in the middle panel. Plots of the mean values from cortical thickness cluster C1, surface area cluster C2, and local 
gyrification index cluster C3 are shown in the right panel.   
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Supplementary Table 1 
 
        Talairach     
Measure Cluster Region Labels Hemisphere Vertices x y z tmax pcluster 
Cortical Thickness 
  
       
 1 superior temporal sulcus, middle frontal 
gyrus, cuneus, fusiform gyrus, inferior 
parietal cortex, inferior temporal gyrus, 
lateral occipital cortex, lingual gyrus, 
middle temporal gyrus, paracentral 
lobule, postcentral gyrus, precentral 
gyrus, precuneus cortex, rostral middle 
frontal gyrus, superior frontal gyrus, 
superior parietal cortex, superior 
temporal gyrus, supramarginal gyrus 
R 130855 62 -11 1 3.95 3.32 x 10-6 
 2 caudal middle frontal gyrus, inferior 
parietal cortex, lateral orbital frontal 
cortex, paracentral lobule, pars orbitalis, 
postcentral gyrus, precentral gyrus, 
precuneus cortex, rostral middle frontal 
gyrus, superior frontal gyrus, superior 
parietal cortex, supramarginal gyrus    
L 29647 -36 -69 41 3.82 3.32 x 10-6 
 3 cuneus cortex, inferior parietal cortex, 
lateral occipital cortex, pericalcarine 
cortex, superior parietal cortex 
L 7447 -36 -76 14 3.76 1.12 x 10-4 
 4 inferior temporal gyrus, middle temporal 
gyrus, superior temporal gyrus 





       
 
1 caudal middle frontal gyrus, paracentral 
lobule, superior frontal gyrus     
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local Gyrification Index 
 
1 caudal middle frontal gyrus, postcentral 
gyrus, precentral gyrus, rostral middle 
frontal gyrus, supramarginal gyrus        
L 10280 -41 20 36 4.35 1.55 x 10-5 
 
2 caudal anterior-cingulate cortex, lateral 
orbital frontal cortex, medial orbital 
frontal cortex, rostral anterior cingulate 
cortex, superior frontal gyrus        
R 6450 10 38 23 3.56 1.55 x 10-5 
 
3 lateral orbital frontal cortex, rostral 
middle frontal gyrus   
L 1144 -37 43 -2 3.18 5.79 x 10-5 
 
4 cuneus cortex, lateral occipital cortex, 
pericalcarine cortex     
L 1599 -4 -73 18 3.28 2.87 x 10-4 
 
5 rostral middle frontal gyrus R 1377 37 41 19 3.44 2.24 x 10-3 
 
6 caudal anterior-cingulate cortex, rostral 
anterior cingulate cortex, superior frontal 
gyrus     
L 1941 -8 37 9 2.58 5.22 x 10-3 
 
7 medial orbital frontal cortex, rostral 
anterior cingulate cortex 
L 1335 -6 11 -9 3.36 7.11 x 10-3 
 
8 caudal middle frontal gyrus, postcentral 
gyrus, precentral gyrus, rostral middle 
frontal gyrus, supramarginal gyrus      
L 929 -42 -28 21 -3.33 2.84 x 10-4 
	
Supplementary Table 1, Clusters of Significant Differences in Cortical Morphometry Utilizing a General Linear Model (TD Females – TD 
Males): left (L), right (R), Vertices indicates the number of vertices within the cluster, tmax represents the maximum t-statistic within the cluster 
located at the x y z Talairach coordinates listed, pcluster is the cluster corrected p value. 
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Supplementary Table 2  
Mean 
  S = 1 S = 0 
  N = 1 N = 0 N = 1 N = 0 
D = 1 0.024 0.019 0.026 0.001 
D = 0 0.976 0.981 0.974 0.999 
      
      
CT 
 S = 1 S = 0 
  N = 1 N = 0 N = 1 N = 0 
D = 1 0.025 0.017 0.013 0.002 
D = 0 0.975 0.983 0.987 0.998 
      
      
SA 
  S = 1 S = 0 
  N = 1 N = 0 N = 1 N = 0 
D = 1 0.025 0.019 0.019 0.002 
D = 0 0.975 0.981 0.981 0.998 
      
      
lGI 
  S = 1 S = 0 
  N = 1 N = 0 N = 1 N = 0 
D = 1 0.019 0.04 0.016 0.002 
D = 0 0.981 0.96 0.984 0.998 
      
      
SULC 
 S = 1 S = 0 
  N = 1 N = 0 N = 1 N = 0 
D = 1 0.024 0.02 0.012 0.003 
D = 0 0.976 0.98 0.988 0.998 
	
Supplementary Table 2, Population Prevalence of ASD for Biological Males and 
Females with Male- or Female-typic Neuroanatomical Brain Phenotypes: Population 
estimates are given based on the predictive class probabilities for each morphological feature 
(i.e. cortical thickness [CT], surface area [SA], the local gyrification index [lGI], and sulcal 
depth [SULC]) as well as the average of these class probabilities across features (mean). D: 
diagnosis of ASD (0=no, 1=yes), S: biological sex (0=female, 1=male), N: neuroanatomical 
brain phenotype (0=female-typical, 1=male-typical). 
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Supplementary Table 3, Clusters of Significant Group-by-Biological Sex Interaction Effects: left (L), right (R), Vertices indicates the number of 
vertices within the cluster, tmax represents the maximum t-statistic within the cluster located at the x y z Talairach coordinates listed, pcluster is the 
cluster corrected p value. 
 
Supplementary Table 3 
 
        Talairach     
Measure Cluster Region Labels Hemisphere Vertices x y z tmax pcluster 
Cortical Thickness 
 1 fusiform gyrus, inferior temporal gyrus, lingual gyrus, 
middle temporal gyrus, parahippocampal gyrus   
L 9368 -29 -71 -5 -3.29 3.55 x 10-6 
 2 fusiform gyrus, inferior temporal gyrus, lateral occipital 
cortex, lingual gyrus, parahippocampal gyrus    
R 6835 26 -27 -18 -3.42 5.49 x 10-4 
 3 banks superior temporal sulcus, middle temporal gyrus, 
superior temporal gyrus 
R 4412 60 -33 -6 -3.51 2.13 x 10-2 
Surface Area 
 
1 medial orbital frontal cortex, rostral anterior cingulate 
cortex, superior frontal gyrus 
R 2985 14 37 11 -2.88 2.48 x 10-2 
local Gyrification Index 
 
1 frontal pole, medial orbital frontal cortex, rostral anterior 
cingulate cortex, superior frontal gyrus            
R 5715 15 39 8 3.05 1.02 x 10-5 
 
2 caudal middle frontal gyrus, precentral gyrus, superior 
frontal gyrus  
R 2415 31 9 48 3.89 4.42 x 10-5 
 
3 rostral middle frontal gyrus L 918 -37 49 -2 3.5 1.49 x 10-3 
 
4 isthmus-cingulate cortex, paracentral lobule, posterior-
cingulate cortex 
R 1922 7 -27 52 2.48 3.14 x 10-3 
 
5 superior frontal gyrus L 584 -19 48 24 3.29 3.92 x 10-2 
 
6 frontal pole, medial orbital frontal cortex, rostral anterior 
cingulate cortex, superior frontal gyrus    
L 1791 -47 29 -2 -3.01 9.73 x 10-4 
 
7 caudal middle frontal gyrus, precentral gyrus, superior 
frontal gyrus     
R 1224 45 -70 8 -2.73 9.91 x 10-3 
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